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Chapter 1 General introduction and outline of the thesis
SPEECH AND DYSARTHRIA
Speech is unique for humans and, despite 
the rise of social media, daily commu-
nication is highly dependent on spoken 
language. Speech is important for any kind 
of communication: from a casual chat to 
business-like conversations, and it is part 
of every social role one plays, e.g. being a 
friend, a partner or a colleague. Therefore, 
difficulties with speech can directly limit 
daily activities and social participation, 
which has a negative impact on quality of 
life.1-5 An illustration of the impact of a 
speech disorder is given in Box 1.1.
When a neurological disease affects speech, 
this is called dysarthria. The word ‘dysar-
thria’ is derived from Latin, and means 
‘problematic’ (dys) – ‘articulation’ (arthron). 
Duffy defined dysarthria as “a collective 
name for a group of neurologic speech dis-
orders resulting from abnormalities in the 
strength, speed, range, steadiness, tone, or 
accuracy of movements required for con-
trol of the respiratory, phonatory, resona-
tory, articulatory, and prosodic aspects of 
speech production”.6
Dysarthria can be caused by (sub-)acute 
central neurological, central neurodegener-
ative or peripheral neuromuscular diseases. 
The evolution of dysarthria depends on its 
etiology. (Sub-)acute central neurological 
diseases like stroke are generally associ-
ated with some level of recovery, whereas 
neurodegenerative and neuromuscular 
diseases are associated with more or less 
progressive dysarthria. Some well-known 
progressive dysarthrias are associated with, 
for instance, Parkinson’s disease and amyo-
trophic lateral sclerosis.7,8 Dysarthria may 
also result from neuromuscular diseases 
(NMD), which are relatively rare progres-
sive diseases of the peripheral nervous 
system. More than 600 NMD have been 
identified, each with a low incidence. Table 
1.1 provides an overview of neurological 
diseases in each category that can cause 
dysarthria. 
In 1969, Darley, Aronson and Brown9 were 
the first who listed 38 speech characteristics 
within the five aspects of speech produc-
tion (i.e., articulation, resonance, phona-
tion, respiration, and prosody), that can 
lead to 6 different types of dysarthria: the 
so-called DAB-classification – named after 
the authors. They showed that there was an 
association between the site of the lesion 
and the type of dysarthria. The types were 
named after their main speech characteris-
tic: ‘flaccid’, ‘spastic’, ‘ataxic’, ‘hypokinetic’, 
‘hyperkinetic’, and ‘mixed’. This classifica-
Box 1.1. Illustration of the impact of a speech disorder on daily life
A 69-year-old man, suffers from dysarthria due to spinocerebellar ataxia. The dysarthria was the 
first symptom of his cerebellar disorder. He noticed that his speech rate slowed down and that 
he tripped over words more often. He had retired since a couple of years, but he was always busy 
doing voluntary work as a guide in the surroundings of his hometown. Even when his dysarthria 
was still mild, he had to stop almost all his voluntary work, because he was often unintelligible 
for strangers, especially during environmental noise. Gradually, staying intelligible in a noisy en-
vironment became a problem also during social events like birthday parties. He withdrew himself 
in silence while being in a group of people. He did not only struggle in the presence of strangers 
and when being in groups. Also at home there were growing irritations. His wife felt that he did 
not try hard enough to speak well, but speaking intelligible was very hard for him. Especially at 
home he did not want to have to pretend he was better than he really was, something he already 
had to do amongst others.
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tion is still used in clinical practice. Later, 
Duffy added the ‘unilateral upper motor 
neuron’ (UUMN) dysarthria to this classi-
fication, because he argued that the UUMN 
dysarthria was a distinct type which could 
not be placed in the DAB-classification.6 In 
Table 1.1, the different types of dysarthria 
that are associated with the different neu-
rological diseases are summarized. 
In the first decades after the introduction 
of the DAB-classification, speech-language 
therapists in the Netherlands were accus-
tomed to use the lesion site to name the dys-
arthrias. ‘Flaccid’ was named ‘bulbar’, ‘spas-
tic’ was named ‘pseudobulbar’, ‘ataxic’ was 
named ‘cerebellar’ and both ‘hypokinetic’ 
and ‘hyperkinetic’ dysarthrias were named 
‘extrapyramidal’. However, this anatomical 
classification has important limitations. 
For example, all flaccid dysarthrias were 
named ‘bulbar’, but a flaccid dysarthria due 
to a neuromuscular disorder is not caused 
by a bulbar lesion. And the hypo- and hy-
perkinetic dysarthrias, both being extrapy-
ramidal disorders, are two totally different 
types of dysarthria. Therefore, about 15 
years ago, our department decided to use 
the original DAB-classification consistently 
Table 1.1. Neurological diseases, categorized by localization, causing different types of dysarthria.
Localization Disease Type of dysarthria
(Sub-)acute central neurological
Unilateral Stroke, brain trauma, brain tumor, meningitis, 
encephalitis
Unilateral upper 
motor neuron
Bilateral Stroke, brain trauma, brain tumor, meningitis, 
encephalitis
Spastic
Central neurodegenerative
Extrapyramidal Parkinson’s disease 
Huntington’s disease
Hypokinetic  
Hyperkinetic
Cerebellar Cerebellar ataxias (e.g., spinocerebellar ataxia 
or autosomal dominant cerebellar ataxia)
Ataxic 
Multiple localizations Progressive supranuclear palsy, multiple sys-
tem atrophy, multiple sclerosis, amyotrophic 
lateral sclerosis
Mixed (types depen-
dent on site of lesion) 
Peripheral neuromuscular
Peripheral motor 
neuron 
Spinal muscular atrophy Flaccid
Peripheral nerve Guillain-Barré, peripheral facial paralysis, 
hypoglossal paresis
Flaccid
Motor endplate/ neuro-
muscular junction
Myasthenia gravis, Lambert-Eaton myasthenic 
syndrome
Flaccid
Muscle Facioscapulohumeral muscular dystrophy, 
myotonic dystrophy, Duchenne muscular dys-
trophy, polymyositis, mitochondrial myopathy
Flaccid
12
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in our patient care, publications, and 
post-graduate dysarthria courses, in order 
to change the use of anatomical labels back 
to the DAB-classification.
Types of dysarthria
As mentioned earlier, the types of dysar-
thria are named after their main speech 
characteristic, with the exception of UUMN 
dysarthria that is actually named after the 
site of the lesion. An overview of the speech 
characteristics associated with the different 
types of dysarthria is depicted in Table 1.2. 
Information in this paragraph is based on 
worldwide accepted manuals by Darley, 
Aronson & Brown9 and Duffy,6 combined 
with the broad clinical experience of the 
speech therapists of our department.
In flaccid dysarthria, weakness is the main 
characteristic. Weakness can be present in 
all aspects of speech production, leading to 
hypotonic articulation with hypernasality 
and hypotonic vocal use. Flaccid dysarthria 
is a characteristic feature of NMD, but it 
can also be part of mixed dysarthrias. 
Spastic dysarthria results from bilateral 
damage to the upper motor neuron. Spas-
ticity may also influence all aspects of 
speech production, but most of all speech 
will be slow with a hypertonic vocal use. 
Because only damage in both hemispheres 
causes spastic dysarthria, this dysarthria 
type is less frequent, but it can result from 
bilateral strokes, traumatic brain injury or 
cerebral palsy. 
Ataxic dysarthria results from damage 
to the cerebellum, caused by for example 
degenerative diseases (cerebellar ataxias), 
demyelinating diseases (multiple sclerosis 
[MS]), stroke, and traumatic injury. The 
lack of coordination can be heard espe-
cially in articulation and prosody. Ataxic 
speech is often characterized as ‘speaking 
like a drunk’. 
Hypokinetic dysarthria is associated with 
lesions of the basal ganglia. The movement 
of the articulators and the vocal cords are 
small due to rigidity and slow due to brady-
kinesia, causing a soft voice with mumbling 
and monotonous speech. Especially pho-
nation, articulation, and prosody will be 
affected in hypokinetic dysarthria, which is 
a typical feature of Parkinson’s disease. 
Hyperkinetic dysarthria is also associated 
with damage to the basal ganglia but, in 
contrast to hypokinetic dysarthria, invol-
untary movements occur. There are two 
types of hyperkinetic dysarthria: chorea 
(with unexpected involuntary movements) 
and dystonia (with increasing muscle tone 
during movements). In the case of chorea, 
the involuntary movements, leading to 
excessive loudness variations and sudden 
disruptions of articulation, will disrupt the 
speech. This type of dysarthria is generally 
associated with e.g. Huntington’s disease, 
but can also be heard in people with Par-
kinson’s disease and severe response fluc-
tuations. In the case of dystonia (like in 
oromandibular dystonias), the increased 
muscle tone will lead to prolonged vowels, 
hypertonic vocal use, and almost normal 
articulation during periods in which mus-
cle tone is not increased. 
UUMN dysarthria results from unilat-
eral damage to the upper motor neuron 
(UUMN), such as in unilateral stroke. In 
the Netherlands, the term UUMN dysar-
thria is not often used. In the acute phase of 
stroke, dysarthria will mostly be flaccid. In 
the chronic phase, ataxic or spastic compo-
nents can be present.
Mixed dysarthrias are combinations of 
two or more different types of dysarthria. 
The underlying disease is characterized 
by damage to at least two parts of the ner-
vous system. Some well-known diseases 
that may cause mixed dysarthria include 
amyotrophic lateral sclerosis (ALS), which 
14
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is caused by degeneration of both central 
and peripheral motor nerves and, there-
fore, will result in a combination of flaccid 
and spastic dysarthria. Second, MS caused 
by a demyelination of the central nervous 
system (i.e., spinal cord, brainstem, cere-
bellum, and cerebral hemispheres), most 
often causes ataxic dysarthria, combined 
with flaccid or spastic dysarthria. Finally, in 
multiple system atrophy (MSA), an atypical 
parkinsonism, damage to the basal ganglia 
and other systems (like brainstem and 
cerebellum) are often involved, resulting 
in hypokinetic dysarthria combined with 
ataxic, spastic or flaccid characteristics.10 
There are two subtypes: MSA-P with main-
ly parkinsonian features and MSA-C with 
mainly ataxic features.
Dysphagia
The term ‘dysphagia’ is derived from Greek 
and means ‘problematic’ (dys) – ‘eating’ 
(phagein). Swallowing is the process trans-
porting (chewed) food and liquid from the 
mouth to the stomach. In Figure 1.1, the 
swallowing process is shown. 
In this thesis, I will only focus on dysphagia 
due to NMD, because in NMD, dysarthria 
often co-occurs with dysphagia. Both dis-
orders are caused by ‘oromotor problems’ 
within overlapping muscle groups.7,11 Dys-
phagia in NMD is, similar to dysarthria, 
characterized by muscle weakness, which 
can influence the oral and pharyngeal stag-
es of swallowing. Oral weakness can cause 
chewing problems and diminished bolus 
control or oral transport. Pharyngeal weak-
ness can reduce pharyngeal constriction, 
resulting in residue of especially solid food.
Prevalence of dysarthria and dysphagia
Because a wide range of neurological dis-
eases can cause dysarthria, it is probably 
one of the most prevalent neurological 
communication disorders, together with 
apraxia of speech and aphasia. For exam-
ple, after stroke, dysarthria is present in 
approximately 40% of the patients.12 Prev-
alence rates of other (sub-)acute central 
neurological diseases, like traumatic brain 
injury, are unknown. In neurodegenerative 
diseases, prevalence rates are higher, with 
70% in Parkinson’s disease8,13 and approx-
imately 44% in MS.8 In the end stage of 
ALS, all patients will suffer from dysarthria 
or even anarthria,7,14 and nearly all patients 
with Friedreich’s ataxia will finally suffer 
from dysarthria.15 
In neuromuscular diseases, prevalence rates 
of dysarthria are difficult to find, probably 
because NMD is a term that encompasses 
more than 600 different diseases, each with 
a low incidence (for an overview of NMD, 
see http://www.spierziekten.nl). In the lit-
erature, prevalence rates between 13% and 
43% have been reported only for dysarthria 
in myasthenia gravis.16,17 In summary, 
although the prevalence of dysarthria is 
Figure 1.1. Swallowing process.
A. Food is chewed and 
mixed with saliva.
B. The tongue moves the 
bolus towards the back of 
the mouth.
C. The bolus moves 
through the pharynx 
towards the esophagus 
by pharyngeal peristalsis.
D. The bolus moves into 
the esophagus towards 
the stomach.
15
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known in some well-known large disease 
groups, in many other diseases including 
NMD, prevalence rates are scarce. 
Regarding dysphagia in NMD, there are 
some prevalence rates known. Willig et al. 
reported an overall prevalence rate of 35% 
in a group of 7 types of NMD (Duchenne 
muscular dystrophy, limb-girdle muscular 
dystrophy, facioscapulohumeral muscular 
dystrophy, spinal muscular atrophy, myo-
tonic dystrophy, myasthenia gravis, and 
dermatomyositis/polymyositis).11 In select-
ed groups of patients with inclusion body 
myositis, a prevalence of 65% has been re-
ported.18 In myasthenia gravis, prevalence 
rates vary between 15% and 35%.16,17
Working at the Center of Expertise for 
Neuromuscular Diseases of the Radboud 
University Medical Centre, I felt that both 
dysarthria and dysphagia might occur in 
all kinds of NMD and co-occur more often 
than could be expected based on the liter-
ature. This discrepancy triggered to pro-
spectively register all patients with NMD 
referred to a speech-language therapist and 
to review the literature for evidence regard-
ing treatment options. 
Assessment of dysarthria
Despite the widespread recognition of the 
different types of dysarthria, the actual as-
sessment of dysarthria type is challenging 
for several reasons. First, the same type of 
dysarthria may sound differently across 
patients, due to inter-subject variability. 
Second, in a clinical setting, the type of 
dysarthria is always determined by (subjec-
tive) interpretation, which makes the judg-
ment dependent on the level of training of 
the assessor (inter-rater variability). For 
dysarthria type classification, one should 
not only hear the deviant speech charac-
teristics, but these have to be interpreted 
in order to acknowledge the underlying 
pathology, like weakness, coordination 
problems etc. Unfortunately, objective 
means to assess the type of dysarthria do 
not yet exist, but research in this field is on-
going.19,20 Lastly, patients will often try to 
compensate for their speech deficit, which 
makes it difficult to differentiate deviant 
speech characteristics from compensatory 
mechanisms.  
Looking at the International Classification 
of Functioning (ICF), speech is a bodily 
function, which can lead to problems at the 
levels of activity and participation (com-
munication and conversation).21 From a 
clinical perspective, assessment at the levels 
of activity and participation is most import-
ant, because of the impact of unintelligible 
speech on daily life. In the Netherlands, 
there are two intelligibility tests available 
at the level of activity: the ‘Nederlandsta-
lig Spraakverstaanbaarheidsonderzoek’ on 
word level (NSVO)22 and on sentence level 
(NSVO-Z).23 For assessment at the level of 
speech functions (e.g. changes in vocal qual-
ity, speaking rate etc.), there was no validat-
ed assessment available in the Netherlands 
at the start of this PhD project. Assessment 
at the level of speech functions is important 
for several reasons. First, the best suitable 
exercises or speech therapy approach is 
determined by the specific speech disorder. 
For example, when weakness is the main 
problem, other exercises are indicated than 
when spasticity is the dominant feature. 
Furthermore, for treatment purposes, it is 
equally important to assess the severity of 
dysarthria. For example, when dysarthria 
is severe, treatment may be focused more 
on using communication aids than when 
dysarthria is mild. Severity assessment is 
also indispensable for the evaluation of 
treatment effects. Lastly, because speech 
characteristics in dysarthria reflect the site 
of the neurological lesion, determining the 
type of dysarthria can also support the pro-
cess of disease diagnostics.
16
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AImS of THIS THESIS
Two of the three aims of this thesis are fo-
cused on dysarthria and dysphagia in adult 
NMD. The third aim is focused on the 
assessment of dysarthria in general. The 
specific aims of this thesis are:
 1. To examine prevalence rates of dysar-
thria and dysphagia in NMD;
 2. To summarize the evidence for treat-
ment of dysarthria and dysphagia in 
NMD;
 3. To develop and evaluate a dysarthria 
assessment at the level of speech func-
tion.
The following research questions related to 
the above aims were formulated: 
 1a. What are the prevalence rates and se-
verity scores of dysarthria and dyspha-
gia in adult patients with NMD and 
how often do dysarthria and dysphagia 
co-occur?
 1b. Is dysphagia present in patients with 
genetically proven myotonic dystro-
phy type 2?
 2. Is there evidence for the efficacy of 
treatments directed at dysarthria and 
dysphagia administered by speech-lan-
guage therapists in NMD patients?
 3a. Is it possible to develop a valid and re-
liable dysarthria assessment for adult 
patients including maximum perfor-
mance tests of speech production? 
 3b. What are the reference values for 
the maximum performance tasks of 
speech production in a large popula-
tion of healthy Dutch adults, and are 
these related to relevant person char-
acteristics?
 3c. Does video training improve the cor-
rect identification of dysarthria type 
and severity by speech-language ther-
apy students as well as by experienced 
speech-language therapists?
oUTLINE of THE THESIS
This thesis is divided into two sections. 
Part I focuses on Aims 1 and 2 (i.e., prev-
alence rates of dysarthria and dysphagia 
and evidence for treatment in NMD) while 
Part II concerns Aim 3 (i.e., the develop-
ment of a dysarthria assessment). 
Part I: prevalence rates of dysarthria and 
dysphagia, and evidence for treatment in 
NMD
In chapter 2, the prevalence rates of dys-
arthria and dysphagia in a large group of 
patients with a wide variation of NMD are 
presented (research question 1a). Chapter 
3 examines if dysphagia is present in myo-
tonic dystrophy type 2 (research question 
1b). In chapter 4, evidence is identified for 
treatment of dysarthria and dysphagia in 
NMD (research question 2).
Part II: development of the Radboud 
Dysarthria Assessment (RDA)
Chapter 5 summarizes the development 
and validation of the Radboud Dysarthria 
Assessment (RDA) (research question 3a). 
In chapter 6, reference values of a large 
population of healthy Dutch adults are 
presented in order to improve the interpre-
tation of the performance of the dysarthric 
speakers (research question 3b). Finally, 
chapter 7 explores whether video training 
using the RDA training videos is effective 
in labeling the type and severity of dysar-
thrias (research question 3c).
Finally, a summary and general discussion 
is provided in chapter 8, followed by a sum-
mary in Dutch in chapter 9.
17
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AbSTRACT
Purpose
Patients with a neuromuscular disease (NMD) can present with dysarthria and/or dysphagia. 
Literature regarding prevalence rates of dysarthria and dysphagia is scarce. The purpose of this study 
was to determine prevalence rates, severity and co-presence of dysarthria and dysphagia in adult 
patients with NMD.  
Methods
Two groups of adult patients with NMD were included: 102 consecutive outpatients (the ‘unselected 
cohort’) and 118 consecutive patients who were referred for multidisciplinary assessment (the ‘select-
ed cohort’). An experienced speech-language pathologist examined each patient in detail. 
Results
The pooled prevalence of dysarthria was 46% (95% CI 36.5 – 55.9) and 62% (95% CI 53.3 – 70.8) 
in the unselected and selected cohorts, respectively. The pooled prevalence of dysphagia was 36% 
(95% CI 27.1 – 45.7) and 58% (95% CI 49.4 – 67.2) in the unselected and selected cohorts, respectively. 
There was a modest but significant association between the presence of dysarthria and dysphagia 
(rs = 0.40; p < 0.01). Although the dysphagia was generally mild, dysarthria was moderate to severe in 
15% of the dysarthric patients. 
Conclusion
The prevalence rates of dysarthria and dysphagia among patients with various types of NMD are 
high. Physicians should therefore be aware of this prevalence and consider referring NMD patients 
to a speech-language pathologist.
Dysarthria and dysphagia 
are highly prevalent 
among various types of 
neuromuscular diseases
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INTRoDUCTIoN
‘Neuromuscular diseases’ (NMD) is the 
generic term encompassing a group of 
approximately 600 rare diseases that are 
characterized by slowly progressive muscle 
weakness. NMDs can manifest at birth or 
later in life. NMDs can cause a wide range 
of disabilities, including oral motor dis-
orders such as dysarthria and dysphagia. 
Dysarthria causes reduced speech intel-
ligibility and can result in limitations in 
social interactions.24 Dysphagia can also 
have a negative impact on daily functions 
and societal participation due to reduced 
food intake and/or restrictions in the con-
sistency of food that can be ingested.25 In 
addition, patients with severe dysphagia 
can experience life-threatening medical 
complications such as extreme weight loss 
or aspiration pneumonia.26,27 
In the Netherlands, approximately 5% of 
patients with an NMD are referred to a 
speech-language pathologist;28 however, 
the clinical prevalence rates of both dysar-
thria and dysphagia appear to be consid-
erably higher. Although some studies have 
investigated the prevalence of dysphagia 
and dysarthria among NMD patients, these 
studies focused only on specific diseases 
such as myotonic dystrophy, myasthenia 
gravis, amyotrophic lateral sclerosis (ALS) 
and inclusion body myositis,7,11,14,16-18,29,30 
all of which are well-documented for caus-
ing dysarthria and/or dysphagia. However, 
little information is available regarding the 
prevalence rates of dysarthria and dyspha-
gia in a wider range of NMD disorders. To 
address this question, we retrospectively 
investigated the prevalence, severity and 
co-presence of dysarthria and dysphagia in 
adult NMD patients.
mETHoDS
Patients
We retrospectively examined the clinical 
data obtained from two groups of adult pa-
tients with NMD who had been referred to 
our university hospital. Group 1 consisted 
of 102 consecutive outpatients who partici-
pated in a previous study to assess the pol-
icy for referring adult NMD patients in the 
Netherlands.28,31,32 The inclusion criteria 
for this group were as follows: (i) probable 
or definite diagnosis of an NMD based on 
the medical records; (ii) 18 years of age or 
older at the time of the original study; and 
(iii) sufficient command of the Dutch lan-
guage. Of 257 outpatients, 155 were exclud-
ed (80 did not meet the inclusion criteria, 
14 did not respond, 53 refused to participate 
and 8 did not participate for another rea-
son). The participants signed an informed 
consent form, and approval was obtained 
from the Medical Ethics Committee of the 
Radboud University Nijmegen Medical 
Center. Group 2 consisted of 133 patients 
who had been referred for a multidisci-
plinary assessment to our ‘neuromuscular 
referral center’ during a period of three and 
a half years. The patients were admitted if 
they had difficulty in multiple domains of 
daily functioning. Fifteen of the original 
133 patients in Group 2 were excluded from 
the analysis; 14 patients could not be defini-
tively diagnosed with an NMD, and speech 
and swallowing were not examined in one 
patient. The patients in Group 2 had not 
formally participated in any previous study. 
The clinical diagnoses were divided among 
the following four major disease categories: 
‘muscle diseases’, ‘disorders of the neuro-
muscular junction’, ‘neuropathies’, and ‘mo-
tor neuron diseases’. Based on the medical 
files, gender and age were recorded for all 
patients; information regarding the dura-
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tion of the complaints associated with the 
NMD was available only for Group 1. 
Dysarthria assessment
For both groups, a standardized history was 
obtained by an experienced speech-lan-
guage pathologist in order to identify any 
speech and swallowing complaints; this 
history was followed by an examination of 
oral motor function, speech and swallow-
ing. Dysarthria was diagnosed using the 
Nijmegen Dysarthria Assessment, which 
includes spontaneous speech, reading a 
standardised text, maximum repetition 
rate, maximum phonation duration and 
maximum phonation frequency range.33,34 
Based on this examination, the dysarthria 
was scored using the validated Dutch mod-
ified version of the dysarthria sub-scales of 
the Therapy Outcome Measures (TOM),35 
with a scale ranging from 5 to 0. We as-
signed the scores to the following three 
severity groups: absent (score 5), mild dys-
arthria (score 4 or 3), and moderate/severe 
dysarthria (score 2, 1 or 0). 
Dysphagia assessment
Swallowing was clinically assessed using 
both quantitative and qualitative measures 
(instrumental investigation of swallowing 
like videofluoroscopy or endoscopy is not 
part of the standard protocol for neuro-
muscular patients in our center). For the 
quantitative assessment, swallowing tests 
were performed and included the swal-
lowing speed and the dysphagia limit.36,37 
For the qualitative assessment, the patients 
were asked to drink water and eat a biscuit, 
and the rate of chewing, the frequency of 
swallowing, the presence or absence of 
compensatory behaviours (e.g. head move-
ments) and signs of residue, penetration 
(the passage of food and/or liquid into the 
larynx) or aspiration (inhalation of food 
and/or liquid through the vocal cords) were 
observed and recorded.38,39 The severity of 
the dysphagia was classified using the fol-
lowing scale: (1) no problems, (2) mild dys-
phagia, and (3) moderate/severe dysphagia. 
A patient who had no swallowing problems 
either in their history or during the clinical 
assessment scored a 1 (‘no problems’). A 
patient who achieved full oral intake with 
some adaptations (e.g. in food consistency 
and/or drinking during the meal) and who 
exhibited minor problems during the qual-
itative assessment or performed just below 
normal on the swallowing tests scored a 2 
(‘mild’). Patients scored a 3 (‘moderate/se-
vere dysphagia’) if they required consider-
able adaptations to achieve full oral intake, 
if a complete oral intake was not possible, if 
they exhibited many problems during the 
qualitative assessment, or if their perfor-
mance was clearly abnormal or they were 
unable to perform the swallowing tests. 
Statistical analysis
The prevalence rates of dysarthria and 
dysphagia were first calculated for each 
disease category. To obtain overall values, 
pooled prevalence rates were estimated per 
patient group by weighting each disease 
category according to sample size, as the 
patients were not distributed equally across 
the disease categories within the groups. 
The Chi-square test was used to analyze 
the between-group differences and the 
differences between the prevalence of dys-
arthria and dysphagia within each group. 
The Spearman correlation coefficient was 
calculated and used to determine the rela-
tionship between dysarthria and dysphagia 
as well as between the severity of impair-
ment and complaint duration within each 
group. All calculations were performed us-
ing SPSS 20.0 (IBM SPSS Statistics, Chica-
go, IL), and differences with p < 0.05 were 
considered to be statistically significant.
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RESULTS
Patients
Data were collected from 220 patients 
(Group 1 contained 102 patients, and Group 
2 contained 118 patients) and analyzed. The 
groups did not differ significantly with 
respect to gender or age, as seen in Table 
2.1. Because the category ‘muscle diseases’ 
encompassed a large, heterogeneous group 
of disorders, this category was sub-divided 
into ‘muscular dystrophies’, ‘metabolic my-
opathies’, ‘inflammatory myopathies’ and 
‘other myopathies’. 
Table 2.1. Demographics and clinical characteristics of the two patient groups in this study.
Category/diagnosis* Group 1 Group 2 Total 
Men / women 50% / 50% 47% / 53% -
Mean age, years (SD) 48 (13.3) 44 (13.8) -
Mean complaint duration, years (SD) 12 (11) - -
Muscle diseases 68 103 171
Muscle dystrophies (myotonic dystrophy type I 
and II (MD), oculopharyngeal muscular dystrophy 
(OPMD), facioscapulohumeral muscular dystrophy 
(FSHD), limb-girdle muscular dystrophy, Becker 
muscular dystrophy, Duchenne muscular dystrophy)
39 55 94
Metabolic myopathies (mitochondrial myopathy) 11 30 41
Inflammatory myopathies (polymyositis (PM), der-
matomyositis (DM), inclusion body myositis (IBM), 
ocular myositis)
8 6 14
Other myopathies (nemaline myopathy, Miyoshi 
myopathy)
10 12 22
Disorders of the neuromuscular junction
(myasthenia gravis and Lambert Eaton myasthenic 
syndrome)
7 0 7
Neuropathies
(chronic inflammatory demyelinating polyneurop-
athy (CIDP), Guillain-Barré syndrome, hereditary 
motor and sensory neuropathy (HMSN), chronic 
idiopathic axonal polyneuropathy (CIAP), multifocal 
motor neuropathy (MMN), polyneuropathy, neural-
gic amyotrophy)
19 9 28
Motor neuron diseases
(amyotrophic lateral sclerosis (ALS), spinal muscular 
atrophy (SMA))
8 6 14
Total 102 118 220
*Main categories are in bold.
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Prevalence and severity of dysarthria 
Overall, 123 of the 220 patients (56%) re-
ceived a score of 4, 3, 2, 1 or 0 on the dysar-
thria severity scale, yielding a pooled prev-
alence of 46% (95% CI 36.5 – 55.9) in Group 
1 and 62% (95% CI 53.3 – 70.8) in Group 2 
(p = 0.006), as seen in Table 2.2. In Group 
1, the highest prevalence rate was among 
patients with disorders of the neuromuscu-
lar junction (71%); in Group 2, the highest 
prevalence rate was in the muscle diseases 
category (68%), particularly within the 
muscular dystrophies (87%). The distribu-
tion of the severity of dysarthria is shown 
in Figure 2.1A. Moderate/severe dysarthria 
was present only in the categories ‘neu-
ropathies’, ‘disorders of the neuromuscular 
junction’ and ‘muscle diseases’; and the 
Figure 2.1. Relative distributions of the severity of dysarthria (A) and dysphagia (B) in Group 
1 and Group 2 for the indicated NMD categories. Abbreviations used: Muscle, muscle diseases; 
Neurom. jun., disorders of the neuromuscular junction; Neuropath., neuropathies; Motor neuron, 
motor neuron diseases.
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majority of the dysarthric patients had 
mild dysarthria. There was no significant 
correlation between the severity of dysar-
thria and complaint duration (rs = 0.107; 
p = 0.142). 
Prevalence and severity of dysphagia 
Overall, 103 of the 220 patients (47%) had 
mild to severe dysphagia, yielding a pooled 
prevalence of 36% (95% CI 27.1 – 45.7) in 
Group 1 and 58% (95% CI 49.4 – 67.2) in 
Group 2 (p <0.001), as seen in Table 2.2. The 
highest prevalence of dysphagia was in the 
category ‘muscle diseases’ for both Group 
1 (40%) and Group 2 (64%). Within the 
muscle diseases category, the patients with 
metabolic myopathies (in Group 1; 55%) 
and the patients with muscular dystrophies 
(in Group 2; 76%) had the highest preva-
lence of dysphagia. The distribution of the 
severity of dysphagia is shown in Figure 
2.1B. Overall, the majority of patients who 
had dysphagia presented with mild dyspha-
gia; moderate/severe dysphagia was found 
only among patients in the muscle diseases 
category. There was no significant correla-
tion between the severity of dysphagia and 
complaint duration (rs = 0.105; p = 0.146). 
Relationship between dysarthria and 
dysphagia
The analysis revealed modest but signifi-
cant correlations between the occurrence 
of dysarthria and dysphagia in both Group 
1 (rs = 0.40, p <0.001) and Group 2 (rs = 0.41, 
p <0.001). In total, 84 of the 220 patients in 
this study (38%) were diagnosed with both 
dysarthria and dysphagia; the majority of 
these 84 patients (76 patients, or 90%) had 
a muscle disease, two patients had a motor 
neuron disease, four patients had a neurop-
athy and two patients had a disorder of the 
neuromuscular junction. In both groups, 
the overall prevalence of dysarthria was 
higher than the overall prevalence of dys-
phagia; this difference reached significance 
in Group 2 (p = 0.013), but not in Group 1 
(p = 0.078). 
DISCUSSIoN AND CoNCLUSIoN
The goal of this study was to investigate the 
frequency, severity and co-presence of dys-
arthria and dysphagia in various types of 
NMD in two relatively large patient cohorts 
who had previously visited our university 
hospital. The principal result is the high 
overall pooled prevalence rates of dysarthria 
(56%) and dysphagia (47%) in both groups. 
The prevalence of each disorder was consis-
tently higher in the group of patients who 
had been referred for multidisciplinary as-
sessment and advice (Group 2) than in the 
‘unselected’ patient cohort (Group 1). This 
difference is likely due to selection bias, as 
the patients who had been referred for mul-
tidisciplinary assessment were referred by 
a specialist on the basis of their complaints 
and disabilities. 
Interestingly, dysarthria and dysphagia 
were found among patients with NMD 
that are not typically associated with these 
disorders. For example, dysphagia has been 
mentioned in the context of inflammatory 
myopathies,11,18 whereas dysarthria has 
not been described explicitly. However, we 
identified dysarthria in half of our patients. 
Another interesting finding was the prev-
alence of both dysarthria and dysphagia 
in half of the patients with metabolic and 
other myopathies; this finding has also not 
been described explicitly in any previous 
report. In the category ‘neuropathies’, only 
Guillain-Barré syndrome is known to cause 
dysphagia and dysarthria. However, we also 
found speech and swallowing impairments 
in two out of six patients with hereditary 
motor and sensory neuropathy, one out of 
two patients with chronic inflammatory de-
myelinating polyneuropathy, and one out 
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of four patients with multifocal motor neu-
ropathy. On the other hand, it is well-doc-
umented that in ALS, both dysarthria and 
dysphagia can occur, and their prevalence 
increases during disease progression in 
nearly all patients;7,40 in our patient cohort, 
all nine ALS patients were affected, albeit 
only mildly.
Overall, the prevalence rates of dysarthria 
and dysphagia in our study are higher than 
the rates reported by previous studies. 
This discrepancy might be due in part to 
the assessment methods. Most reported 
prevalence rates are based on interviews 
and/or questionnaires,11,16,17,40 whereas 
our patients were assessed by an experi-
enced speech-language pathologist who 
examined both speech and swallowing 
functions. Because a clinical examination 
is generally more sensitive than a self-re-
porting assessment by the patient,41 an un-
derreporting of complaints and disabilities 
can occur among patients with NMD, as 
many patients become accustomed to the 
relatively mild impairments in speech and 
swallowing during the progression of their 
disease.
Although the severity of symptoms gener-
ally increases with disease progression, we 
found no significant correlation between 
the duration of complaints and the sever-
ity of either dysarthria or dysphagia. This 
finding is likely due to the heterogeneity of 
the diagnoses included within our patient 
groups and the extremely slow progression 
of some of the individual diseases. In addi-
tion, recall bias may have played a role in 
affecting the patients’ ability to accurately 
indicate the duration of their complaints.
The results of this study suggest that dys-
arthria is generally more prevalent than 
dysphagia among NMD patients. This find-
ing is consistent with several other chronic 
neurological disorders such as Parkinson’s 
disease and multiple sclerosis.42,43 In our 
study, the observed correlation between 
dysarthria and dysphagia in each patient 
group was modest and can be explained 
physiologically. Although speech is gen-
erally considered to be a voluntary motor 
process, the pharyngeal and oesophageal 
stages of swallowing are characterized as a 
predominantly reflexive process. In addi-
tion, the lingual forces and jaw movements 
are quite different during the oral stages 
of swallowing than during vocalization; 
vocalization uses more rapid and differ-
entiated movements than oral preparation 
and the transport of food.44 Thus, because 
dysarthria need not necessarily present 
together with dysphagia, both disorders 
should be assessed. 
The following limitations of our study 
should be mentioned. First, this was a 
retrospective cohort study in which the 
data were not originally collected for the 
purpose of defining the prevalence rates of 
dysarthria and dysphagia. Nevertheless, all 
of the patients were seen by a speech-lan-
guage pathologist who provided us with 
complete data sets for all 220 patients. Sec-
ond, the neurology and rehabilitation de-
partments that were involved in this study 
specialize in the assessment and treatment 
of patients with NMD, and this may have 
caused an overrepresentation of some dis-
ease categories. Third, any comparison with 
previous studies that reported prevalence 
rates of dysarthria and dysphagia is ham-
pered by the various assessment techniques 
that have been used. Therefore, future re-
search should attempt to standardize the 
assessment methods so that symptomatic 
patients can be properly identified, char-
acterized and referred. To this end, a short 
questionnaire was developed and evaluated 
for patients with NMD to facilitate their 
referral to a speech-language pathologist 
when warranted.45 
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Taken together, our results support the 
conclusion that physicians should be aware 
that speech and/or swallowing problems 
are highly prevalent among many NMD 
patient types, irrespective of the patient’s 
disease stage. Even though some patients 
with a progressive disease may not bene-
fit from treatment directed at improving 
their speech and/or swallowing efficacy, 
these patients may still benefit from learn-
ing individually tailored functional com-
pensations delivered by an experienced 
speech-language pathologist.6,28,46-48  
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AbSTRACT
The phenotype of Myotonic Dystrophy type 2 (DM2) shows similarities as well as differences to 
that of Myotonic Dystrophy type 1 (DM1). Dysphagia, a predominant feature in DM1, has not yet 
been examined in DM2. In a recent nationwide questionnaire survey of gastrointestinal symptoms 
in DM2, 12 out of 29 DM2 patients reported to have difficulty in swallowing for solid food. The aim 
of the study was to investigate the presence of dysphagia in patients with genetically proven DM2 
who reported difficulty in swallowing for solid food at the questionnaire survey. Swallowing function 
and fiberoptic endoscopic evaluation of swallowing (FEES) were examined by a speech therapist and 
otorhinolaryngologist, respectively. In DM2 patients who reported difficulty in swallowing the pres-
ence of dysphagia could be confirmed (clinically in 100%, by FEES in 88%). A correlation exists be-
tween Dysphagia Outcome and Severity Score (DOSS) and age (p = 0.05). None of the patients was 
underweight, and none of the patients had suffered aspiration pneumonia in the past. Dysphagia is 
present among DM2 patients and is more severe in older patients. However, dysphagia is generally 
mild, and does not lead to weight loss, or aspiration pneumonia.
Dysphagia is present 
but mild in Myotonic 
Dystrophy type 2
32
Chapter 3 Dysphagia is present but mild in Myotonic Dystrophy type 2
INTRoDUCTIoN
Myotonic Dystrophy type 2 (DM2, MIM 
602668) is a dominantly inherited multisys-
tem disorder characterized by progressive 
proximal muscle weakness, myotonia, cata-
racts, cardiac arrhythmia, and muscle pain. 
DM2, earlier known as Proximal Myotonic 
Myopathy (PROMM) is caused by a CCTG 
expansion in intron 1 of the ZNF9 gene on 
chromosome 3q21.49 The clinical picture of 
DM2 shows similarities as well as differ-
ences to that of Myotonic Dystrophy type 1 
(DM1). Shared core features are autosomal 
dominant inheritance, muscle weakness, 
myotonia, cataracts, and multi-organ in-
volvement with cardiac conduction defects, 
insulin resistance, and gonadal atrophy. 
Notably absent is a congenital form of 
DM2, and evidence of anticipation is less 
striking than in DM1, while muscle pain is 
more prominent in DM2.50
Dysphagia, a predominant and potentially 
life-threatening feature in DM1, has not 
yet been examined in DM2. Dysphagia has 
been described in a few scattered PROMM 
and DM2 case reports.51-53 We recently 
performed a prospective nationwide study 
to explore the presence and characteristics 
of gastrointestinal dysfunction in DM2 
patients.54 In that validated questionnaire 
survey, 12 out of 29 patients reported to 
have swallowing difficulties for solid food.
In this study, we set out to assess oropha-
ryngeal swallowing in patients with genet-
ically proven DM2 who reported difficulty 
in swallowing at the questionnaire survey 
in order to objectify this symptom. 
PATIENTS AND mETHoDS
Patients
In a recently performed nationwide sur-
vey genetically proven DM2 patients filled 
out the Dutch Gastrointestinal Symptoms 
Questionnaire (GSQ).54 This standard-
ized questionnaire covers symptoms from 
all parts of the gastrointestinal tract and 
contains questions about the severity of 
gastrointestinal symptoms during the last 
4 weeks.55 All DM2 patients who reported 
swallowing difficulties at the GSQ were 
recruited for this study. Exclusion criterion 
for participating was pregnancy because of 
its increased risk of pulmonary aspiration.
Patients were approached for additional in-
formation about their medical history and 
the body mass index (BMI) was calculated 
for all patients. The medical ethics commit-
tee approved the protocol and all patients 
gave written consent.
mETHoDS
All DM2 patients were clinically investi-
gated by an experienced speech therapist 
in neuromuscular disorders. Eight DM2 
patients gave additional informed consent 
to fiberoptic endoscopic evaluation of swal-
lowing (FEES).
Clinical investigation
An orofacial examination was performed 
as previously described in literature.56 In 
short, the clinical examination included:
 • Assessment of the strength of the jaws, 
lips, and tongue; weakness was scored 
as mild, moderate or severe.
 • Assessment of myotonia of the masse-
ter muscles and tongue; myotonia was 
scored as absent or present.
 • Observation while eating solid food (a 
bisquit).
 • A timed test of swallowing.37 
FEES
FEES is a valid and exceptionally safe tech-
nique for assessing pre-swallow anatomy 
and physiology in order to objectively eval-
uate patients with dysphagia.57 Diagnosis of 
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oropharyngeal dysphagia was determined 
by premature spillage, pharyngeal residue, 
laryngeal penetration, and aspiration. 
Dysphagia outcome and severity scale
All symptoms were scored with the 
Dysphagia Outcome and Severity Scale 
(DOSS), a reliable scale developed to rate 
the functional severity of dysphagia based 
on objective assessment.58 Scores range 
from 1 (severe oropharyngeal dysphagia 
necessitating non-oral nutrition) to 7 (nor-
mal in all situations). Oropharyngeal dys-
phagia was diagnosed when a patient was 
scored on level 1 to 6.
Statistical analysis
We used the Pearson partial correlation 
coefficient for calculating correlations, and 
considered p < 0.05 significant.
RESULTS
Clinical investigation
Twelve DM2 patients complaining of 
swallowing difficulties were recruited. Ten 
(from eight DM2 families) of the 12 patients 
took part in the study, two patients refused 
to participate. Mean age was 58.0 years 
(SD 11.6) and mean age of disease onset was 
26.7 years (SD 13.0). Mean BMI in DM2 pa-
tients was 25.1 (SD 4.0), none of the patients 
was underweight (BMI < 18.5). None of the 
patients had suffered aspiration pneumonia 
in the past. Seven patients showed signs of 
weakness of the jaws, lips, or tongue. None 
of the patients showed myotonia of the jaws 
or tongue.
Evaluation of eating showed slowness in all 
DM2 patients, and frequent swallowing in 
nine. Six patients demonstrated adapting 
head position upon swallowing. Coughing 
and wet phonation, indicating possible 
residue, penetration or aspiration, were 
observed in five patients. 
A Timed Test of swallowing showed the 
swallowing speed (average volume per 
swallow) to be too low, that is to say lower 
than normal, in four patients (patient 3, 4, 
8, and 9). Five other patients (patient 1, 5, 6, 
7, and 10) drank more slowly than the mean 
swallowing speed of age and sex matched 
healthy controls from literature, but still 
fell within normal values (Table 3.1).59
FEES
One patient exhibited normal swallowing 
and seven (88%) exhibited dysphagia; res-
idue of solid food in seven cases (88%), 
residue of milk in six cases (75%), and 
residue of saliva was observed in two cases 
(25%). Spillage of milk was revealed in two 
patients (25%), spillage of solid food was 
detected in one patient (13%). No penetra-
tion or aspiration of milk or solid food was 
detected (Table 3.1).
Dysphagia outcome and severity scale
DOSS was found to be abnormal in all 
DM2 patients, ranging in severity from 
‘mild-moderate’ (score 4) to ‘within func-
tional limits’ (score 6). DOSS score and 
age correlated in patients (rho = -0.66, 
p = 0.05), age at disease onset and swal-
lowing speed correlated significantly 
(rho = -0.68, p = 0.04). There was no cor-
relation between DOSS score and age at 
disease onset or disease duration.
DISCUSSIoN
In DM2 patients who reported difficulties in 
swallowing the presence of dysphagia could 
be confirmed (clinically 100%, by FEES 
88%). Dysphagia was more pronounced in 
older DM2 patients. None of the 10 patients 
had suffered aspiration pneumonia in the 
past, and no patient was underweighted or 
had significantly lost weight. These findings 
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Table 3.1. Patient characteristics and results of clinical investigation (orofacial examination, 
timed test of swallowing and evaluation of eating), FEES and DOSS.
Pt 1 Pt 2 Pt 3 Pt 4 Pt 5 Pt 6 Pt 7 Pt 8 Pt 9 Pt 10
Characteristics
Sex F F M M F F F F F F
Age, y 68 55 37 64 71 72 55 62 46 48
Age at disease onset, y 43 18 27 52 22 12 10 28 26 29
Orofacial examination
Weakness of jaws – – – – – ± – – – –
Weakness of lips – – – ± – ± – – ± –
Weakness of tongue ± ± – ± ± ± – ± – –
Timed test of swallowing
Swallowing speed in mL/s 8 14 16 11 11 12 11 4 8 9
Evaluation of eating
Slowness ++ + + + + + ++ ++ + ±
Frequent swallowing + + + + + + – + + +
Adapting head position + + + – – + – + – +
Coughing, wet phonation + – + – – + – – + +
FEES NA NA
Deviant anatomy – + – – – – – –
Residue of saliva – + – – – – – +
Spillage of milk + – – – + – – –
Spillage of biscuit + – – – – – – –
Residue of milk + + + + – + – +
Residue of biscuit + + + + + + – +
Penetration of milk – – – – – – – –
Penetration of biscuit – – – – – – – –
Aspiration of milk – – – – – – – –
Aspiration of biscuit – – – – – – – –
DOSS 4 4 5 4 4 4 5 4 6 4
Symbols used: (–) absent; (±) minimal signs; (+) clear signs; (++) severe; NA, not assessed. Abbrevi-
ations used: DOSS, Dysphagia Outcome and Severity Score (7 = normal, 6 = within functional limits, 
5 = mild, 4 = mild-moderate, 3 = moderate, 2 = moderate-severe, 1 = severe dysphagia).58
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are in correspondence with the results that 
dysphagia is generally mild. 
These results give little or no indication of 
the underlying pathology of swallowing 
difficulties. Weakness of the oropharyngeal 
muscles as well as subclinical myotonia 
may play a role. In DM1 both myopathic 
weakness and myotonia encountered in 
oropharyngeal muscles play an important 
part in the oral and the pharyngeal phases 
of swallowing dysfunction.60 In our group, 
minimal weakness of the orofacial muscles 
but no myotonia was observed clinically. 
Electrophysiological evaluation of swal-
lowing is necessary to show the possible 
existence and frequency of subclinical 
electrophysiological abnormalities in oro-
pharyngeal swallowing and may clarify the 
mechanisms of dysphagia. 
Recognition of dysphagia may have impli-
cations for the management of DM2 pa-
tients and for recommendations regarding 
the prognosis. Firstly, DM2 patients with 
dysphagia may benefit from conservative 
interventions such as speech therapy and 
modification of food consistency. Secondly, 
since the major complication of dysphagia 
is aspiration, dysphagia may be a problem 
that can lead to pneumonia. We found, 
however, no evidence of severe late stage 
dysphagia and pneumonia due to aspi-
ration in DM2 patients as is the case in 
adult-onset DM1 patients. 
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AbSTRACT
Purpose
A systematic review was conducted to summarize and evaluate the literature on the effectiveness of 
speech pathology interventions in adults with neuromuscular diseases. 
Method
Databases searched included the Cochrane Database of Systematic Reviews, the Cochrane Central 
Register of Controlled Trials, MEDLINE, CINAHL, EMBASE, PsychINFO and Pubmed. A total of 1,772 
articles were independently screened on title and abstract by two reviewers. 
Results
No randomized controlled trials or clinical controlled trials were found. Four other designs were in-
cluded. Only one study on oculopharyngeal muscle dystrophy (OPMD) appeared to have sufficient 
methodological quality. There is evidence indicating that correction of head position in patients with 
OPMD improves swallowing efficiency (level III evidence). 
Conclusion
Despite 1,772 studies, there is only evidence of level III regarding the effectiveness of speech pathol-
ogy interventions in patients with OPMD. Recommendations for future research are given.
Speech pathology 
interventions in patients 
with neuromuscular 
diseases: a systematic 
review
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INTRoDUCTIoN
Neuromuscular diseases (NMD) represent 
a subfield of neurology, including hetero-
geneous groups of patients with approxi-
mately 600 diseases of the muscle, neuro-
muscular transmission, peripheral nerve 
and nerve root or motor neuron. NMD can 
lead to dysarthria and dysphagia, which 
are both diagnosed and treated by speech 
pathologists (SP). 
Both dysarthria and dysphagia are not only 
relatively frequently prevalent, but also 
clinically relevant symptoms in NMD. The 
impact of dysarthria on quality of life is 
obvious, since communication is generally 
considered to be a critical determinant of 
quality of life. Dysphagia can lead to aspi-
ration pneumonia and therefore to serious 
health problems. Dysphagia and concomi-
tant pneumonia may even be life-threaten-
ing in otherwise weakened NMD patients.
In a sample of 102 NMD patients, we found 
that 45% of the patients had an indica-
tion for SP advice regarding dysarthria or 
dysphagia.28 However, this judgment was 
based on the expertise of the participating 
speech pathologists. The aim of this article 
is to assess whether there is evidence for 
the efficacy of treatments administered by 
speech pathologists in patients with NMD. 
mETHoDS
Search strategy
We searched the Cochrane Database of 
Systematic Reviews and the Cochrane 
Central Register of Controlled Trials (The 
Cochrane Library November 2007, Issue 
3), MEDLINE (1966 through November 
2007), CINAHL (1982 through November 
2007), EMBASE (1980 through November 
2007), PsycINFO (1806 through November 
2007) and Pubmed (1950 through Novem-
ber 2007). The search strategy was built on 
different types of NMD and different types 
of SP interventions. For all search strate-
gies, Medical Subject Headings (MeSH) or 
indexed terms were used as well as free text 
words. The full search strategy is shown 
in Table 4.1. Reference lists of reviews and 
Table 4.1. Free text words and MeSH terms 
used in search strategy to find evidence for the 
effectiveness of speech pathology in NMD.
Free text words
Speech pathology
speech pathology, speech therapy, speech 
and language therapy, speech disorder, 
communication disorder, articulation 
disorder, swallow disorder, deglutition 
disorder, dysphagia, dysarthria, dietary 
modification, swallow, intelligibility, alter-
native communication 
NMD
neuromuscular disease, neuromuscular 
disorder, muscle disease, muscle disorder, 
neuromuscular junction disease, neuro-
muscular junction disorder, motor neuron 
disease, motor neuron disorder, moto-
neuron disease, motoneuron disorder, 
neuropathy, polyneuropathy, peripheral 
nervous system disease, peripheral ner-
vous system disorder, neuralgia, neuritis, 
myopathy, dystrophy, myotony, myositis
MeSH terms
Speech pathology
dysarthria, speech disorder(s), speech 
therapy, speech pathology, communi-
cation disorders, communication aids, 
speech intelligibility, facilitated commu-
nication, communication aid, alternative 
and augmentative communication, com-
munication aids for the disabled, dyspha-
gia, deglutition disorders
NMD
neuromuscular disease(s), neuromuscular 
disorders
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selected articles were scanned for further 
potentially relevant articles. 
Selection criteria
Inclusion was restricted to peer-reviewed 
articles published in the English, German, 
French or Dutch language. Randomized 
Controlled Trials (RCTs), Clinical Con-
trolled Trials (CCTs) and other designs 
(ODs) were included. Single case studies 
were excluded. Participants included adults 
(>18 years) with various types of NMD 
(disorders of the muscle, neuromuscular 
transmission, peripheral nerve and nerve 
root or motor neuron).
SP interventions included information and 
advice or teaching compensatory strate-
gies. Information and advice incorporated 
(1) dietary modification; (2) augmentative 
and alternative communication; or (3) 
instruction of the patient and relatives. 
Compensatory strategies included teaching 
swallowing maneuvers and/or strategies 
to improve intelligibility. Brain computer 
communication devices such as thought 
translation devices were excluded, as this 
is not considered a regular SP interven-
tion. For the same reason, we also excluded 
medical interventions related to dysphagia, 
such as myotomy of the cricopharyngeal 
muscle.
The outcome measures included swal-
lowing at the level of body functions and 
intelligibility, communication and eating 
and drinking at the level of activities and 
participation, according to the definitions 
of International Classification of Function-
ing, Disability and Health (ICF).21
Procedure for inclusion
Two reviewers (S.K. and E.H.C.) inde-
pendently carried out a preliminary selec-
tion based on title and abstract of articles. 
Full texts of articles that seemed to fit the 
inclusion criteria were retrieved for further 
evaluation. A final selection was made in-
dependently by the two reviewers on the 
basis of full-texts. When different conclu-
sions were drawn, consensus was reached 
through discussion.
Methodological quality
The methodological quality of the studies 
was independently rated using criteria 
recommended by Van Tulder et al.61 The 
2 reviewers independently assessed the 
methodological quality. Disagreements 
were resolved by discussion between the 
reviewers.
For RCTs and CCTs, the quality of reporting 
was scored on 6 criteria (eligibility criteria, 
comparability of groups, explicit descrip-
tion of interventions, adverse effects, short-
term and long-term follow-up measure-
ments). Methodological quality was scored 
on 9 criteria (randomization, concealed 
allocation, avoidance of co-interventions, 
compliance, blinding of outcome assessor, 
relevance of outcome measures, acceptable 
drop-out rate, comparable timing of out-
come assessment and intention-to-treat 
analysis). Statistical quality was scored 
using 2 criteria (description of sample 
size and presentation of point estimates/
measures of variability). One criterion re-
garding  statistical quality (between-group 
statistical comparison) of the PEDro scale 
was added.62 
Methodological quality of articles was con-
sidered sufficient when 3 out of 6 reporting 
criteria, 6 out of 9 methodological crite-
ria, and 2 out of 3 statistical criteria were 
scored positively.61 For ODs, the criteria of 
comparability of groups, randomization, 
allocation, and between-group comparison 
were not applicable. For these designs, 2 
out of 5 reporting criteria, 4 out of 7 meth-
odological criteria, and 1 of 2 statistical 
criteria had to be scored positively to be of 
sufficient quality.63 
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Best evidence synthesis
A best-evidence synthesis was performed 
according to the classification of the Dutch 
Institute for Health Care Quality Improve-
ment.64 Three levels of evidence and con-
clusions were formulated. Level I evidence 
refers to at least 2 RCTs of sufficient quality. 
Conclusions are formulated as “it has been 
shown that…”. Level II evidence refers to 1 
good quality RCT or at least 2 independent 
controlled studies (RCTs or CCTs) of less 
methodological quality. Conclusions are 
formulated as “it is likely that…”. Level III 
evidence refers to an RCT or CCT of low 
methodological quality or at least 1 OD of 
sufficient methodological quality. Conclu-
sions are formulated as “there are indica-
tions that…”. When inconsistent findings 
were found in studies of similar design 
and methodological quality, conclusions 
are formulated as “there is insufficient ev-
idence that…”.
RESULTS
Selection
The search strategy identified 1,772 arti-
cles, duplicates excluded (Figure 4.1). After 
screening on title and abstract, 1,723 ar-
ticles were excluded because they did not 
meet predefined criteria for study design, 
type of participants, type of intervention, 
type of outcome measures, or English, 
French, German or Dutch language. In 42 
abstracts, there was discussion between 
the two reviewers, leading eventually to 
retrieval of 17 full-text articles that seemed 
to fit the inclusion criteria. In addition, 7 
review articles were retrieved and screened 
for additional articles. Another 15 articles 
from reference lists were retrieved full text. 
Following evaluation of all full-text articles, 
4 fulfilled all inclusion criteria.46,65-67 These 
studies were subjected to assessment of 
methodological quality.  
Methodological assessment
The 4 studies included were all ODs. The 
methodological quality of 3 studies was 
insufficient65-67 and the methodological 
quality of 1 study was found sufficient (Ta-
ble 4.2).46 De Swart et al. found a negative 
influence of ptosis on swallowing function 
in patients with oculopharyngeal muscle 
dystrophy (OPMD).46 The instruction 
‘head position slightly flexed’, i.e. head 
not adapted to the ptosis, significantly 
increased swallowing efficiency. This was 
objectively evaluated with videofluorosco-
py (with 20 ml. thin and thick liquid) and 
maximum swallowing volume. 
Best-evidence synthesis
The study of De Swart et al. is an OD of suf-
ficient methodological quality. Therefore, 
the evidence-based conclusion was that 
there are indications (level III evidence) 
that when head position is slightly flexed 
and not adapted to the ptosis, swallowing 
efficiency improves in OPMD-patients.
DISCUSSIoN
The main conclusion of this study is that 
the published evidence for effectiveness of 
SP in adults with NMD is very limited, as 
our search strategy did not identify RCTs 
or CCTs on this topic. There was only 1 OD 
(uncontrolled pre-post study) which was of 
sufficient methodological quality. 
Regarding dysphagia, the only available 
evidence (level III) found was based on 
an uncontrolled study.46 As we know from 
normal swallowing, extension of the neck 
leads to ineffective swallowing.68-70 There-
fore, basic instructions about the influence 
of posture of head and neck on swallowing 
seem valuable in NMD in general – par-
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Figure 4.1. Selection strategy for the systematic review of the effectiveness of speech pathology 
interventions in adults with neuromuscular diseases.
Pubmed
n=468
PsycINFO
n=71
Cinahl
n=177
Embase
n=981
Cochrane
n=73
Medline
n=1055
2825 articles
1053 duplicates excluded
1772 articles
Excluded (n=1723) with reasons: 
Type of study (not an 
intervention study)
Participants (not (only) patients 
with NMD)
Intervention (not a (current) ST 
intervention)
Type of outcome measures
Case study
Potentially relevant articles 
identified and screened on 
title and abstract for retrieval 
(n=42)
Reviews retrieved for further 
screening (n=7)
Retrieved from reference lists 
for more detailed information 
in full article (n=15)
Retrieved for more 
detailed information in full 
article (n=17)
Excluded (n=25) with reasons: 
Type of study (not an intervention 
study)
Case study
Participants (not (only) patients 
with NMD)
Excluded (n=12) with reasons: 
Type of study (not an intervention 
study)
Case study
Participants (not (only) patients 
with NMD)
Intervention (not a (current) ST 
intervention)
Selected for systematic review 
(n=4) 46,65-67
Excluded (n=14) with reasons: 
Type of study (not an 
intervention study)
Type of outcome measures
Participants (not (only) patients 
with NMD)
Intervention (not a (current) ST 
intervention)
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ticularly when the disease leads to changes 
in posture or weakness in the head-neck-
shoulder region or when the disease leads 
to weakness in muscles involved in speech 
or swallowing. 
Regarding dysarthria, despite the extensive 
number of articles, no evidence was found 
for the effectiveness of SP in NMD. We only 
found two articles in which one-time ma-
nipulations of speaking rate led to a slower 
speaking rate, but this technique did not 
have a positive effect on intelligibility.71,72  
All 4 studies included a homogeneous pa-
tient population with regard to the medical 
diagnosis. This may limit the generalization 
of the results to other groups of patients 
Table 4.2. Methodological quality of included studies showing 3 studies of insufficient method-
ological quality65-67 and one study of sufficient methodological quality.46
Criteria
Silbergleit et 
al. 1991 67
Oh et al. 
2007 65
Scott & Aus-
tin, 1994 66
De Swart et 
al. 2006 46
Reporting criteria
Eligibility criteria specified? Yes Yes Yes Yes
Intervention explicitly described? Yes Yes No Yes
Adverse effects described? No Yes Yes No
Short-term follow-up measure-
ment performed?
No No Unknown Yes
Long-term measurement per-
formed?
Yes Yes Yes No
Total descriptive criteria 
(at least 2/5)
3/5 4/5 3/5 3/5
Methodological criteria
Co-interventions avoided? Unknown No No Yes
The compliance acceptable? Yes Unknown Yes Yes
Outcome assessor not involved in 
the treatment?
Unknown Unknown No N.A.
Outcome measures relevant? Yes Unknown No Yes
Withdrawal/drop-out rate de-
scribed and acceptable?
Yes No Yes Yes
Timing of the outcome assess-
ment in all patients comparable?
No No Unknown Yes
Analysis included an intention to 
treat analysis?
No No Unknown No
Total internal validity 
(at least 4/7)
3/7 0/7 2/7 5/7
Statistical criteria
Was the sample size of the group 
described?
Yes Yes Yes Yes
Were point estimates and mea-
sures of variability presented for 
the primary outcome measures?
Yes No No Yes
Total statistical criteria 
(at least 1/2)
2/2 1/2 1/2 2/2
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with NMD. However, many NMD patients 
suffer from weakness in speech and swal-
lowing muscles. Therefore, we hypothesize 
that the SP interventions are applicable 
to different groups of NMD patients with 
comparable impairments and disabilities. 
The comparison between studies is also 
difficult because of the different outcome 
measures used. Finally, considering the 
small number of patients, there might be 
a matter of a type II error in the included 
studies. This problem can be solved by in-
cluding different groups of NMD patients 
with comparable impairments in one study.
Exclusion of studies
Our extensive search resulted in a large 
number of articles, most of which were ex-
cluded. Many studies did not evaluate the 
effectiveness of SP interventions but were 
descriptive studies, for instance on dysar-
thria or dysphagia in patients with NMD. 
The use of MeSH and free text words for 
different types of NMD resulted in many 
studies concerning other neurological 
conditions, such as Parkinson’s disease or 
stroke, which did not fulfill our inclusion 
criteria. 
RECommENDATIoNS foR 
fUTURE RESEARCH
Despite their potential limiting effect on 
quality of life and general health condition, 
there are hardly any studies focusing on 
the effects of dysarthria and dysphagia. We 
would like to propose that both dysarthria 
and dysphagia are of utmost importance 
in NMD patients and treatment strategies 
with respect to these impairments should 
be the topic of well-designed RCTs. Pref-
erably, these trials should be performed in 
homogenous patient samples, with compa-
rable levels of impairments. Conclusions of 
those trials might be used in other groups 
of NMD patients, with similar impairments 
at the bulbar level. However, these remarks 
should not discourage researchers to per-
form less ambitious research, for example 
observational cohort studies or controlled 
trials. Results of such trials also add to the 
required level of evidence of SP.
As for the interventions, it is important that 
all patients are given standardized inter-
ventions and that SP interventions are be-
ing properly described. It should be noted 
that the feasibility of interventions depends 
on the type of intervention. Swallowing 
techniques are internationally uniform and 
well described in the literature.73 However, 
there is less uniformity regarding tech-
niques to improve intelligibility, although 
interventions like decreasing speaking rate 
or producing a louder voice can be objec-
tively described in syllables per second or 
by measuring sound levels. Interventions 
regarding augmentative and alternative 
communication and instruction of the pa-
tient and relatives are tailor made to such 
an extent that they cannot be standardized. 
With regard to the type of outcome mea-
sures, we recommend using videofluoros-
copy or flexible endoscopic evaluation of 
swallowing to objectively evaluate swallow-
ing. Also, other quantitative measurements 
like the timed test37 and the dysphagia 
limit36 can be easily used as objective out-
come measures. Secondary outcome mea-
sures like body weight, percentage of oral 
intake and quality of life can be valuable. For 
evaluating speech at the level of activities, 
we recommend using a speech intelligibil-
ity test.22,74,75 At the level of participation, 
a scale of communicative participation is 
being developed.76 Acoustic measurements 
are the most objective measurements to 
evaluate speech at the level of body func-
tions. It should be kept in mind, however, 
that acoustic measurements have limited 
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predictive value with regard to communi-
cation effectiveness.77-79 Therefore, we rec-
ommend using the acoustic measurements 
only in combination with measurements 
on the levels of activities or participation.
A consensus meeting with experts on 
speech pathology, neurology and method-
ology is recommended to further discuss 
and agree on the outlines of future trials. 
Previous meetings along these lines and 
covering various neuromuscular topics, 
such as on myotonic dystrophy, have been 
very successful.80
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AbSTRACT
Objective
In the absence of an adequate dysarthria assessment in the Netherlands, we developed the Radboud 
Dysarthria Assessment (RDA). This article describes its development and clinimetric evaluation.
Patients and methods
Forty-three patients were assessed with the RDA. The recording forms were subjected to exploratory 
factor analysis and estimation of internal consistency. The self-evaluation questionnaire was tested 
for internal consistency and the severity scale for intra- and inter-rater reliability. Construct validity 
of the severity scale and questionnaire was determined by relating them to the Speech Handicap 
Index (SHI), Dutch sentence intelligibility assessment (NSVO-Z), and category fluency task. 
Results
Exploratory factor analysis extracted 4 factors (articulation, resonance, phonation, respiration/
prosody) yielding an explained variance of 70.3%. Each factor showed good internal consistency 
(Cronbach’s α = 0.89 – 0.91). The self-evaluation questionnaire showed excellent internal consistency 
(Cronbach’s α = 0.90). Intra-class correlation coefficients of the severity scale (0.85 – 0.86) showed 
good reliability. The severity scores and self-evaluation questionnaire correlated substantially to 
strongly with the SHI (rs = 0.40 and 0.80) and substantially with the NSVO-Z (rs = -0.65 and -0.52). 
Conclusions
The RDA is a valid and reliable tool, but further investigation is needed to demonstrate whether this 
instrument can successfully support speech-language therapists in correctly diagnosing the type of 
dysarthria.
The Radboud 
Dysarthria Assessment: 
development and 
clinimetric evaluation
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INTRoDUCTIoN 
Dysarthria is a common feature of both 
central and peripheral neurological diseas-
es, including stroke, brain trauma, neuro-
degenerative and neuromuscular disorders. 
Many speech-language therapists (SLTs), 
especially those working in acute care, 
nursing homes and rehabilitation centres, 
are regularly confronted with patients who 
are speaking effortful, who are poorly in-
telligible, or who sound abnormal. In these 
patients, it is important to identify whether 
the speech disorder can indeed be classified 
as dysarthria and, if so, what the type and 
severity of the dysarthria is. This involves 
insight in the neurological abnormalities 
regarding the 5 aspects of speech produc-
tion, i.e., articulation, resonance, phona-
tion, respiration and prosody9 through 
proper assessment. In addition, diagnos-
ing the type of dysarthria may support the 
medical diagnosis, because a speech disor-
der often reflects the localization of neu-
rological dysfunction.6,81 Lastly, a reliable 
judgment of the severity of dysarthria is 
needed for adequate monitoring and treat-
ment evaluation. 
Unlike aphasia tests, the clinical assess-
ment of dysarthria is typically based on 
subjective judgments that are often less 
reliable than objective judgments. The 
subjective judgment of dysarthric speech 
is complex and notoriously difficult, be-
cause the 5 aspects of speech production 
interact with each other (e.g. the breath-
ing pattern influences the vocal quality).81 
On top of that, speech can be influenced 
by other factors, like cognition, behavior, 
dentition, and emotion.82,83 Based on our 
experience of providing post-graduate dys-
arthria courses for more than 10 years, we 
felt that many discussions about treatment 
are based on inadequate assessment of the 
dysarthria, resulting in misinterpretation 
of the dysarthric speech characteristics. We 
also learned that most SLTs use their own 
speech tasks and checklists to assess dysar-
thria. Hence, we felt there was a need for 
a proper and validated dysarthria assess-
ment, which should be supported by video 
examples to facilitate the interpretation of 
the various speech characteristics. 
As far as we could find in the international 
literature, the only published standardized 
diagnostic instrument for dysarthria in 
adults is the Frenchay Dysarthria Assess-
ment (FDA-2).84 The FDA-1 was translated 
and made available in the Netherlands be-
tween 1996 and 2010,85 but we learned from 
our courses and our nationwide contacts 
that it never became widely used. When 
the Dutch version of the FDA-1 was no lon-
ger for purchase, we decided to improve 
and validate the Radboud Dysarthria As-
sessment (RDA) for adult patients that we 
made available online in 200734 and that 
we promoted during our post-graduate 
dysarthria courses. The original RDA was 
developed at the department of Rehabili-
tation of the Radboud University Medical 
Centre, based on the international litera-
ture and our clinical practice. It consisted 
of two components: a qualitative recording 
form and a severity scale, accompanied by a 
short manual with instructions how to per-
form and interpret the speech tasks (spon-
taneous speech, text reading, maximum 
repetition rate, maximum phonation time, 
maximum phonation volume and funda-
mental frequency range). Since its release 
in 2007, many SLTs in the Netherlands and 
Flanders have downloaded this freely avail-
able assessment. 
We did not translate or promote the FDA-2 
for of a couple of reasons. First, the FDA-2 
combines observation of oral structures 
and nonverbal oral functions, assessment 
of speech characteristics, and measurement 
of intelligibility. Because SLTs in the Neth-
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erlands have an orofacial examination at 
their disposal86 as well as validated Dutch 
intelligibility tests on word and sentence 
levels,22,23 there was no need for an instru-
ment combining all these domains. Sec-
ond, because the FDA-2 combines several 
domains, the assessment of speech charac-
teristics is less extensive than we think is 
needed for a clinician to adequately assess 
dysarthria. Third, in the FDA-2, the dysar-
thria types are less specific than clinically 
required. For instance, hypokinetic and hy-
perkinetic dysarthrias are both categorized 
under ‘extrapyramidal dysarthria’, whereas 
these are clearly two distinctive disorders. 
Moreover, in the FDA-2, ‘mixed dysar-
thria’ is applied as a general term, although 
mixed flaccid/spastic dysarthria as in amy-
otrophic lateral sclerosis is clearly different 
from (and requires other a different thera-
peutic approach than) for example mixed 
hypokinetic/ataxic dysarthria as in multi-
ple system atrophy. 
Our 4-step approach to improve and val-
idate the RDA was to: (1) seek national 
consensus for the tasks and the qualitative 
recording form, (2) add a self-evaluation 
questionnaire, (3) critically evaluate the 
clinimetric properties of the qualitative re-
cording form, severity scale and self-eval-
uation questionnaire, and (4) add training 
videos of all types and severities of dysar-
thria including detailed interpretation of 
the assessment for self-training purposes. 
This paper aims to describe the improve-
ment of the original RDA for adult patients 
(step 1 and 2) and to report the dimen-
sionality of the qualitative recording form 
(i.e., whether it is consistent with the five 
aspects of speech production), the internal 
consistency within each dimension and 
of the self-evaluation questionnaire, the 
construct validity of the severity scale and 
of the self-evaluation questionnaire, and 
the intra- and inter-rater reliability of the 
severity scale (step 3). The study that fo-
cused on the construction and usefulness 
of training videos (step 4) to improve the 
assessment of the type of dysarthria will be 
published in a separate paper.
mETHoDS
Approval was obtained from the Medical 
Ethics Committee of the Radboud Univer-
sity Medical Center and all patients signed 
an informed consent. 
Improvement of the original RDA 
(step 1 and 2)
The process of improving the original RDA 
was led by an expert group of 7 SLTs work-
ing in four different hospitals in the Neth-
erlands, 4 of them with more than 30 years 
of experience in motor speech disorders. 
The qualitative recording form of the free-
ly available and unvalidated original RDA 
was thoroughly scrutinized by the expert 
group based on their experience of using 
it for a couple of years. A major adapta-
tion was to structure the form according to 
the 5 aspects of speech production and to 
add information about posture and other 
speech-related aspects like dentition. Be-
sides, speech characteristics were described 
more consistently regarding problems in 
strength, speed, range, tone, and precision 
of movements. Face validity of the record-
ing form was established as follows. All 
items were described in detail in the test 
manual. The members of the expert group 
tested the recording form in clinical prac-
tice and their comments were collected 
and discussed until consensus about the 
recording form was reached. To create even 
broader support, a Delphi-method was 
used to ask for comments and feedback on 
the recording form and test manual from 
SLTs in the Netherlands and Belgium. 177 
SLTs were contacted, and 49 (27.7%) agreed 
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to participate. These 49 colleagues worked 
in different settings (either in an [academ-
ic] hospital, rehabilitation center, nurs-
ing home, or private practice) and 58% of 
the respondents had more than 10 years 
of experience with neurological patients. 
Everyone readily agreed on the speech 
tasks, but much more time than we antici-
pated was needed to reach consensus on the 
terminology in Dutch. We named speech 
characteristics based on how they were re-
ferred to in the international literature,6,84 
but we experienced that many SLTs used 
their own terminology. After discussing all 
comments in the expert group and defining 
all terms used, the second versions of the 
recording form and test manual were con-
structed. In this process, we also used the 
feedback obtained after presentations of 
preliminary versions at international con-
gresses.87,88 Lastly, 3 independent experi-
enced SLTs with a special interest in motor 
speech disorders thoroughly reviewed the 
second versions of the test manual and re-
cording form. Based on their feedback, the 
final version of the RDA was constructed.
The RDA focuses on dysarthria, i.e. on the 
process of execution of speech. The aims 
of the RDA are to recognize the speech 
characteristics that lead to a particular 
type of (or mixed) dysarthria and to assess 
the severity of dysarthria. This requires 
the use of relevant speech tasks, of which 
spontaneous speech and reading are most 
functional and representative of daily life. 
There is a lively discussion about including 
maximum performance (speech-like) tasks 
in dysarthria assessment.89 According to 
some authors speech and speech-like tasks 
are controlled by separate motor control 
systems,42,90 whereas others believe that 
motor control of speech and speech-like 
tasks overlap or are, at least clinically, in-
distinguishable.89,91 We decided to include 
maximum performance tasks primarily 
to facilitate the interpretation of specific 
characteristics observed in spontaneous 
speech and reading, such as signs of hypo-
tonia, hypertonia, hypokinesia, hyperkine-
sia, and ataxia. Indeed, patients need to be 
challenged to examine the upper limits of 
especially phonation and articulation33 to 
observe their voice and speech capacities 
without compensations. This is because 
compensatory strategies are harder to use 
in maximum performance tasks, thereby 
uncovering the true nature of the motor 
disorder. In addition, some types of dysar-
thria are characterized by a specific pattern 
in maximum performance tasks. For ex-
ample, oral dysdiadochokinesis is a feature 
of ataxic dysarthria,6,92 which manifests 
itself or becomes more prominent during 
a maximum repetition task. Another ar-
gument in favor of including speech-like 
tasks is that maximum performance tasks 
are effort-based that can help to identify 
therapeutic options. For instance, the of-
ten-normal maximum phonation volume 
in hypokinetic dysarthria reveals the voice 
capacity that is needed for successful train-
ing. Therefore, the following tasks were in-
cluded in the RDA:
 • Spontaneous speech by a semi-struc-
tured interview. Spontaneous speech 
is the task most representative of 
speaking in daily life and was, there-
fore, selected as the starting point of 
the assessment of speech characteris-
tics. 
 • Text reading. When reading out loud, 
prosodic features like speaking rate 
and intonation become evident. Be-
sides, fatigue can be provoked when the 
text is long enough, because there are 
no interruptions. A fictional reading 
text (‘Niets’ 93), already used by many 
Dutch SLTs, was added after being 
adapted for acoustic measurements. In 
the Netherlands, clinicians generally 
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do not use acoustic measurements, but 
with this adaptation the text was made 
suitable for a more profound clinical 
examination as well as for research 
purposes. We paid particular attention 
to the correct position of plosives and 
vowels within words (in stressed or 
non-stressed syllables) and within sen-
tences, taking into account the normal 
phonological processes.94,95 Based on 
these criteria, sentences were rewritten 
and the final text now consists of 520 
words.
 • Maximum repetition rate (syllables/
second). MRR of /pa/, /ta/, /ka/, and 
/pataka/ was included to assess the up-
per limits of the articulatory system.
 • Maximum phonation time (seconds). 
MPT or sustained phonation on /a:/ 
was included to specifically assess the 
phonatory-respiratory systems. To dis-
tinguish the phonatory from the respi-
ratory aspects of speech production, 
the sustained productions of /s/ and 
/z/ can be compared and the s/z ratio 
can be calculated, with a ratio of >1.4 
indicating phonatory problems.96 In 
the case of respiratory problems, both 
sustained /s/ and /z/ will be shorter 
than normal. 
 • Maximum phonation volume (dB). 
MPV was included to examine the 
dynamic range by asking the patient 
to produce “Hallo!” (Hello!) and “Kom 
hier!” (Come here!) as loud as possible. 
A decline in dynamic range may not 
be detected in spontaneous speech, 
because in normal conversation only a 
small part of the full range is used. Be-
sides, if a loud voice is possible during 
MPV in a patient with hypokinetic 
dysarthria, it makes weakness unlikely 
and shows spare capacity that can be 
utilized for therapy. 
 • Fundamental frequency range (semi-
tones). FFR was included to examine 
the melodic range by asking patients 
to produce an /a:/ from the lowest pos-
sible to the highest possible pitch and 
vice versa. Like in MPV testing, a de-
cline of the FFR may not be detected in 
spontaneous speech when only a small 
part of the range is used. 
All maximum performance tasks are per-
formed 3 times and the best performance 
is rated. 
In parallel with the improvement of the 
RDA, we collected maximum performance 
reference values of 224 men and women97 
to be able to compare the performance of 
each patient with the normal population. 
However, when clinicians do not assess the 
maximum performance tasks instrumen-
tally (e.g. with PRAAT), they can score the 
performance of the patient subjectively on 
a 4-point Likert scale ranging from ‘0 = 
normal’ to ‘3 = severe problems/impossi-
ble’. All other speech characteristics are rat-
ed on the recording form with this 4-point 
scale as well. When scoring ≥ 1, a qualitative 
judgement has to be given, which is printed 
on the qualitative recording form. In Ap-
pendix 5.1, the recording form is shown. It 
includes all relevant items to assess the 5 as-
pects of speech production. We translated 
the form from Dutch into English only for 
the purpose of this article and would like 
to emphasize that the wording is merely in-
dicative of the Dutch original. In the Dutch 
manual of the RDA, all terms are explained 
in detail. 
For the judgement of the severity of dysar-
thria, we included a 6-point scale inspired 
by the Therapy Outcome Measures98 rang-
ing from ‘0 = normal’ and ‘5 = most severe’. 
The scores 1 to 5 were defined by applying 
the terminology of the qualitative record-
ing form (Appendix 5.1). This severity score 
is an overall score that reflects the interpre-
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tation of the performance on all different 
tasks and it is given after completion of the 
full assessment. If a patient scores mostly 0 
or 1 on the qualitative recording form, the 
overall severity is considered to be mild. 
The overall severity score reflects the most 
severely affected aspect of speech produc-
tion, so when, for example, the articulation 
is more severely affected than the phona-
tion, the severity score will reflect the se-
verity of the articulation. 
Lastly, we included a short self-evaluation 
questionnaire to quantify the patient’s 
speech complaints and experienced con-
sequences in daily functioning, but also as 
a clinical guidance for the history taking. 
We adjusted the Radboud Oral Motor in-
ventory for Parkinson’s disease (ROMP-
speech)99 by replacing two items that were 
specific for hypokinetic dysarthria (vocal 
quality and starting problems) by items 
for all types of dysarthria (ability to speak 
for a longer period and ability to raise the 
voice). The self-evaluation questionnaire 
consists of seven questions with a 5-point 
response scale that cover the “function”, 
“activity” and “participation” domains of 
the ICF 21, yielding a total score from 7 (no 
complaints) to 35 (most severe complaints).
Clinimetric evaluation of the RDA (step 3)
Table 5.1 provides an overview of the clini-
metric evaluations that we used to validate 
the different parts of the RDA.
Patients 
Forty-three adult patients with dysarthria 
were recruited from the 4 hospitals to which 
the members of the expert group were af-
filiated. No specific inclusion or exclusion 
criteria were applied, because the aim was 
to collect examples of all dysarthria types 
and severities.  
Raters
Usually, the expert SLT who included the 
patient also made the video recordings of 
the dysarthria assessment, with a high defi-
nition camera and a separate microphone. 
After completion of all videos, the expert 
group discussed the type and severity of the 
dysarthria of each patient until full agree-
ment was reached, while they were kept un-
aware for the clinical information (medical 
diagnosis etc.). 
Table 5.1. Overview of the clinimetric evaluations.
Clinimetric characteristic Based on judgement or scores by:
Qualitative recording form
 Face validity  Expert group
 Dimensionality  Expert group
 Internal consistency  Expert group
Severity scale
 Construct validity  Expert group
 Reliability  SLTs
Self-evaluation questionnaire
 Construct validity  Patients
 Internal consistency  Patients
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Forty-six SLTs were approached by e-mail 
to ask for participation. This e-mail was 
sent to a study group of SLTs working in 
hospitals across the Netherlands and to a 
group of SLTs working with neurological 
patients in the region of Nijmegen. Twen-
ty-two of them (48%), with on average 11 
years of experience with dysarthria (range 
2–24 years), agreed to participate. 
Construct validity
To evaluate the construct validity of the 
severity scale (severity score given by the 
expert group) and the self-evaluation ques-
tionnaire, the scores were compared with 
(a) the Speech Handicap Index (SHI)100, 
(b) the Dutch sentence intelligibility as-
sessment (NSVO-Z)23, and (c) a category 
fluency task101. The SHI and NVSO-Z were 
used to test convergent validity, whereas 
the category fluency task was used to test 
divergent validity as it assesses linguistic 
skills rather than speech. The NSVO-Z and 
the category fluency task were performed 
and videotaped after the assessment with 
the RDA by the expert SLT. Patients com-
pleted the self-evaluation questionnaire at 
home, maximally 1 week before the assess-
ment. The expert SLT who performed the 
assessment of the RDA, NSVO-Z, and cat-
egory fluency task was unaware of the pa-
tient’s scores on the SHI and the self-evalu-
ation questionnaire.
The SHI is a validated self-reported Dutch 
questionnaire for dysarthric patients con-
taining 15 questions about dysarthria in 
the physical, functional and emotional do-
mains. Patients answer the SHI questions 
on a 5-point-scale from ‘never’ to ‘always’ 
(0–4) generating a total score ranging 
from 0 to 60. The NSVO-Z contains 1200 
semantically unpredictable sentences. For 
each patient, 18 sentences are randomly 
generated, which have to be read out loud. 
A member of the expert group, who was 
not responsible for videotaping the patient, 
transcribed all sentences spoken by the pa-
tient before discussing the type and severi-
ty of the dysarthria. The first author (S.K.) 
compared the transcription to the original 
sentences, resulting in a percentage of in-
telligibility for each patient. The category 
fluency task requires naming as many an-
imals as possible in 1 min. The total num-
ber of animals is converted into a Z-score 
dependent on age and level of education.101 
When a slow speaking rate is responsible 
for a limited number of animals, correction 
is allowed. We hypothesized substantial 
to strong correlations (rs > 0.40)102 of the 
severity scale and the self-evaluation ques-
tionnaire with the SHI and the NSVO-Z, 
whereas weak correlations (rs < 0.40) were 
expected with the category fluency task. 
Reliability
Twenty-two SLTs agreed to score a set of 
videos at two separate times. Three SLTs 
scored 10 selected videos twice, with a 
2-week interval, to assess the intra-rater 
reliability of the severity scale. The videos 
included minimally 1 example of each se-
verity level and the SLTs scored the vid-
eos independently using a secured online 
connection. The other 19 SLTs scored 10 
selected videos before and after an online 
video-training. Inter-rater reliability of the 
severity scale was determined by compar-
ing their scores of the second assessment 
(after the online training).
Dimensionality and internal consistency
The qualitative recording forms filled in by 
the expert group during the consensus pro-
cess were used to assess the dimensionality 
and internal consistency of the recording 
form. The self-evaluation questionnaires 
completed by the patients were used to cal-
culate the internal consistency of the ques-
tionnaire.
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Statistics
An exploratory factor analysis was per-
formed to evaluate whether the items on 
the qualitative recording form loaded on 
the factors that corresponded with the a 
priori defined five aspects of speech pro-
duction (articulation, resonance, phona-
tion, respiration and prosody). Principal 
axis factoring was used as the extraction 
method together with varimax rotation. 
Extraction of the factors was based on the 
Kaiser’s criterion for Eigenvalues being 
equal to or greater than 1.0. Cronbach’s α 
was used to calculate the internal consis-
tency of each factor found and to test the 
internal consistency of the self-evaluation 
questionnaire. 
Construct validity was determined by cal-
culating Spearman’s correlation coefficients 
of the severity scale and the self-evaluation 
questionnaire with the SHI, NSVO-Z, and 
the category fluency task. We a priori con-
sidered (absolute) correlation coefficients 
< 0.40 as ‘weak’, 0.40 to 0.70 as ‘substantial’, 
and > 0.70 as ‘strong’.102 
The Intraclass Correlation Coefficient 
(ICC) for consistency (two-way random) 
was used to calculate the intra- and in-
ter-rater reliability of the severity scale. A 
value of 0.70 was considered as a minimum 
standard for reliability.103 
Calculations were performed with IBM 
SPSS Statistics 20 for Windows (IBM 
Corp., Armonk, NY) and SAS 9.2 for Win-
dows (SAS Institute, Cary, NC).
RESULTS
We included 18 women and 25 men with a 
mean age of 61 years (range 14–79 years). Ta-
ble 5.2 provides an overview of the type and 
severity of dysarthria in these 43 patients 
(including their medical diagnosis). Their 
mean SHI-score was 24 (range 6–49), the 
mean NSVO-Z score 86% (range 34–100) 
and the mean ROMP-score 18 (range 9–35). 
Qualitative recording form
The exploratory factor analysis extract-
ed four dimensions yielding an explained 
variance of 70.3% with all items loading 
on 4 components (Table 5.3). Those com-
ponents could be identified as: phonation 
(1), articulation (2), respiration/prosody (3) 
and resonance (4). Cronbach’s α was be-
tween 0.89 and 0.91 for the individual fac-
tors, indicating good internal consistency 
within each dimension.
Severity scale
The scores of the 19 SLTs were consistent 
with the expert group for 53.2%. The cor-
relation of dysarthria severity with both 
the SHI (rs = 0.40, p < 0.01) and the NS-
VO-Z (rs = -0.65, p < 0.01) was substantial, 
whereas the correlation of dysarthria sever-
ity with the category fluency task was weak 
(rs = -0.28, p = 0.05) (Table 5.4). Both the 
inter-rater and the intra-rater reliability of 
the severity scale were high (ICCs 0.85 or 
0.86). 
Self-evaluation questionnaire
The internal consistency of the self-evalua-
tion questionnaire was high (Cronbach’s α 
= 0.90). The correlation of the self-evalua-
tion questionnaire with the SHI was strong 
(rs = 0.80, p < 0.01), with the NSVO-Z 
substantial (rs = -0.52, p < 0.01), and with 
category fluency weak (rs = -0.27, p = 0.06) 
(Table 5.4). 
DISCUSSIoN
In this paper, we present the RDA, a stan-
dardized set of common speech and max-
imum performance (speech-like) tasks for 
the perceptual analysis of speech, using a 
qualitative recording form, a severity scale 
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Table 5.3. The factor loadings of the different items of the rating sheet on the four components. 
Items
Component*
1 2 3 4
Lip movements .55 .60
Jaw movements .51 .43
Tongue movements .65
Vowels .73
Consonants .80
Clusters .81
Syllable structure .79
Oral diadochokinetics .72
Resonance .83
Vocal quality .82
Vocal use .79
Loudness .66
Pitch .70
Fundamental frequency range .82
Maximum phonation volume .64
Maximum phonation duration .57 .55
Inhalation .59
Breathing pattern .41 .75
Breath groups .44 .68
Melodic accent .52 .53
Dynamic accent .53 .64
Temporal accent .67
Cronbach’s α .89 .90 .91
* Factor loadings suppressed below 0.4. Bold numbers indicate the highest factor loading per item.
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and a self-evaluation questionnaire. We es-
tablished its clinimetric properties in adult 
Dutch speaking persons, but the RDA itself 
is not language-specific and easy to con-
struct in any other language. 
Factor analysis indicated that the items on 
the recording form represent 4 domains of 
speech production: phonation, articula-
tion, respiration/prosody and resonance. 
We had expected that prosody would be 
identified as a separate dimension, but our 
results demonstrated that it proved to be 
part of the respiration domain. This is con-
ceivable as it is a supra-segmental speech 
aspect. Because the internal consistency 
within each dimension was good, it is safe 
to conclude that the items within each do-
main were adequate. 
The severity scale showed good intra- and 
inter-rater reliability scores, indicating that 
it is sufficiently accurate to become used in 
clinical practice by SLTs. Regarding the va-
lidity, the fact that the correlation between 
dysarthria severity (which is clinician-rat-
ed) and the SHI (which is patient-rated) 
was substantial (rs ≥ 0.40) but not strong 
(rs ≥ 0.70) is plausible. Whether patients 
experience problems due to dysarthria as 
indicated by the SHI is highly personal 
and depends on their daily activities. This 
emphasizes that collecting clinician-rated 
scores as well as patient reports is import-
ant for setting shared treatment goals.104 
The substantial (rs = -0.65) (but not strong) 
correlation between dysarthria severity 
and the NSVO-Z is conceivable as well. Pa-
tients with severe dysarthria according to 
the RDA can still be intelligible according 
to the NSVO-Z, if they adapt their speak-
ing technique.6 In line with our hypothesis, 
dysarthria severity correlated only weakly 
with category fluency, because the latter is 
dependent on linguistic ability rather than 
speech capacity. Overall, the results sup-
port the construct validity and reliability of 
the severity scale.
The self-evaluation questionnaire showed 
good internal consistency, indicating 
that all questions measure the same con-
struct. The strong correlation between the 
self-evaluation questionnaire and the SHI 
indicates that SLTs can choose either ques-
tionnaire to obtain information about the 
speech difficulties as perceived by the pa-
tient. The weak to substantial correlations 
with category fluency and the NSVO-Z 
further underline that the self-evaluation 
questionnaire measures a specific and pa-
tient-rated construct. 
The improved RDA was based on nation-
al consensus and was, therefore, readily 
accepted as the preferred dysarthria as-
sessment in the Netherlands according 
to sales figures and feedback during our 
post-graduate dysarthria courses. By striv-
ing to achieve consensus about the tasks, 
Table 5.4. The Spearman’s correlation coefficients (p-value) between the severity of dysarthria, 
the self-evaluation questionnaire, the Speech Handicap Index (SHI),100 intelligibility (NSVO-Z)23 
and the category fluency task in the 43 patients.
Dysarthria 
severity
SHI NSVO-Z Fluency
Dysarthria severity 1.00         (n.a.) 0.40 (p < 0.01) -0.65 (p < 0.01) -0.28 (p = 0.05)
Self-evaluation questionnaire 0.53 (p < 0.01) 0.80 (p < 0.01) -0.52 (p < 0.01) -0.27 (p = 0.06)
 Abbreviation used: n.a., not applicable.
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the terminology of the recording form, and 
about the speech characteristics of the 43 
patients, we learned at least two import-
ant lessons. We needed all tasks, including 
the maximum performance tasks, to reach 
consensus, in particular to distinguish pri-
mary deficits from compensatory mecha-
nisms that patients used to optimize their 
speech. At the same time, we did not an-
ticipate that reaching consensus with high-
ly experienced clinicians would be such a 
time-consuming challenge. It seems that 
experienced clinicians all have their own 
internal acoustic anchors, which makes it 
even more important that we managed to 
reach consensus for the use of our instru-
ment in the Netherlands and Flanders.  
We primarily aimed at publishing a concise 
perceptual clinical assessment to be used by 
any dedicated SLT in daily practice. Nev-
ertheless, by adding normative values for 
the maximum performance tasks97 and a 
reading text adapted for acoustic measure-
ments, the RDA is also suitable for scientif-
ic purposes, for instance for the objective 
registration and analysis of speech tasks. 
During our study, there was hardly any 
dysarthria assessment that we could use 
as a reference. Recently, the German in-
strument Bogenhausen Dysarthria Scales 
(BoDys) has been published,105 which is 
also a fully perceptual assessment, but with 
4 tasks to elicit connected speech only (con-
versational speech, sentence repetition, text 
reading, and picture story). Because this in-
strument is based on a different theoretical 
approach that strictly distinguishes speech 
motor control from the motor control of 
speech-like tasks,89 a direct comparison be-
tween the RDA and BoDys is not possible. 
Future perspectives
The RDA has been developed for assessing 
adult neurological patients, but a pediat-
ric version is underway with speech tasks 
adapted to children aged from 4 to 18 years, 
including age-related reference values for 
the maximum performance tasks. Because 
the RDA includes internationally accepted 
speech tasks and terminology, the instru-
ment can easily be translated into other lan-
guages, with two possible limitations: every 
language may need its own set of videos 
with all dysarthria types and severities and 
only future data gathering can demonstrate 
whether or not the reference values of the 
speech tasks are language-dependent.106 
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APPENDIx
Radboud Dysarthria Assessment (RDA) 
 
Name patient:      Date: 
Date of birth:      SLT: 
                   
 
 
0 = normal    1 = minimal problems     2 = mild/clear problems      3 = severe problems/impossible 
 
Articulation (spontaneous speech, reading, maximum repetition rate) 
 
Lip movements: 0 - 1 - 2 - 3  O small   O tense   O uncontrolled 
     O slow  O flaccid  O involuntary move- 
     O asymmetric in disadvantage to left / right     ments 
 
Jaw movements : 0 - 1 - 2 - 3  O small  O tense    O involuntary move- 
     O slow  O flaccid      ments 
      
Tongue movements: 0 - 1 - 2 - 3 O small  O tense   O uncontrolled 
     O slow  O flaccid  O involuntary move- 
     O asymmetric in disadvantage to left / right     ments 
 
Vowels:    0 - 1 - 2 - 3  O distorted O prolonged O shortened 
 
Consonants:   0 - 1 - 2 - 3 O flaccid O tense  O imprecise O prolonged 
 
Clusters:   0 - 1 - 2 - 3 O schwa- insertion  O reduced O imprecise 
 
Syllable structure:  0 - 1 - 2 - 3 O phoneme-/syllable repetitions O phoneme-/syllable omissions 
 
Reading better/worse than spontaneous speech: …………………..…………………………………………………….. 
 
Changed quality of articulation over time: improvement / deterioration ………………………………………………… 
 
Maximum   pa 0 - 1 - 2 - 3 O flaccid O slow   O problems increase           
repetition rate    O tense  O dysrhythmic   
  ta 0 - 1 - 2 - 3 O flaccid O slow   O problems increase 
 O tense  O dysrhythmic  
  ka 0 - 1 - 2 - 3 O flaccid O slow   O problems increase 
 O tense  O dysrhythmic   
  pataka 0 - 1 - 2 - 3 O flaccid O slow   O disturbed pattern 
 O tense  O dysrhythmic O problems increase 
Observations ………………………………………………………………………………………………………………….. 
 
Resonance (spontaneous speech, reading) 
 
Nasality:  0 - 1 - 2 - 3 O hyper  O hypo  O variable O nasal emission 
 
Reading better/worse than spontaneous speech: ..……………………………………………………………………….. 
 
Changed quality of nasal resonance over time: improvement / deterioration..………….……………………………… 
 
Observations …………………………………………………………………………………………………………………… 
 
Phonation (spontaneous speech, reading, fundamental frequency range, maximum phonation volume, maximum phona-
tion duration) 
 
Vocal quality:  0 - 1 - 2 - 3 O breathy O harsh  O diplophonic O aphonic 
O tremor O staccato O falsetto O unsteady 
O cracking 
 
Vocal use:  0 - 1 - 2 - 3  O hypotonic O hypertonic 
 
Loudness:   0 - 1 - 2 - 3 O increased O reduced O uncontrolled 
 
Pitch:   0 - 1 - 2 - 3 O high  O low  O uncontrolled 
 
Reading better/worse than spontaneous speech: ..……………………………………………………………………….. 
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Radboud Dysarthria Assessment (RDA) 
 
 
* in case of mixed dysarthrias, tick two or more types 
 
 
Changed quality of phonation over time: improvement / deterioration.……………….………………………………… 
  
Fundamental freq range: 0 - 1 - 2 - 3 O reduced  O uncontrolled 
 
Max phonation volume: 0 - 1 - 2 - 3 O reduced  O forced  O strained 
 
Max phonation time: 0 - 1 - 2 - 3 O impaired quality ……………. O deviant duration: .……… sec. 
     s/z ratio: ………………………………………………………………….. 
Observations …………………………………………………………………………………………………………………. 
    
Respiration (during speech) (spontaneous speech, reading, maximum phonation volume, maximum phonation dura-
tion) 
 
Place:    O clavicular  O costal  O costo-abdominal  O abdominal  
 
Inhalation:  0 - 1 - 2 - 3 O irregular  O stridor without phonation O stridor with phonation
   
Respiration 0 - 1 - 2 - 3 O short breath groups O short breath support O impaired coordination 
during speech:                    of breath and vocalisation 
 
Pattern  0 - 1 - 2 - 3 O too fast   O forced  O shallow O paradoxical 
of breathing: 
 
Reading better/worse than spontaneous speech: ..……………………………………………………………………….. 
 
Observations: ………………………………………………………………………………………………………………….. 
 
Prosody (spontaneous speech, reading) 
 
Melodic accent: 0 - 1 - 2 - 3 O monopitch O unnatural O uncontrolled / excess 
 
Dynamic accent: 0 - 1 - 2 - 3 O monoloudness   O uncontrolled / excess 
 
Temporal accent: 0 - 1 - 2 - 3 O slow  O accelerations O variable O fast 
    O chanted O stop problems O start problems  
 
Reading better/worse than spontaneous speech: ..……………………………………………………………………….. 
 
Observations …………………………………………………………………………………………………………………… 
 
Posture 
 
Body:   O normal O movements in extremities  O movements in trunk  
  O flexion O extension O deviation to L / R  O slumped 
 
Head:   O normal  O rotation to L / R O movements with head 
  O flexion O extension   O lateroflexion to L / R 
Observations:…………………………………………………………………………………………………………………… 
 
Other   
 
O apraxia of speech O dental problems, nl. ………………………………………………………………………… 
O physical capability ↓ O control of saliva ↓  O other. ……………………...……..…………………. 
 
Conclusion 
 
Dysarthria:  
 __ no 
 __ yes* O spastic O ataxic  O hypokinetic O hyperkinetic    O chorea/athetosis 
 O flaccid O mononeuropathic       O dystonia 
   O myogene  
   O bulbar 
   O UUMN 
 O undetermined:………………………………………………………………………………………….. 
 Non-dysarthric components:…...………………………..…………………………………………..……………… 
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Radboud Dysarthria Assessment (RDA) 
Severity scale: 
0. No dysarthria
1. Minimal dysarthria: minimal problems with articulation, resonance, phonation or respiration.
2. Mild dysarthria: tonus, range of motion or speed of articulation movements are mildly affected, leading to mildly
affected consonants and/or vowels. Mild problems with resonance, phonation or respiration. 
3. Mild / severe dysarthria: tonus, range of motion or speed of articulation movements are clearly affected, leading
to deviant consonants and/or vowels. Clearly affected resonance, phonation or respiration. 
4. Severe dysarthria: tonus, range of motion or speed of articulation movements are severely affected, leading to
severely affected consonants and/or vowels. Severely affected resonance, phonation or respiration. Very slow 
speech with only a few syllables per breath group. 
5. Very severe dysarthria/anarthria: articulation movements are almost impossible, leading to mainly open vowels
and very severely distorted consonants. Very severely affected resonance, phonation (aphonic) or respiration 
(almost no breath support).  
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AbSTRACT
Purpose
Maximum performance tests examine upper limits of speech motor performance, as used by 
speech-language pathologists in dysarthria assessment protocols. The Radboud Dysarthria Assess-
ment includes maximum repetition rate, maximum phonation time, fundamental frequency range 
and maximum phonation volume to assist in detecting pathological performance. This study aims to 
obtain reference values for each of these tests. 
Method
A group of 224 healthy Dutch adults aged 18–80 years performed the maximum performance tests. 
Age, sex, body height, smoking habit, and profession were registered. Using multivariable linear 
regression, a wide range of models was tested to examine the relationship between these person 
characteristics and speech performance. The Likelihood-Ratio was used to test the goodness of fit 
to the data. 
Result
Above 60 years of age, maximum repetition rate, fundamental frequency range and maximum pho-
nation volume were all negatively affected by age. Below 60 years, only women showed effects of 
age on fundamental frequency range (increase) and maximum phonation volume (decrease). Maxi-
mum phonation time was primarily related to body height (increase). 
Conclusion
This study presents reference values of four maximum performance tests for comparing the perfor-
mance of dysarthric patients with non-pathological performance. Age was identified as most import-
ant factor influencing maximum speech performance. 
Reference values of 
maximum performance 
tests of speech 
production
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INTRoDUCTIoN
Maximum performance tests of speech 
production examine the upper limits of 
speech motor performance33 and are used 
in dysarthria assessment protocols by 
speech-language pathologists (SLPs) to 
investigate the articulatory and phonato-
ry-respiratory systems more independently 
than in spontaneous speech.6 Typically, in 
spontaneous speech all systems (articulato-
ry, velopharyngal, phonatory and respira-
tory) are co-operating during highly vari-
able speech patterns, while the maximum 
performance tests have a limited variability. 
In 2014, the Radboud Dysarthria Assess-
ment (RDA) was published,107 which in-
cludes four maximum performance tests 
of speech production: maximum repetition 
rate (MRR), maximum phonation time 
(MPT), fundamental frequency range 
(FFR) and maximum phonation volume 
(MPV). Despite the ongoing debate about 
motor control in speech versus non-speech 
tasks,42,89,108,109 we think that maximum 
performance tasks are of utmost impor-
tance in clinical dysarthria assessment. The 
most important reason is that, compared 
to spontaneous speech, repetitive speech 
patterns are less variable and, thus, easier to 
judge. Other reasons to include maximum 
performance tests in the RDA are the fol-
lowing. First, in spontaneous speech, a per-
son with dysarthria can compensate speech 
motor deficits, for example, by slowing 
down the speaking rate. During maximum 
performance tests, such compensatory 
strategies are much harder to use, resulting 
in a more realistic expression of the differ-
ent capacities of the articulatory and pho-
natory-respiratory systems. Second, maxi-
mum performance tests can help SLPs with 
distinguishing different types of dysarthria. 
For example, a dysrhythmic MRR is a spe-
cific feature of ataxic dysarthria6,92,110 and 
hypokinetic dysarthria is characterized by 
a normal MRR with reduced amplitude 
of the articulatory movements.92 Finally, 
maximum performance tests can help to 
identify therapeutic options. For example, 
a high MPV in a patient with hypokinetic 
dysarthria reveals the voice capacity that is 
needed for successful training.
To distinguish pathological from 
non-pathological speech performance and 
to obtain an indication of the severity of 
pathological performance, reference values 
are needed. These data are partially avail-
able in the literature,33,106,111 but reference 
values from a sizable population with a 
clinically relevant age span are lacking. 
In addition, maximum speech and voice 
capacity may be related to language or 
culture. Indeed, Icht and Ben-David106 
recently showed significant differences in 
MRRs between English, Portuguese, Farsi 
and Greek speaking persons. Therefore, the 
purpose of this study was to collect refer-
ence values for MRR, MPT, FFR and MPV 
in a large population of healthy Dutch 
adults and relate these to relevant person 
characteristics.
mETHoDS
Participants
We included 224 healthy native Dutch 
speakers (108 men and 116 women) aged 
18–80 years. They were recruited by the 
investigators from the local community. 
Participants with a history of any swal-
lowing, speech or voice problem were ex-
cluded. The participants were divided into 
age groups of one decade (18–29, 30–39, 
40–49, 50–59, 60–69, 70–80) and we aimed 
to include a more or less equal number of 
participants per age group. We collected 
the following person characteristics that 
might influence maximum performanc-
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es: age (years), sex (men/women), body 
height (cm), smoking habit (yes/no), and 
professional occupation. Age and sex were 
registered as basic person characteristics. 
In addition, body height was registered 
because of its effect on lung capacity112 and 
smoking habit and professional occupation 
because of their known effect on the quality 
of the voice.113,114 Based on profession, the 
level of vocal use was categorized by the 
classification of Koufman and Isaacson: (I) 
elite vocal performer (singers and actors), 
(II) professional voice user (teachers, re-
ceptionists), (III) non-vocal professionals 
(doctors, lawyers) and (IV) non-vocal 
non-professionals (students, laborers).115
All participants signed informed consent 
before participating in the study. We ob-
tained approval from the Committee on 
Research Involving Human Subjects of 
Arnhem and Nijmegen. 
Speech measurements
The participants performed all speech tasks 
three times, in similar order, while sitting 
upright. All performances were recorded 
with a linear PCM recorder (Tascam DR-
05, Tokyo, Japan) and the best maximum 
performance was used in the statistical 
analysis. Five trained examiners recruited 
and instructed the participants and record-
ed all performances. The examiners worked 
in pairs, but the participant was assessed by 
just one examiner. The specific tasks were 
described as follows.
Maximum repetition rate
The participants were instructed to repeat 
the monosyllabic sequences /pa/, /ta/ and 
/ka/ and the trisyllabic sequence /pataka/ as 
fast as possible for at least 6 seconds. MRR 
was analyzed with Praat116 and expressed 
in syllables per second. The count-by-time 
method was used during the first 5 seconds 
of the sequence.117
Maximum phonation time of /a:/
The participants were instructed to pro-
duce an /a:/ as long as possible after taking 
a maximal inhalation, at a comfortable 
pitch and at their habitual loudness. MPT 
was analyzed with Praat and expressed in 
seconds.
Fundamental frequency range
The participants were instructed to produce 
an /a:/ from the lowest possible to the high-
est possible pitch and vice versa. Producing 
a musical scale was also allowed. People who 
experienced difficulties while performing 
this test were stimulated to produce only 
their lowest and highest pitches. FFR was 
analyzed with Praat and expressed in Hz. 
FFR was converted from Hz to semitones 
using the formula: ST = 39,87 * log (F/50).95
Maximum phonation volume
The participants were instructed to pro-
duce “Hallo!” (Hello!) and “Kom hier!” 
(Come here!) as loud as possible. MPV was 
measured with a dB-meter (Voltcraft SL-
100, Hirschau, Germany) at 30 cm distance 
from the mouth, which was standardized 
by using the A4 assessment form.
Statistical methods
First, we used univariate analysis to ex-
plore the association between each max-
imum performance task and each person 
characteristic using Pearson correlation 
coefficients (age and body height), Spear-
man correlation coefficients (profession), 
and independent-samples t-tests (sex and 
smoking habit) to identify possibly influ-
ential person characteristics. Regarding 
MRR (articulation), we only explored the 
association with sex and age, whereas for 
MPT, FFR and MPV (voice), we explored 
the association with all person character-
istics. Characteristics with a p-value of 
< 0.05 were selected for multivariate anal-
ysis (determinants). Second, multivariate 
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linear regression was used to study the 
unique influence of the identified deter-
minants (independent variables) on each 
maximum task performance (dependent 
variable) separately. We searched for the 
independent variable with the strongest 
influence to be able to construct reference 
lines. Therefore, we studied a wide range 
of models for each maximum performance 
test: first- to third-degree polynomials in 
age and body height, piece-wise regression 
in age and height, interaction terms with 
sex, and untransformed and logarithmic 
transformed values of the performance 
tests. The Likelihood-Ratio was used to 
test differences between the models for 
their goodness of fit to the data. With re-
spect to MPT, the dependent variable was 
the logarithmic transformed value of the 
MPT. The antilog-transformed results were 
calculated. For all other maximum perfor-
mance tests, the dependent variable was the 
original performance. 
A paired-samples t-test was used to test 
differences between the four individual se-
quences of the MRR (α-level: p = 0.05). All 
statistical analyses were performed using 
SAS 9.2 for Windows (SAS Institute, Cary, 
NC).
Table 6.1. Characteristics of all participants (n=224).
median  (range)
Age (year) 43 (18 – 80)
Body height (cm) 175 (155 – 201)
Weight (kg) 73    (50 – 120)
n (%) men (n) (%)
Total 224 108 (48.2)
18-29 y 76 30 (39.5)
30-39 y 28 14 (50.0)
40-49 y 27 15 (55.6)
50-59 y 37 22 (59.5)
60-69 y 30 15 (50.0)
70-80 y 26 12 (46.2)
Smokers 68 (30.4)
Profession (level of vocal use)*
level I 3 (1.3)
level II 63 (28.1)
level III 74 (33.0)
level IV 84 (37.5)
* Level I: elite vocal performer; level II: professional voice user; level III: nonvocal professionals; 
level IV: nonvocal nonprofessionals.
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RESULTS
A total of 224 participants (108 men and 
116 women) were included with a mean 
age of 43 years (standard deviation [SD] = 
19.0, range 18–80) and a mean body height 
of 175.5 cm (SD = 9.6, range 155–201). Six-
ty-eight participants (30.4%) were smokers 
and 66 (29.4%) were vocal professionals 
(level I and II, see Table 6.1). The age group 
18–29 years was the largest for two reasons. 
Initially, we started including participants 
from 20 years old, but we extended the 
youngest age group from 20–29 years to 18–
29 years, as adulthood starts at 18 years and 
the pediatric version of the RDA (under 
construction) reaches up to 17 years. Sec-
ond, this youngest group initially seemed 
to score lower than expected. By including 
more participants, we intended to obtain a 
better representation of this age group.
Overall, smoking habit and profession (vo-
cal use) did not influence the maximum 
performance tests, leaving age, sex and 
body height as independent variables for 
the multivariate regression analyses. When 
testing the models for their goodness of fit, 
the best fit was the piece-wise regression 
model with a cut-off point chosen at 60 
years of age. Regression coefficients with 
95% confidence intervals (95% CI) of the fi-
nal models are presented. The 5th, 25th, 50th, 
75th and 95th percentile reference lines are 
visualized in a graph. Reference lines are 
presented by sex when relevant.
Maximum repetition rate
The median and range of each MRR se-
quence are shown by age group in Table 
6.2. Across all age groups, /ka/ was by far 
the slowest sequence (with 6.0 syl/s) and 
differed significantly from /pa/ (p < 0.01), 
/ta/ (p < 0.01) and /pataka/ (p < 0.01). 
/Pataka/ was the fastest sequence (with 
6.9 syl/s) and differed, in addition to /ka/, 
significantly from /pa/ (p = 0.04) and /ta/ 
(p < 0.01). Finally, /pa/ was a significantly 
faster sequence than /ta/ (p < 0.01).
MRR was only significantly related to age. 
In Table 6.3, the estimated mean decrease 
Table 6.3. The estimated mean change per year in MRR, FFR, and MPV using a piece-wise linear 
regression model with cut-off point at 60 years.
 < 60 years ≥ 60 years
mean (95% CI) mean (95% CI)
MRR
/pa/ (syl/s) -0.00 (-0.01– 0.00) -0.03 (-0.06 – -0.01)
/ta/ (syl/s) -0.00 (-0.01 – 0.01) -0.06 (-0.09 – -0.02)
/ka/ (syl/s) 0.00 (-0.00 – 0.01) -0.05 (-0.08 – -0.02)
/pataka/ (syl/s) -0.00 (-0.01 – 0.01) -0.04 (-0.08 – 0.01)
FFT (semitones)
men 0.03 (-0.05 – 0.12) -0.45 (-0.80 – -0.12)
women 0.24 (0.14 – 0.35) -0.43 (-0.88 – 0.01)
MPV (dB)
men -0.00 (-0.02 – 0.02) -0.11 (-0.20 – -0.02)
women -0.05 (-0.08 – -0.01) -0.19 (-0.34 – -0.05)
Abbreviations used: CI, confidence interval; syl, syllable; s, second.
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in syllables per second per year is presented 
for each sequence, using a piece-wise linear 
regression model with a cut-off point at 60 
years. After the age of 60 years, there was a 
significant decrease in the speed of perfor-
mance (/pa/: r = -0.03 [95% CI -0.06 –  -0.01]; 
/ta/: r = -0.06 [95% CI -0.09 – -0.02]; 
/ka/: r = -0.05 [95% CI -0.08 – -0.02]), 
whereas the age range between 18 and 60 
years did not show a significant decline. 
The percentile reference lines are shown in 
Figure 6.1. Note that findings were nearly 
identical for men and women.
Maximum phonation time
In Table 6.2, the median and range of the 
MPT are shown by age group. Across all 
age groups, MPT was significantly related 
to body height (p < 0.01). In Table 6.4, the 
median and range are shown by category of 
body height. The percentile reference lines 
are shown in Figure 6.2. The mean differ-
ence between men and women was 4.9 s 
(p < 0.01), but the effect of body height was 
stronger. 
Fundamental frequency range
The median and range of the FFR are 
shown by age group in Table 6.2. FFR was 
significantly related to age and sex. In Table 
6.3, the estimated mean change per year is 
presented for both sexes using a piece-wise 
linear regression model with a cut-off point 
at 60 years. In men, there was a significant 
Figure 6.1. The percentile reference lines of the individual sequences of MRR against age, using 
a piece-wise linear regression with a cut-off point at 60 years of age.
72
Chapter 6 Reference values of maximum performance tests of speech production
decrease in FFR per year after the age of 60 
(r = -0.45 [95% CI -0.80 – -0.12]), where-
as in women this decrease was similar 
but did not reach significance (r = -0.43 
[95% CI -0.88 – 0.01]). Yet for women, there 
was a significant increase in FFR per year 
in the age span of 18 to 60 years (r = 0.24 
[95% CI 0.14 – 0.35]) (Table 6.3). The per-
centile reference lines are shown in Figure 
6.3A and B.
Maximum phonation volume
In Table 6.2, the median and range of the 
MPV are shown by age group. MPV was 
significantly related to age and sex. In 
Table 6.3, the estimated mean decrease 
in MPV per year is presented using a 
piece-wise linear regression model with 
a cut-off point at 60 years. In men, there 
was a significant decrease above 60 years 
of age (r = -0.11 [95% CI -0.20 – -0.02]), 
which was also found in women (r = -0.19 
[95% CI -0.34 – -0.05]). However, only for 
women, there was a significant decrease in 
MPV below the age of 60 years (r = -0.05 
[95% CI -0.08 – -0.01]). MPV was influ-
enced by body height as well, but the effect 
of age was stronger. Percentile reference 
lines are shown in Figure 6.3C and D.
DISCUSSIoN
This study presents reference values of four 
maximum performance tests of speech 
production from a sizeable healthy Dutch 
population. Overall, the data showed a fair-
ly stable performance up to 60 years, but 
an age-related decline above the age of 60 
years for MRR, FFR, and MPV, leaving the 
MPT relatively unaffected. Only in women 
fundamental frequency range showed a 
marked increase from 18 to 60 years. Smok-
ing habit and profession (vocal use) had no 
influence on any of the performances.  
Looking at MRR, the age effect we found 
for the monosyllabic sequences is con-
sistent with other studies that found an 
age-related effect in people older than 65 
years.108,118,119 In contrast, Pierce et al. re-
cently assessed healthy subjects older than 
65 years and found no significant age effect 
between 65 and 86 years,111 although the 
raw scores of the 75+ group were lower than 
of the 65+ group for all but one sequence. 
We found no age effect for the trisyllabic 
sequence, although the median speed of 
performance of the 70+ age group was by 
far the slowest. The absence of an age effect 
for the trisyllabic sequence under 60 years 
Figure 6.2. The percentile reference lines of 
the individual sequences of MRR against age, 
using a piece-wise linear regression with a 
cut-off point at 60 years of age.
Table 6.4. MPT by category of body height.
body 
height
n
MPT (s)
median (range)
<159 cm 8 18.2 (11.2 – 24.0)
160-169 cm 53 17.1 (6.6 – 32.9)
170-179 cm 81 18.9 (7.7 – 47.7)
180-189 cm 65 26.8 (10.1 – 55.5)
>190 cm 17 21.1 (11.1 – 54.0)
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of age is in line with the study by Icht and 
Ben-David.106 In all age groups, /ka/ was the 
slowest sequence, which is consistent with 
previous findings.33,118 Pronouncing /ka/ 
requires moving the tongue dorsum, which 
requires movement of most of the mass of 
the tongue. Men and women performed 
equally for all MRR sequences, which is 
in line with the literature. Indeed, studies 
regarding speech production, speaking and 
articulation rates hardly ever revealed sex 
differences.33,120,121 
Previously published norm data on the FFR 
are scarce. Only data on maximum pitch 
are available, as maximum pitch is one 
of the four parameters of the Dysphonia 
Severity Index.122 In accordance with our 
study, the maximum pitch lowers in ageing 
men and women, although the causes of 
laryngeal changes are different between the 
sexes.123-125 In ageing men, bowing and vo-
cal fold atrophy are most often described, 
whereas in ageing women vocal fold edema 
is most frequent. Besides, the fundamental 
frequency (F0) decreases in post-meno-
pausal women and increases in elderly 
men.126-128 To sum up, in men, the F0 rises 
and the maximum pitch lowers, whereas in 
women both the F0 and the maximum pitch 
lower, which may explain that the full range 
(FFR) decreases more in men than in wom-
en. MPT was not related to age, but only 
Figure 6.3. The percentile reference lines of FFR and MPV against age by sex, using a piece-wise 
linear regression model with a cut-off point at 60 years of age.
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to body height, most likely because of the 
relationship between body height and lung 
function.112 Indeed, Awan reported a sig-
nificant correlation between MPT and vital 
capacity.129 The fact that we found higher 
rates for men compared to women is evi-
dent because of the interaction between sex 
and body height, and in line with the litera-
ture, revealing a longer MPT for men.122-124 
Unlike MPT, MPV was more dependent on 
age than on body height, although MPV 
depends on lung capacity as well, which 
is related to body height.112 MPT may be 
more dependent on lung volume, whereas 
MPV may be more dependent on muscle 
strength. With ageing, a decreased muscle 
strength in combination with the above 
mentioned laryngeal changes may account 
for the larger influence on MPT of age than 
body height.
In three of the four tasks, age was the most 
important factor influencing maximum 
performance tests of speech production. 
Most of this effect was observed from the 
age of 60 years and older. Human function-
ing generally declines above the age of 60 
years due to neurological, metabolic, and 
hormonal changes.130 These changes can 
have a negative influence on speech, just as 
on the physical performance of a person.131 
Looking at speech, ‘presbyphonia’ is the 
term typically used for age-related vocal 
changes.132 Yet, our study clearly shows 
that age-related changes are not confined 
to the voice, but reach out to the articula-
tion domain as well, which could be termed 
‘presbyarthria’. Indeed, in 1974, Ryan and 
Burk suggested that speech of aged adults 
may fall at the mild end of a dysarthric con-
tinuum.133 This conclusion was confirmed 
by Parnell and Amerman in a perceptual 
study, in which a mild dysarthric speaker 
was difficult to distinguish from healthy 
geriatric participants.134 Other studies that 
confirm the age-related effects regarding ar-
ticulation are those showing that speaking 
rate slows down with advanced age131,135,136 
and studies showing that the variability of 
acoustic and kinematic measures increases 
with older age.44,137 
Hence, the question is justified which un-
derlying mechanism is responsible for this 
decline of speech quality above the age of 
60 years? As healthy persons typically use 
a small amount of their maximum tongue 
strength during speech,138 normal age-re-
lated loss of orofacial muscle strength139,140 
can probably not account for loss of speech 
quality at older age. Recently, research has 
been conducted regarding non-muscular 
tissue stiffness. It was found that fibrosis 
(accumulations of excessive connective 
tissue), lipomatosis (accumulations of fatty 
cells), and amyloidosis (deposits of waxy 
proteins and polysaccharides) in tongue 
tissue increase progressively with age.141,142 
In line with these findings, Dietsch et al. 
found increased non-muscular tissue stiff-
ness of the skin overlying the masseter, 
the cheek and lateral tongue with age.143 
Another example is the study by Mefferd 
and Corder,144 who found that older adults 
(>65 years) were able to increase lower lip 
and jaw speed during an MRR test with 
/fa/, but that they had more difficulties with 
stiffness regulation and force production 
than younger adults (22–55 years). Conse-
quently, it is plausible that non-muscular 
stiffness of oral structures is a relevant cause 
for the decline in speech quality above the 
age of 60–65 years. In addition, the above 
mentioned insidious neurological changes 
may have a negative effect on speech as 
well. Indeed, if the central and peripheral 
nervous systems gradually decline, there 
will be slowing of movements, loss of 
coordination, and an increase in speech 
variability,145 although people can adapt to 
these changes by using compensatory strat-
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egies (e.g., slowing down their speaking 
rate to ensure movement accuracy).146
Typically, for all maximum performance 
tests in this study, the range of non-patho-
logical performance was large. Although 
a large range of normality has been found 
for other maximum performance tests 
such as maximum inspiratory pressure147 
or the 6-min walk test,148 a large normal 
range may complicate the interpretation of 
the performance of individual dysarthric 
speakers. Yet, the reference lines provide 
the patient’s performance with a percentile 
score. Nevertheless, qualitative character-
istics of maximum performance tasks are 
equally important to identify underlying 
pathology (weakness, rigidity, coordina-
tion deficits) and, thus, to contribute to 
the assessment of the type and severity of 
dysarthria. 
Strengths and limitations
Our participants formed a fair represen-
tation of the general Dutch population,149 
as we included various age groups between 
18 and 80 years with a mean body height 
of 175.5 cm (SD = 9.6, range 155–201) and 
a variation in professional voice use. How-
ever, we assessed only participants who 
had Dutch as their first language. It is, 
therefore, questionable whether our refer-
ence values are also applicable to people 
with other first languages or to people 
with Dutch as a second language. Icht and 
Ben-David suggested that their across-lan-
guage differences in the trisyllabic MRR 
sequence could be explained by different 
tongue settings, influencing the /t/ and 
/k/.106 In addition, the English /p/, /t/ and 
/k/ are aspirated, whereas these syllables in 
Dutch are not. Therefore, it seems valuable 
to extend our population with participants 
speaking Dutch as a second language and 
to compare our data with equally sized 
groups with other first languages using the 
same assessment protocol. 
Generalizability is related to age range 
as well. We included participants from 18 
years old, because normal values of chil-
dren up to 17 years are being collected in 
preparation of the pediatric RDA. Because 
we took 80 years as the upper age limit, the 
normal values are not applicable to dysar-
thric patients older than 80 years. 
Another limitation is that we used several 
examiners to collect the data. Although 
they were all trained by the first author 
(S.K.), we cannot rule out subtle differences 
in examination approach due to inter-ob-
server variability. We did not control for 
test-retest variability either, but all partici-
pants performed each task three times and 
we used their best performance for analysis.
CoNCLUSIoN
This study provides reference values of four 
maximum performance tests of speech 
production to compare the performance of 
dysarthric patients with non-pathological 
speech performance. Age was identified 
as the most important factor influencing 
MRR, FFR, and MPV (> 60 years), where-
as MPT was primarily influenced by body 
height. Only women showed effects of age 
on FFR (increase) and MPV (decrease) 
< 60 years. Interestingly, age-related chang-
es were not confined to the voice, but 
reached out to the articulation domain as 
well, which could be referred to as ‘presby-
arthria’.
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7 Dysarthria assessment: a first step to reach better levels of accuracy by video training
AbSTRACT
Background
Diagnosing dysarthrias is notoriously difficult and requires extensive training. For this purpose, the 
Radboud Dysarthria Assessment was provided with 43 online training videos of all dysarthria types 
and severity levels. 
Aims
This pilot study was conducted to evaluate whether the use of training videos improves the correct 
identification of dysarthria type and severity by both experienced speech-language therapists (SLTs) 
and SLT students. 
Methods and procedures
Twenty-six SLT students received a one-day training including 10 videos and 19 SLTs were given 
access to 20 online videos for self-study. Before and after the training, both groups identified the 
type and severity of dysarthria in 10 new test videos. Their judgments were compared to a reference 
diagnosis, which was based on consensus by experts.
Outcomes and results
On average, the SLT students improved their agreement with the reference diagnosis on the type of 
dysarthria from 29.2% to 37.2%, and from 47.9% to 52.5% regarding the severity of dysarthria. Expe-
rienced SLTs improved their agreement regarding the type of dysarthria from 42.8% to 46.9%, and 
from 53.2% to 54.7% regarding the severity of dysarthria.
Conclusions and implications
Our results show that improvement in the correct identification of dysarthria type and severity is 
possible by means of a short training program with either 10 guided training (SLT students) or 20 
self-study (experienced SLTs) videos, but that both training programs did not yet lead to acceptable 
levels of agreement with a reference diagnosis. To obtain better levels of diagnostic accuracy, more 
intensive training programs are needed.
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INTRoDUCTIoN
In 2014, we developed the Radboud Dysar-
thria Assessment (RDA), a diagnostic tool 
for Dutch and Flemish speech-language 
therapists (SLTs) to assess both the type 
and severity of dysarthria.107 In the RDA, 
the speech characteristics are assessed 
using spontaneous speech, a reading text, 
and four maximum performance tasks of 
speech production (maximum repetition 
rate, maximum phonation duration, max-
imum phonation volume and fundamen-
tal frequency range). The development of 
the RDA and the construct validity and 
reliability of the severity scale have been 
described in a previous article.150 In this 
study, we evaluate the correct assessment of 
the type of dysarthria, which has been prov-
en to be very difficult, even for experienced 
SLTs.151,152 Thus, in an attempt to stimulate 
SLTs to improve their diagnostic skills, the 
RDA has been provided with 43 training 
videos of all dysarthria types and severity 
levels to be used for self-study or education. 
We applied the Mayo Clinic classification 
system9 to categorize dysarthria as either 
‘flaccid’, ‘spastic’, ‘ataxic’, ‘hypokinetic’, ‘hy-
perkinetic’ or ‘mixed’. This classification is 
commonly used by Dutch SLTs as part of 
their initial SLT education. The purpose of 
this pilot study was to evaluate our aim that 
adding training videos to the RDA would 
improve the correct identification of dysar-
thria type and severity by SLT students as 
well as by experienced SLTs. 
mETHoDS
Participants
Twenty-six SLT students who participat-
ed in a minor ‘Neurorehabilitation’ at the 
HAN University of Applied Sciences agreed 
to participate. All participants had received 
basic education about dysarthria as part of 
their bachelor SLT education. 
To recruit experienced SLTs, requests were 
sent by e-mail to 46 SLTs who were either 
part of a network of SLTs working in hospi-
tals across the Netherlands or of a network 
of SLTs working with neurological patients 
in the region of Nijmegen; 22 of them (48%) 
responded positively. Because 3 SLTs were 
asked to score the selected videos twice to 
determine the intra-rater reliability of the 
severity scale,150 19 SLTs were included in 
this training study. Twelve SLTs worked 
in a general hospital, three in a university 
hospital, two in a nursing home, and one in 
a private practice. One SLT worked both in 
a hospital and in a nursing home. On aver-
age, the 19 SLTs had worked 12 years with 
dysarthric patients (range 4–26 years).
Videos
For the training videos, we videotaped 25 
men (mean age 55, range 26–77 years) and 
18 women (mean age 58, range 14–79 years) 
while they were assessed with the RDA. 
These 43 patients suffered from a variety 
of acute neurological, neuromuscular or 
neurodegenerative disorders. All video re-
cordings were made with a high definition 
camera and a separate microphone. The 
type and severity of the dysarthria of each 
patient was discussed in an expert group of 
seven SLTs who developed the RDA, until 
consensus was reached.150 The outcome 
of this consensus process is referred to as 
the ‘reference diagnosis’. The 43 available 
videos showed all dysarthria types: ‘flaccid’ 
(n = 12), ‘spastic’ (n = 2), ‘ataxic’ (n = 8), 
‘hypokinetic’ (n = 5), ‘hyperkinetic’ (n = 5), 
and ‘mixed’ (n = 11). We constructed two 
sets of 10 test videos, whereas 27 training 
videos were created by adding detailed 
patient information and diagnostic de-
scriptions. We matched the test videos for 
type and severity of dysarthria with the 
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training videos (i.e., if the test video includ-
ed an ataxic dysarthria, severity level 3, at 
least one of the training videos included a 
similar type and severity of dysarthria). In 
addition, one non-dysarthric person was 
videotaped, which we included in the set 
of 10 test videos for the experienced SLTs 
in order to be able to identify false positive 
judgments. The reason for this was that the 
experiment with the SLT students made us 
realize that before deciding on the type of 
dysarthria, judging whether speech is nor-
mal or pathological can already be difficult.
All patients signed informed consent. Ap-
proval was obtained from the Medical Eth-
ics Committee of the Radboud University 
Medical Center.
Procedure 
The 26 SLT students received a one-day 
training by a lecturer specialized in mo-
tor speech disorders. Their training was 
focused on the correct assessment of the 
type and severity of dysarthria in 10 se-
lected (based on the matching) training 
videos. The number of training videos was 
restricted to 10, because the training was 
limited to one day. One week before and 
ten days after the training, the students 
were asked to score the type and severity of 
dysarthria for the same set of 10 test videos. 
The 19 experienced SLTs were given access 
to 20 online training videos via a secured 
online web service. They also got access 
to the part of the test manual containing 
detailed diagnostic descriptions of all dys-
arthria types. These SLTs had 3 weeks to 
complete the online training, during which 
they noted the number of training hours. 
Shortly before and after the training they 
scored the same set of 10 online test videos, 
including the video of the non-dysarthric 
person, but they were kept unaware of 
the neurological diagnosis of the patients 
shown on the videos. All raters scored the 
dysarthria type and severity using a Mic-
rosoft Office Access form. All ratings were 
compared with the reference diagnosis. 
Statistical analysis
The number of test videos (10) in relation 
to the number of dysarthria types (6) did 
not allow calculation of representative 
Kappa values, so instead we calculated the 
percentage of absolute agreement with the 
reference diagnosis per dysarthria type 
and severity before and after the training. 
The overall percentage of agreement was 
calculated per group for all 10 test videos. 
The following rules were applied to handle 
the ‘mixed’ dysarthrias. First, if a single 
dysarthria was incorrectly identified as 
‘mixed’, the individual dysarthria type that 
was correctly identified was counted for 
1/(number of dysarthria types identified). 
Second, if a ‘mixed’ dysarthria was scored 
as a single dysarthria type, this added to 
the agreement on the ‘mixed’ type for 50% 
if the single dysarthria type was part of 
the mixed reference diagnosis. Third, if a 
‘mixed’ dysarthria type was scored partial-
ly correct, the individual dysarthria types 
that were correctly identified were counted, 
each for 1/(number of dysarthria types iden-
tified). Therefore, the column of the mixed 
dysarthria in Tables 7.1 and 7.3 does not 
always sum up to 100%. 
Chi-square tests were used to assess wheth-
er the years of dysarthria experience and 
the number of training hours affected the 
level of agreement with the reference diag-
nosis (IBM SPSS Statistics 22 for Windows; 
IBM Corp., Armonk, NY).
RESULTS
SLT students
Before the training, the type of dysarthria 
was correctly identified by 29.2% of the 
26 students (Table 7.1). After the training, 
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this number improved to 37.2% (27% rela-
tive improvement), while the error pattern 
stayed almost the same. Both ‘flaccid’ and 
‘hypokinetic’ dysarthrias were correctly 
identified by the majority of the students, 
albeit with a higher percentage after the 
training. ‘Spastic’ and ‘ataxic’ dysarthrias 
were most frequently misclassified as 
‘flaccid’ dysarthria, and ‘hyperkinetic’ as 
‘spastic’ dysarthria. None of the students 
was able to correctly identify ‘mixed’ dysar-
thria, neither before nor after the training. 
In 32% of the cases before and in 21.2% after 
the training, ‘mixed’ dysarthria was scored 
Table 7.1. Percentage absolute agreement of SLT students with the reference diagnosis (type of 
dysarthria) before and after the training. 
Reference diagnosis (type of dysarthria)
Flaccid 
(n = 3)
Spastic 
(n = 1)
Ataxic 
(n = 2)
Hypokinetic 
(n = 2)
Hyperkinetic 
(n = 1)
Mixed*  
(n = 1)
before after before after before after before after before after before after
Flaccid 64.6 71.0 34.0 38.5 58.3 57.7 22.8 22.1 4.2 - 8.0 28.8
Spastic 1.3 6.3 19.6 15.4 2.0 - 11.7 10.6 57.6 40.4 ** **
Ataxic 12.6 15.7 25.3 36.5 12.2 30.8 11.3 3.8 26.4 36.5 ** **
Hypo 16.9 0.6 12.3 - 21.6 11.6 35.0 65.4 - 3.8 2.0 23.1
Hyper 4.7 6.1 8.7 9.6 6.0 - 19.3 - 11.8 19.2 32.0 3.8
Mixed N. A. N. A. N. A. N. A. N. A. N. A. N. A. N. A. N. A. N. A. 32.0 21.2
Bold: highest agreement. * mixed spastic-ataxic. This column does not amount to 100% (see section on 
statistical analysis). ** included in the mixed dysarthria for 50% per type. Abbreviations used: N. A., not 
applicable (they are included in the individual types for 50%).
Table 7.2. Percentage absolute agreement of SLT students with the reference diagnosis (severity 
of dysarthria) before and after the training.
Reference diagnosis (severity of dysarthria*)
0 1 2 
(n = 3)
3 
(n = 4)
4 
(n = 2)
5  
before after before after before after before after before after before after
0 2.5 0 3.1
1 44.1 41.0 12.9 4.0
2 44.3 42.2 29.6 38.5 1.9 3.9
3 9.0 15.4 40.6 44.1 7.7 9.6
4 1.3 16.0 8.7 58.7 71.2
5 0.8 1.6 31.7 15.4
Bold: highest agreement. * Severity rating: 0, no dysarthria; 1, minimal dysarthria; 2, mild dysarthria; 3, 
mild-moderate dysarthria; 4, severe dysarthria; 5, very severe dysarthria/anarthria.
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partially correctly: i.e. only one of the dys-
arthria types contributing to ‘mixed’ dysar-
thria was scored correctly.  
The severity of dysarthria was correctly 
identified by 47.9% of the students before 
the training (Table 7.2). After the training, 
this number improved to 52.5% (10% rela-
tive improvement). 
Experienced SLTs
Before the training, the SLTs agreed with 
the reference diagnosis in 42.8% of the 
cases (Table 7.3). After the training, they 
Table 7.3. Percentage absolute agreement of experienced SLTs with the reference diagnosis (type 
of dysarthria) before and after the training.
Reference diagnosis (type of dysarthria)
Flaccid 
(n = 2)
Spastic 
(n = 1)
Ataxic 
(n = 2)
Hypokinetic 
(n = 1)
Hyperkinetic 
(n = 2)
Mixed*  
(n = 1)
before after before after before after before after before after before after
Flaccid 52.8 54.0 10.5 10.5 30.3 36.8 28.9 26.3 13.9 18.4 ** **
Spastic 16.7 14.5 55.3 34.2 2.7 - 15.8 18.4 13.5 9.3 23.7 25.4
Ataxic 4.2 14.5 18.4 34.2 36.9 44.7 2.6 15.8 23.1 13.2 ** **
Hypo 19.5 17.1 2.6 - 22.4 13.2 42.1 39.5 8.4 9.2 9.6 5.3
Hyper 7.0 - 13.2 21.1 7.9 5.3 10.5 - 41.3 50 25.4 10.5
Mixed N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 28.1 58.7
Bold: highest agreement. * mixed flaccid-ataxic. This column does not amount to 100% (see section on 
statistical analysis). **included in the mixed diagnosis for 50%. N. A.: not applicable (they are included 
in the individual types for 50%).
Table 7.4. Percentage absolute agreement of experienced SLTs with the reference diagnosis (se-
verity of dysarthria) before and after the training. 
Reference diagnosis (severity of dysarthria*)
0 
(n = 1)
1 2 
(n = 4)
3 
(n = 3)
4 
(n = 2)
5  
before after before after before after before after before after before after
0 52.6 36.8 2.6 1.8
1 42.1 57.9 35.5 10.5 1.8
2 5.3 5.3 38.2 51.3 22.8 8.8
3 23.7 38.2 50.9 59.7 21.1 18.4
4 22.8 28.2 71.1 71.1
5 7.9 10.6
Bold: highest agreement. * Severity rating: 0, no dysarthria; 1, minimal dysarthria; 2, mild dysarthria; 3, 
mild-moderate dysarthria; 4, severe dysarthria; 5, very severe dysarthria/anarthria.
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agreed in 46.9% of all cases (10% relative 
improvement). Before the training, only 
one SLT was able to correctly identify 
‘mixed’ dysarthria versus two SLTs after the 
training. Correct identification of one of 
the dysarthria types contributing to ‘mixed’ 
dysarthria was improved after the training 
from 28.1% to 58.7%. The highest agreement 
per dysarthria type was consistently in line 
with the reference diagnosis.
The non-dysarthric speaker was judged 
as being dysarthric nine times before the 
training (47.4% false positives) versus 12 
times after the training (63.2% false posi-
tives). None of the dysarthric patients were 
judged as non-dysarthric (0% false nega-
tives).
The severity of dysarthria was correctly 
identified by 53.2% of the SLTs before the 
training (Table 7.4). After the training, this 
number improved to 54.7% (3% relative im-
provement).
The SLTs used on average 5.5 hours (range 
1.5–19 hours) for the online training. Eleven 
SLTs (57.9%) trained less than 5 hours, five 
SLTs (26.3%) 5 to 10 hours, and three SLTs 
(15.8%) 10 hours or more. Chi-square tests 
revealed no significant correlations be-
tween the level of agreement with the refer-
ence diagnosis and the number of training 
hours (p = .541), nor between level of agree-
ment and years of experience (p = .678).
DISCUSSIoN
This pilot study showed that correct clas-
sification of dysarthria type and severity 
can be improved by a short training using 
10 or 20 videos, but also that percentages 
of correct dysarthria type identification 
remained below 50%. Percentages of cor-
rect judgment of dysarthria severity were 
slightly higher, but did not exceed 55%. For 
SLT students, the initial percentages and 
the relative improvement can be consid-
ered acceptable because of their inexpe-
rience and the fact that they are still in a 
learning process. For the SLTs experienced 
with dysarthric patients, however, the over-
all agreement before and after training was 
unsatisfactory.
In both study groups, the training results 
showed only small improvements, which 
was much less than we expected. In fact, if 
we had not allowed the mixed dysarthrias 
to be partially correct, the overall agree-
ment would have been even lower. We 
know from previous studies that absolute 
agreement rates regarding the type of dysar-
thria do not exceed 40% when the medical 
diagnosis is unknown, even in experienced 
SLTs, although this may differ for different 
types of dysarthria.151-153 In these studies, 
however, the speech tasks presented were 
limited. We anticipated that providing 
all speech tasks of the RDA might result 
in higher levels of agreement, as critical 
speech characteristics leading to a particu-
lar dysarthria type may be more prominent 
in specific speech tasks. In addition, in both 
study groups, we explicitly highlighted the 
specific speech characteristics per dysar-
thria type in the different speech tasks. For 
example, mild coordination problems in 
ataxic dysarthria may not be identified in 
spontaneous speech if a patient slows down 
his speaking rate. But when performing 
maximum repetition rate, the sequence will 
likely be dysrhythmic or the articulation 
more slurred. However, because we did not 
explicitly compare the difference between 
scoring dysarthria type based on sponta-
neous speech versus using all speech tasks, 
we cannot draw any conclusions from this 
study about the added effect of providing 
all speech tasks.  
In both study groups, agreement on the se-
verity of dysarthria was higher than on the 
type of dysarthria. This is not surprising 
given the fact that the inter-rater reliability 
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of the severity scale showed good agree-
ment (ICC 0.85) previously.150 Remarkably, 
experienced SLTs showed a relatively high 
number of false positives judgments of the 
non-dysarthric patient, which may be ex-
plained by two factors. First, the non-dys-
arthric person spoke very articulated, 
which might have caused suspicion of this 
person using a compensation strategy for 
some type of dysarthria. Second, the SLTs 
were focused on classifying dysarthria and 
were kept unaware that a non-dysarthric 
speech sample was included. 
Differences between the performance of 
SLT students and SLTs.
The observation that SLT students showed 
a lower level of agreement than experienced 
SLTs before and after the training is un-
derstandable, because the students lacked 
clinical experience. In fact, the majority of 
the SLT students had never seen a patient 
with dysarthria in real life yet. In contrast, 
we can assume that the experienced SLTs 
had developed internal perceptual repre-
sentations of several types of dysarthria by 
assessing and treating these patients over 
the years. The lack of experience of SLT 
students may also explain why their relative 
improvement after training was larger than 
for the experienced SLTs. The fact that the 
experienced SLTs improved on average only 
10% by watching the training videos may be 
explained by two factors. First, more than 
half of the SLTs trained less than 5 hours. 
As each video takes approximately 15 min-
utes to watch, the majority did not study 
all 20 videos in detail. Second, established 
internal perceptive representations may be 
difficult to change by only watching videos 
without interaction or feedback. 
Remarkably, the SLT students were able to 
identify flaccid and hypokinetic dysarthria 
types better than spastic, ataxic and hyper-
kinetic types. The latter three probably rep-
resent more variable speech deficits, which 
are difficult to interpret for inexperienced 
SLT students. In accordance with the study 
of Fonville et al.,152 our study also showed 
that mixed dysarthria was the most difficult 
type to identify.
Factors that may influence dysarthria type 
classification
Table 7.3 shows that the highest level of 
agreement per dysarthria type in experi-
enced SLTs was always in line with the ref-
erence diagnosis, which supports the fact 
that the reference diagnoses were set cor-
rectly by the experts. Still, the percentage of 
agreement was around 50% or lower sug-
gesting that, in general, SLTs wrongly clas-
sify dysarthric patients in half of the cases. 
There are several explanations for this re-
sult. One important reason is the misinter-
pretation of compensatory speech behavior. 
During the expert meetings in which the 
reference diagnoses were set, we learned 
that the use of compensatory speech strat-
egies by dysarthric patients was the most 
problematic factor for reaching agreement. 
For example, some patients with a weak 
vocal quality compensated with hyperton-
ic vocal use. The hypertonic vocal use was 
not consistently present during all speech 
tasks but, on occasion, it was erroneously 
classified as a spastic speech characteristic, 
which is incorrect because a dysarthric 
characteristic is supposed to be consistent-
ly present.6 In line with this explanation, 
some speech characteristics may have been 
overrated, because the SLT students and 
experienced SLTs tried very hard to iden-
tify every deviant characteristic. Another 
explanation for the difficult identification 
of dysarthria type may be that we provid-
ed our participants only with the patients’ 
speech performances. In clinical practice, 
however, SLTs usually perform an oral mo-
tor examination for a better interpretation 
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of the speech characteristics. In addition, 
the medical history of the patient is often 
known, which facilitates the recognition 
of typical speech characteristics.153 Final-
ly, we assessed and videotaped dysarthric 
patients without selecting ‘typical’ patients 
as they are reported in textbooks, which 
supports the clinical validity of our test and 
training videos, but also revealed that many 
different patients samples and many hours 
of training are needed to correctly diagnose 
motor speech disorders. 
Finally, the relevance of a correct or incor-
rect dysarthria diagnosis may be questioned 
from a clinical perspective. In a medical 
diagnostic process correct identification is 
obviously of crucial importance, but what 
are the consequences of a misdiagnosis of 
dysarthria for its treatment? In acute neuro-
logical disorders such as stroke, SLTs make 
use of rehabilitation techniques that are dif-
ferent for predominant weakness than for 
predominant coordination problems.6 In 
progressive neurological disorders, speech 
therapy is primarily aimed at learning com-
pensatory speaking techniques, which are 
also (partly) dependent of dysarthria type. 
For example, in hypokinetic dysarthria, 
the Pitch Limiting Voice Treatment154 or 
Lee Silverman Voice Treatment155 are rec-
ommended to overcome the hypokinetic 
speech, whereas in amyotrophic lateral 
sclerosis speech therapy is more focused on 
communicative effectiveness and augmen-
tative communication.7 Thus, a correct di-
agnosis of dysarthria type seems to matter 
when deciding on the type of treatment.
Limitations of the current study
SLT students were trained as part of their 
initial education, whereas experienced 
SLTs were expected to be able to use the 
RDA after self-study of the videos and de-
scriptions. Hence, because of the different 
experimental set-ups, the comparison be-
tween SLT students and experienced SLTs 
can only be descriptive. The experienced 
SLTs did not have an interactive training, 
where the interaction and discussions 
with the SLT students may have led to a 
relatively large improvement. We did not 
monitor the self-study of the experienced 
SLTs, nor did we ask them if they felt that 
they had been struggling or if they were 
surprised about the correct outcomes. As 
a consequence, we are unaware of which 
videos they studied, how they studied these 
videos, and how they valued the diagnostic 
tests. A final study limitation is that not 
all dysarthria types were equally available 
in our video material, which restricted the 
matching of the test videos with the train-
ing videos. 
CoNCLUSIoN AND fUTURE 
PERSPECTIVES
A short training program with 10 or 20 
videos improves correct identification of 
dysarthria type and severity, but agreement 
rates are still clinical unacceptable. To im-
prove and re-evaluate clinicians’ skills to 
correctly diagnose dysarthria types, we aim 
to complete our set of video examples with 
all different dysarthria types and severity 
levels. Because this study suggests that ac-
cess to exemplary videos alone is not very 
effective in itself, the next step will be to 
design attractive e-learning modules with 
explicit training tasks and questions or to 
develop a combined program of e-learn-
ing and an interactive course (blended 
learning). Although reports on the clinical 
consequences of misdiagnosed dysarthrias 
for the efficacy of treatment are lacking, we 
believe that with more effective learning 
programs agreement rates of 80% or higher 
may be attainable with a potentially im-
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portant impact on the efficacy of dysarthria 
treatment. 
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SUmmARY
Speech is unique for humans and, despite 
the rise of social media, daily communi-
cation is highly dependent on spoken lan-
guage. When a neurological disease affects 
speech, this is called dysarthria. Dysarthria 
can be caused by (sub-)acute central neu-
rological, central neurodegenerative or pe-
ripheral neuromuscular diseases (NMD). 
The first part of this thesis focuses on the 
prevalence rates and the evidence for 
treatment of dysarthria and dysphagia in 
patients with NMD. Dysphagia is added, 
because dysarthria often co-occurs with 
dysphagia, as both disorders are caused 
by oromotor problems within overlapping 
muscle groups. The second part of this 
thesis focuses on the development of the 
Radboud Dysarthria Assessment (RDA).
This thesis aims to 1) examine prevalence 
rates of dysarthria and dysphagia in NMD, 
2) summarize the evidence for treatment 
of dysarthria and dysphagia in NMD, and 
3) develop and evaluate a dysarthria assess-
ment at the level of speech function. 
In chapter 1, a general introduction to 
dysarthria and dysphagia is provided by 
presenting an overview of neurological 
diseases that can cause dysarthria and/or 
dysphagia. In addition, a theoretical ap-
proach to the different types of dysarthria is 
presented. Finally, aims and outline of this 
thesis are described.
Part I
In part one of this thesis, prevalence rates 
of dysarthria and dysphagia in NMD are 
presented, and evidence for treatment of 
dysarthria and dysphagia in NMD is iden-
tified (aims 1 and 2). 
In chapter 2, high prevalence rates of 
dysarthria and dysphagia in a large group 
(n = 220) of patients with various types of 
NMD are demonstrated. Pooled prevalence 
rates were estimated per patient group by 
weighting each disease category accord-
ing to sample size, as the patients were 
not distributed equally across the disease 
categories within the groups. The pooled 
prevalence of dysarthria was 46% in an 
unselected cohort of outpatients and 62% 
in a selected cohort. The pooled prevalence 
of dysphagia was 36% in an unselected co-
hort and 58% in a selected cohort. There 
was a modest but significant association 
between the presence of dysarthria and 
dysphagia (rs = 0.40; p <0.01). Although 
dysphagia was generally mild, dysarthria 
was moderate to severe in 15% of the dys-
arthric patients. Interestingly, dysarthria 
and dysphagia were found among patients 
with NMD that are not typically associated 
with these disorders. The most remarkable 
results were the high prevalence rates of 
both dysarthria and dysphagia in patients 
with metabolic and other myopathies. The 
fact that dysarthria and dysphagia were 
both highly prevalent in (most of the time) 
slowly progressive diseases emphasizes the 
need that physicians should evaluate both 
dysarthria and dysphagia independent of 
the type of NMD. Even though not every 
patient with a progressive disease will ben-
efit from treatment directed at improving 
their speech and/or swallowing efficacy, 
these patients may still profit from learn-
ing individually tailored functional com-
pensations delivered by an experienced 
speech-language pathologist.
Chapter 3 describes the presence of dys-
phagia in Myotonic Dystrophy type 2 
(DM2). Dysphagia is a predominant and 
potentially life-threatening feature of Myo-
tonic Dystrophy type 1, but had not been 
examined in DM2. DM2 patients who 
reported swallowing difficulties based on 
the Gastrointestinal Symptoms Question-
naire were recruited for this study (n = 10). 
They were clinically investigated by an 
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experienced speech therapist in neuro-
muscular disorders. Eight DM2 patients 
gave additional informed consent to fiber-
optic endoscopic evaluation of swallowing 
(FEES). Dysphagia could be confirmed in 
all patients (clinically in 100%, with FEES 
in 88%), and was more pronounced in old-
er DM2 patients. The severity of dysphagia 
was generally mild and none of the patients 
had suffered aspiration pneumonia in the 
past or had significant weight loss.
Chapter 4 identifies the evidence for the 
effects of interventions by speech-language 
pathologists in adult patients with NMD. 
In a systematic review, we summarized 
and evaluated the literature on the effec-
tiveness of interventions for dysarthria 
and dysphagia. Inclusion was restricted to 
peer-reviewed articles published in the En-
glish, German, French or Dutch language. 
Inclusion criteria were 1) information and 
advice regarding dietary modification, aug-
mentative and alternative communication 
and instruction of the patient and relatives, 
and 2) compensatory strategies regarding 
teaching of swallowing maneuvers and/or 
strategies to improve intelligibility. Single 
case studies were excluded. The search 
strategy identified 1.772 articles, but only 
4 fulfilled all inclusion criteria. Those 4 
studies were all ranked as ‘other designs’. 
The methodological quality of the studies 
was found sufficient for only one uncon-
trolled pre-post study. This study assessed 
the influence of ptosis on swallowing in 
patients with oculopharyngeal muscle dys-
trophy (OPMD).46 When the head position 
was slightly flexed and, thus, not adapted 
to the ptosis, there were indications that 
swallowing efficiency improved in patients 
with OPMD (level III evidence). The main 
conclusion from this review was that the 
published evidence for the effectiveness 
of interventions by speech-language pa-
thologists in adults with NMD is still very 
limited. 
Part II
In the second part of this thesis, the de-
velopment of the Radboud Dysarthria 
Assessment (RDA) is described, includ-
ing the provision of reference values for 
maximum performance tests of speech 
production (aim 3).
Chapter 5 summarizes the development 
and validation of the RDA. A first version 
of the RDA (freely available and unvalidat-
ed) was made available online in 2007, but 
we felt the need to improve and validate 
the instrument. First, national consensus 
was sought for the tasks and the qualita-
tive recording form. Second, we added a 
self-evaluation questionnaire. Third, we 
clinimetrically evaluated the recording 
form, severity scale, and the self-evalua-
tion questionnaire. Finally, training videos 
were added, demonstrating all types and 
severities of dysarthria including a de-
tailed interpretation of the assessment for 
self-training purposes. Exploratory factor 
analysis of the recording form extracted 
four factors (articulation, resonance, pho-
nation, respiration/prosody) that yielded 
an explained variance of 70.3%. Each fac-
tor showed good internal consistency. The 
self-evaluation questionnaire showed ex-
cellent internal consistency and intra-class 
correlation coefficients of the severity scale 
showed good reliability. The severity scores 
and self-evaluation questionnaire correlat-
ed substantially to strongly with the Speech 
Handicap Index (SHI) and substantially 
with the Dutch sentence intelligibility 
assessment (NSVO-Z). Based on these re-
sults, we concluded that the RDA is a valid 
and reliable tool for diagnosing the severity 
of dysarthria. Further investigation is need-
ed to demonstrate whether this instrument 
can successfully support speech-language 
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therapists in correctly diagnosing also the 
type of dysarthria.
Chapter 6 describes a study assessing mul-
tiple maximum performance tests of speech 
production in a large population (n = 224) 
of healthy Dutch adults between 18 and 80 
years with the aim to collect reference val-
ues. All subjects performed the following 
maximum performance tests: maximum 
repetition rate (MRR), maximum phona-
tion time (MPT), fundamental frequency 
range (FFR), and maximum phonation vol-
ume (MPV). Initially, univariate analysis 
was used to explore the association between 
each maximum performance test and per-
sonal characteristics (age, sex, body height, 
profession, and smoking habit). Then, 
characteristics with a p-value of < 0.05 were 
included in a multivariate linear regression 
to study their unique influences. We used 
a wide range of models on each maximum 
performance test of speech production. The 
Likelihood-Ratio test was used to test the 
differences between the models for their 
goodness of fit to the data. MRR, FFR and 
MPV were statistically significant related 
to age, whereas MPT was related to body 
height. Thus, in three of the four tasks, age 
was the most influential factor, especially 
from the age of 60 years and older. It was 
not clear which underlying mechanism 
was responsible for the observed decline 
with age, but we argued that — in addition 
to neurological, metabolic, hormonal and 
physical changes — non-muscular tissue 
stiffness might play a role. The range of 
non-pathological performance was large, 
which may complicate the interpretation 
of the performance of individual dysarthric 
speakers.
In chapter 7, we evaluate whether the use 
of the training videos of the RDA improves 
the correct identification of dysarthria 
type and severity by both experienced 
speech-language therapists (SLTs) and SLT 
students. The SLT students received a one-
day training focused on the correct assess-
ment of the type and severity of dysarthria 
in 10 selected training videos. One week 
before and ten days after the training, the 
students were asked to score the type and 
severity of dysarthria for the same set of 
10 test videos. The experienced SLTs were 
given access to 20 online training videos 
via a secured online web service. They also 
got access to the part of the test manual 
containing detailed diagnostic descriptions 
of the different dysarthria types. The SLTs 
had 3 weeks to complete the online train-
ing, during which they noted the number 
of training hours. Shortly before and after 
the training they scored the same set of 
10 online test videos. All judgments were 
compared to a reference diagnosis, which 
was based on consensus by multiple ex-
perts. Regarding the type of dysarthria, 
SLT students improved from 29.2% to 37.2% 
and SLTs from 42.8% to 46.9%. Regarding 
the severity of dysarthria, SLT students 
improved from 47.9% to 52.5% and SLTs 
from 53.2% to 54.7%. In SLTs, there were no 
significant correlations between the level of 
agreement with the reference diagnosis and 
the number of training hours, nor between 
the level of agreement and years of experi-
ence. Both training programs did not yet 
lead to acceptable levels of agreement with 
the reference diagnosis. To obtain better 
levels of diagnostic accuracy, it appears 
that more intensive, or adapted training 
programs are needed.
GENERAL DISCUSSIoN
The general discussion of this thesis is di-
vided in three parts. Part one of this general 
discussion is aimed at the scope of interna-
tional dysarthria assessments and the ratio-
nale behind some of the choices we made 
during the process of developing the RDA. 
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In addition, the importance of determin-
ing the type and severity of dysarthria are 
discussed. Subsequently, the importance of 
treating dysarthria (Part two of this gener-
al discussion) and dysphagia (Part three) 
in NMD will be discussed, as well as our 
thoughts regarding treatment options and 
future perspectives.
GENERAL DISCUSSIoN PART ONE
Dysarthria assessments worldwide
The first attempt to clinically assess dysar-
thria was made in 1969 by Darley, Aronson 
and Brown who listed 38 auditory param-
eters to rate on a 7-point scale: the Mayo 
Clinic rating system.9 They concluded that 
specific combinations of speech character-
istics could differentiate six types of dysar-
thria, i.e. flaccid, spastic, ataxic, hypokinet-
ic, hyperkinetic, and mixed. However, the 
rating system never became a standardized 
assessment tool, probably because of its ex-
tensive number of parameters and limited 
inter-rater reliability.151,156 Despite the fact 
that the Mayo Clinic rating system was not 
clinically used, a hand full of other dys-
arthria assessments have been developed 
over the last decades. 
In 1980, the well-known and later on in 
German and Dutch translated Frenchay 
Dysarthria Assessment (FDA) was devel-
oped in the UK.157 The FDA was revised 
in 2008 (FDA-2).84 In the UK, the FDA-2 
is still the standard assessment tool, al-
though international contacts told us that 
especially experienced SLTs have devel-
oped their own scoring system. The FDA-2 
combines observations of oral structures 
and nonverbal oral functions, assessment 
of speech characteristics, and measure-
ment of intelligibility in eight sections and 
is, therefore, aimed at all domains of the 
International Classification of Functioning 
(ICF), i.e. function (motor speech and oral 
motor), activity and participation. After 
the assessment, the scores lead to a ‘profile’ 
which should match with a specific dysar-
thria type. One could argue that the FDA-2 
has too much focus on the observation of 
oral structures, whereas the assessment of 
speech characteristics is relatively limited. 
Besides, intelligibility is tested with 12 ran-
domly chosen words out of 50 words, lead-
ing to familiarity with the words by the SLT 
after only a couple of patients. Familiarity 
with the words influences the intelligibility 
scores, making the test less reliable. 
In 1982, the Robertson Dysarthria Profile158 
was published in the UK, but it never be-
came equally known as the FDA. The Rob-
ertson Dysarthria Profile is largely focused 
on facial musculature and speech-like tasks 
to examine the respiration and phonation, 
while articulatory characteristics are only 
scarcely assessed and described. The Italian 
version of the Robertson Dysarthria Profile 
is the most frequently used dysarthria as-
sessment in Italy. 
In 1993, the ‘Dysartritest’ was developed in 
Sweden, which was revised in 2015.159 This 
dysarthria assessment is the standard dys-
arthria assessment in Sweden. It includes 
14 oromotor tasks, but is also focused on 
speech functions and intelligibility. The 
‘Dysartritest’ is not aimed at classifying 
dysarthria types, but only at severity and 
a description of dysarthric characteristics 
(e.g. slow speaking rate, monoloudness). 
Recently, in 2017, the Bogenhausener Dys-
arthrieskalen (BoDys) was developed in 
Germany.105 The BoDys is the only instru-
ment that focuses purely on speech (con-
versational speech, sentence repetition, text 
reading, and picture story) because, based 
on the authors opinion, the motor system 
controlled for speech is independent of the 
motor control system for speech-like (e.g. 
maximum repetition rate) and non-speech 
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tasks (i.e. oromotor movements).90,105,160 
Like the ‘Dysartritest’, the BoDys focuses 
only on the severity of dysarthria, using a 
4-point scale from most severe (0) to no im-
pairment (4) for the following nine scales: 
respiration, voice level, voice quality, voice 
stability, articulation, nasal resonance, 
articulation rate, fluency, and prosodic 
modulation. The BoDys has a good inter-
rater reliability and a high discriminant 
and convergent validity.105 Italian SLTs are 
currently translating the BoDys with the 
aim to replace the Robertson Dysarthria 
Profile.
Parallel to the process of developing the 
BoDys, we developed the RDA to provide 
Dutch and Flemish SLTs with a stan-
dardized and valid dysarthria assessment 
(Chapter 5). In the Netherlands, the RDA 
is called ‘Nederlandstalig Dysartrieonder-
zoek – volwassenen’ (Dutch Dysarthria 
Assessment – adults). In international 
publications, the word ‘Dutch’ was changed 
into ‘Radboud’ – the institution where the 
instrument was developed. The addition 
‘Dutch’ would suggest that the assessment 
is language-specific, which is not the case, 
as the assessment can easily be translated 
into another language. When developing 
the RDA, we explicitly chose to focus on 
both the type and severity of dysarthria, 
similar to the FDA-2. However, in contrast 
to the FDA-2, we aimed at an instrument 
to assess only speech function, using two 
speech (spontaneous speech and reading) 
and four speech-like tasks (maximum 
repetition rate, maximum phonation time, 
maximum phonation volume and funda-
mental frequency range). A description of 
these speech-like maximum performance 
tests can be found in Chapter 5. In the next 
paragraph, the choices we made for the use 
of four maximum performance tasks in our 
clinical dysarthria assessment will be dis-
cussed. Thereafter, the focus will be on the 
importance of both dysarthria severity and 
type classification.
The importance of using maximum 
performance tests
There is a lot of discussion about the im-
portance of maximum performance tests 
in clinical dysarthria assessment. There are 
authors who call those tasks ‘non-speech’, 
because in maximum performance tests an 
acoustic signal is produced without a com-
municative goal.42 Kent defined speech as 
‘movements or movement plans that pro-
duce as their end result acoustic patterns 
that accord with the phonetic structure of a 
language’.109 In for example /pataka/, a pho-
netic-acoustic pattern is produced, howev-
er, the fact that such patterns are repetitive 
and have no meaning makes them ‘speech-
like’, or ‘quasi-speech’, a term proposed by 
Weismer.161
There are two theories about motor control 
of speech and speech-like or non-speech 
tasks. The first theory adheres to the 
‘task-dependent model’ 42,162 and proposes 
a specialized, distinct motor control system 
dedicated to speech production, indepen-
dent of the control system for non-speech. 
Recently, the research group that proposed 
the task-dependent model, which is the 
same group that developed the BoDys, 
found dissociations between movement 
rates obtained from speech, maximum 
repetition rate, and oral motor tasks in 
130 patients with a variety of neurogenic 
movement disorders, which strengthened 
their belief in the task-dependent model.90 
Therefore, the BoDys only includes speech 
tasks. 
The second theory adheres to an ‘integra-
tive model’ 91 and proposes that speech 
production involves a particular, unique 
combination of skills and properties, some 
of which are shared with other motor be-
haviors, such as those assessed in maximum 
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performance tests. The RDA is based on the 
integrative model, although the basis of the 
RDA is spontaneous speech. There is no 
discussion about the fact that spontaneous 
speech is the most representative task of 
daily communication. However, in order to 
interpret speech characteristics for the dif-
ferential diagnostic goal of dysarthria type 
classification, maximum performance tests 
may be very helpful. For example, a vocal 
tremor can be heard better during the max-
imum phonation duration task than during 
spontaneous speech and patients who tend 
to slow down their speaking rate during 
spontaneous speech can exhibit some 
difficulties (e.g. slow maximum rate or a 
dysrhythmic sequence) during maximum 
repetition rate. 
The importance of dysarthria severity 
classification
All currently used dysarthria assessments 
include severity classification. Scoring 
the severity of dysarthria is important for 
a couple of reasons. First, a severity score 
is helpful to monitor the dysarthria over 
time, for instance, to evaluate progression, 
recovery or treatment effects. Although 
the severity scale of the RDA showed high 
reliability scores, we did not assess its sen-
sitivity to change. Second, a severity score 
is important for treatment focus. Gener-
ally, in the case of a minimal dysarthria, 
patients can be helped satisfactorily with 
subtle adjustments of their speech habits. 
In mild to moderate dysarthria, the therapy 
usually will be more focused on practicing 
speaking techniques, whereas in severe 
dysarthria speech functions are more com-
pensated with augmentative and alternative 
communication strategies (see Part two of 
this general discussion).
The importance of dysarthria type 
classification
Categorizing the different types of dysar-
thria is a clinical challenge, not only be-
cause it is difficult, even for experienced 
SLTs, but also because it remains unsure 
whether defining the type of dysarthria is 
essential for diagnostic and/or treatment 
purposes. These two aspects will be dis-
cussed in more detail. 
Why is categorizing the type of dysarthria 
difficult? There are a couple of reasons: 1) 
speech symptoms within a specific dys-
arthria type may vary in their severity, 2) 
there is considerable overlap in speech 
symptoms among the dysarthria types 
(e.g., imprecise consonants can be pres-
ent in every type of dysarthria), 3) not all 
speakers with the same medical diagnosis 
exhibit exactly the same speech symptoms, 
and 4) patients use compensatory strategies 
for improving their intelligibility, which in-
terferes with the dysarthric characteristics. 
If categorizing the type of dysarthria is 
that difficult, is it essential for diagnostic 
and/or treatment purposes? Labeling the 
type of dysarthria by an expert SLT can be 
helpful for the medical diagnosis, because 
specific speech characteristics may point 
towards the site of the lesion or the under-
lying disease. For example, hypokinesia is 
a key characteristic of Parkinson’s disease 
(PD). However, when besides the hypoki-
netic speech e.g. coordination problems are 
heard, the diagnosis idiopathic PD must be 
reconsidered, because a mixed dysarthria is 
more likely a feature of atypical parkinson-
ism. For this reason, at the Radboud Uni-
versity Medical Center, SLTs are frequently 
consulted to assist in medical diagnosing. 
For treatment purposes, there are also 
important reasons to know the type of dys-
arthria, because some treatments are devel-
oped for a specific type of dysarthria. This 
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will be illustrated more in detail in Part 
two of this discussion. On the other hand, 
some treatment approaches are applicable 
to different types of dysarthria, especially 
compensatory speaking techniques. For 
example, both in ataxic and flaccid dysar-
thria, slowing down the speaking rate can 
be very effective.48 And although the Lee 
Silverman Voice Treatment (LSVT) was 
developed for hypokinetic dysarthria in 
PD, studies show that this treatment may 
also be a successful approach for patients 
with an ataxic, spastic and unilateral upper 
motor neuron dysarthria.163-165 Besides, it 
must be acknowledged that several studies 
have shown that dysarthria type is not a sig-
nificant predictor of the efficacy of specific 
speech therapies.48,166 So, if the treatment 
is purely focused on learning an adequate 
compensatory speaking technique, it could 
be argued that labeling the type of dysar-
thria is not crucial. 
The alternative for characterizing the type 
of dysarthria is to describe dysarthria in 
terms of deviant speech characteristics. 
This is especially emerging in childhood 
dysarthria, because children tend to exhibit 
different speech characteristics than adults, 
probably due to the fact that 1) dysarthria 
in adults is generally caused by an acquired 
disease, whereas in children it is commonly 
due to an early acquired or inherited dis-
ease, 2) in children, the motor control sys-
tem is still developing, whereas in adults it 
is fully developed, and 3) the adaptability of 
a child’s brain is larger than the adaptabil-
ity of the adult brain.167 Because of these 
differences between adults and children 
and the fact that speech tasks may differ 
between adults and children (e.g. the read-
ing text is not suitable for children), the 
pediatric RDA is being developed. 
One example of describing dysarthria in 
terms of deviant speech characteristics is 
the BoDys. However, importantly, if we 
only identify speech characteristics, we still 
don’t know why they occur. We need at least 
a correct interpretation of the speech char-
acteristics. For example, ‘imprecise conso-
nants’ can be due to weakness, spasticity or 
coordination problems. Or hypernasality 
can occur due to weakness or spasticity, 
etc. For those underlying deficits, different 
treatments will be needed. 
How to train dysarthria type classification?
If we want to improve the diagnostic skills 
of SLTs (including SLT students) or other 
clinicians, the next question that arises 
is how to train them. We observed in our 
study that SLT students who had never 
seen patients in real life improved by 27% 
after a one-day course, leading to 37% 
agreement with the reference diagnosis 
(Chapter 7). This improvement can proba-
bly be enlarged, because learning modules 
for bachelor SLT students concerning a 
specific disorder like dysarthria are usually 
not restricted to one day. With many more 
video examples and perhaps diagnosing 
real-life patients more improvement is 
feasible. SLTs who watched videos with de-
tailed descriptions, but without additional 
training, testing and monitoring their un-
derstanding, did not improve to acceptable 
levels of agreement. Skill training requires 
consistent feedback, and this can be of-
fered by making the video training part of 
dedicated e-learning modules or by using 
blended learning as an educational method 
(a combination of e-learning and classroom 
methods). Blended learning appears to be 
more effective than non-blended instruc-
tions for knowledge acquisition in health 
professions.168 In the case of dysarthria, 
in which perceptual judgments are given, 
it probably has an added value when the 
subjective perceptions can be discussed in 
a classroom situation instead of only being 
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told which speech characteristics should be 
heard.
The value of objective measurements for 
diagnosing dysarthrias
In the RDA, we explicitly chose to include 
maximum performance tests of speech 
production. When including those tests, 
reference values are indispensable to com-
pare the performance of the patient to the 
healthy population (Chapter 6). However, 
if we want to use the reference values, we 
need to ‘measure’ speech-like performance 
(i.e. maximum repetition rate, maximum 
phonation time, maximum phonation vol-
ume and fundamental frequency range). 
The maximum phonation time is quite 
easy to analyze with a stopwatch and 
maximum phonation volume with a dB 
meter. Fundamental frequency range and 
maximum repetition rate are more elabo-
rate to analyze. Software package ‘Praat’ 116 
can be used for acoustic analysis, but 
this is not commonly used in the average 
SLT practice. The question is: do we need 
acoustic measurements to better diagnose 
dysarthrias? Experienced SLTs should 
be able to recognize non-pathological 
from pathological performance and they 
should be able to at least differentiate be-
tween some types of dysarthria. In 2015, an 
SLT-student from the Radboud University 
acoustically analyzed the dysarthric speech 
of the patients on the training videos of 
the RDA.169 She analyzed speech and ar-
ticulation rate, maximum repetition rate 
and its temporal stability and coefficient 
of variation, fundamental frequency range, 
maximum phonation time, and maximum 
phonation volume. Unfortunately, based 
on those measurements, she was not able 
to classify dysarthria types, but there were 
significant effects of dysarthria severity re-
garding speech rate, articulation rate, and 
maximum repetition rate. Recently, new 
attempts were made to acoustically qualify 
different types of dysarthria. One study with 
hypokinetic (n = 23) and ataxic (n = 9) dys-
arthrias showed that in ataxic dysarthria an 
increased spatial variability of sound pres-
sure level occurs in comparison to hypo-
kinetic dysarthria.20 In addition, Boutsen 
et al. used an acoustic multidimensional 
prosody index (AMPI) for classification.170 
Spastic and ataxic dysarthrias showed lon-
ger vowel durations, whereas hypokinetic 
and flaccid dysarthrias showed a higher 
pitch. In short, it seems that we cannot rely 
on acoustic measurements alone to qualify 
dysarthria types, but some easy measure-
ments may be helpful to distinguish at 
least pathological from non-pathological 
performances and to evaluate progression, 
recovery, or treatment effects. 
In conclusion, with the development and 
publication of the RDA (NDO-V), Dutch 
and Flemish SLTs have the opportunity to 
use a standardized and validated dysarthria 
assessment, which is supported by 43 video 
examples. The RDA can be used to classi-
fy the severity and type of dysarthria, but 
determining the correct type of dysarthria 
is still challenging. For this purpose, we 
need better learning modules. Maybe in 
the future computerized techniques based 
on large databases of dysarthric speech can 
help the SLTs by making the correct diag-
nosis.
GENERAL DISCUSSIoN PART TWO
Relevance of dysarthria treatment in NMD
In chapter 2 of this thesis, an overall prev-
alence rate of 56% for dysarthria in NMD 
patients was found, i.e. more than half of 
the patients with NMD will experience 
speech difficulties during the time course of 
their disease. Because communication is an 
essential need in life, dysarthria can direct-
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ly affect communicative effectiveness5,171 
and participation,5,104 as well as quality 
of life.2,3,104,172 In the study of Hartelius 
et al.,104 several very illustrative quotes of 
patients have been published about the 
burden of dysarthria on their lives, perfect-
ly reflecting the difficulties patients deal 
with: “I often need to repeat what I’ve said, 
because people don’t understand me”; “it’s 
difficult to talk in a group of people that I 
don’t know”; “my difficulties in communi-
cating affect my possibilities to actively take 
part in work and studies”; “my difficulties 
in communicating affect my possibilities to 
express my personality in the way I would”; 
“my speech difficulties negatively affect my 
self-image”.
Thus, dysarthria may not only directly 
limit communication, activities and partic-
ipation, but also self-esteem and behavior. 
This huge and multi-facetted impact of dys-
arthria on a person’s quality of life, in com-
bination with the relatively high prevalence 
of dysarthria in NMD, underscores the im-
portance of speech therapy interventions in 
this patient category. In the absence of evi-
dence about treatment options in NMD, we 
will discuss our ideas according to current 
knowledge and personal experience. 
Treatment options in NMD
Dysarthria therapy in NMD is usually not 
aimed at intensive motor training with the 
aim to recover speech functions, such as 
in stroke. This is because NMDs are char-
acterized by progressive muscle weakness 
and gradual worsening of functions over 
time, which makes intensive motor train-
ing less feasible and unlikely to be effective. 
In NMD, therapy should be aimed at 1) 
education and awareness, 2) correction of 
inadequate compensations, and 3) learning 
to apply adequate compensations, either 
speaking techniques or use of augmenta-
tive and alternative communication (AAC) 
strategies. The combination of dysarthria 
severity and disease progression will direct 
the choice for a specific therapy. In slowly 
progressive or minimal to mild dysarthria, 
education, awareness, and corrections or 
small adjustments can be sufficient. In 
moderate dysarthria, therapy will be more 
focused on using compensatory speaking 
techniques, whereas in fast progressive or 
severe dysarthria the therapy is more fo-
cused on compensating speech functions 
with AAC strategies. 
Education and awareness
In the case of dysarthria, education is aimed 
at giving insight in the process of speech 
production, the influence of the current 
disease on speech, and the effect of the 
dysarthria on communication. When the 
patient and his caregivers are aware of the 
consequences of the dysarthria and under-
stand the problems at hand, this may elicit 
goals and solutions by the patient — instead 
of the speech therapist formulating solu-
tions — that will help to increase the pa-
tient’s treatment compliance. Besides, early 
education can prevent the occurrence of 
inadequate compensations. 
Patients are also educated about conditions 
that may optimize speech. For example, 
the influence of posture on speech is ex-
plained, because a good posture can facil-
itate speech, for instance retroflexion of the 
head has a negative influence on the vocal 
quality by increasing laryngeal tension, 
while a flexed posture reduces the breath 
volume. In the case of myotonic dystrophy, 
myotonia may impede starting articulation, 
reduce speech rate or evoke disfluencies. 
Warming-up strategies can decrease those 
problems.47 And in the case of myasthenia 
gravis, speaking can lead to exhaustion, 
which results in an increased flaccid ar-
ticulation and hypernasality. Therefore, 
patients have to be educated about how to 
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prevent unnecessary muscle weakness due 
to relative overuse. If needed, attention for 
these aspects is continued during therapy.
Correction of inadequate compensations 
in NMD
When body functions change, compensa-
tion often occurs unconsciously. This is also 
true for speech: dysarthric patients often 
use compensatory strategies to optimize 
their speech. These compensatory strate-
gies are sometimes adequate (e.g. slow ar-
ticulation rate), but can also be inadequate 
(e.g. a hypertonic vocal use to compensate 
for a poor breath support). During dysar-
thria assessment, compensatory mecha-
nisms get clear, most of the time because of 
speech characteristics that are not expect-
ed to be part of the flaccid dysarthria in 
NMD (i.e. hypertonic vocal use), but also 
because characteristics are not consistently 
heard. For example, the hypertonic vocal 
use is present during spontaneous speech, 
but not during maximum phonation du-
ration. It is important to identify and to 
correct or stop inadequate compensations, 
as they may negatively interfere with the 
dysarthria. The already mentioned hyper-
tonic vocal use can lead to voice problems. 
Patients who want to speak louder may 
demonstrate a quick and shallow breathing 
pattern, causing a chanted performance 
and sometimes even hyperventilation and 
patients with weak neck musculature may 
compensate by resting their head in their 
hands, thereby limiting the articulatory 
movements.
In slowly progressive NMD with minimal 
dysarthria, a single therapy session of one 
hour can be sufficient to perform dysar-
thria assessment, education and correction 
of inadequate compensations. However, 
it should be noted that, although patients 
may understand the problem and react 
positively to the corrections, it is general-
ly difficult to maintain corrected speech 
in daily communicative situations after a 
single therapy session. For these patients, 
some kind of follow-up therapy may be 
needed, which will be discussed in the next 
section. In Box 8.1, an example of the effect 
of a single therapy session is given.
Learning to apply adequate compensations
When dysarthria severity is mild to moder-
ate and disease progression is slow, therapy 
will be aimed at applying compensatory 
speaking techniques to improve intelligi-
bility. Using the RDA for dysarthria assess-
ment (as described in Chapter 5) cannot 
only clarify the most impaired speech 
characteristics, but also the remaining 
capacities. Both these aspects can direct 
treatment focus. 
For NMD, there are no specific therapy 
programs, like for other types of dysar-
thria. However, the techniques used in oth-
er therapy programs can be applicable in 
NMD, but this requires detailed assessment 
of the characteristics of the dysarthria, 
Box 8.1. Example of the effect of a single therapeutic session.
A 28-year-old woman was diagnosed with a mitochondrial myopathy. During a single therapeutic 
session, she was made aware of her use of a slightly hypertonic voice to compensate beginning 
vocal weakness. In this session, she was educated about the effect of her mitochondrial disease 
on her voice and, after correction, she experienced that the release of the tension lowered her 
voice and resulted in a better vocal quality. She was immediately able to apply this modification 
in daily life and, therefore, a follow-up session was not deemed necessary. She was instructed, 
however, to contact the SLT in the case of questions or when her voice would deteriorate.
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knowledge about neurological and physi-
cal aspects of the specific disease, and also 
skills to determine and deal with cognitive, 
behavioral, motivational, energetic and 
emotional characteristics of the patient. As 
a consequence, treatment of dysarthria in 
NMD patients is typically tailor-made and 
sometimes even based on trial and error. 
The large number of NMD and the diver-
sity of the characteristics of the diseases in 
combination with patient-related speech 
performance and personality makes that 
treatments will be practice-based or con-
text-based, rather than evidence-based. 
For most NMD, an SLT will have to find, 
together with the patient, a balance be-
tween residual capacities and participation 
in communicative daily situations (social, 
occupational or digital). In patients with 
severe dysarthria or anarthria, AAC strat-
egies may be necessary to ensure such par-
ticipation.
Techniques used in existing therapy 
programs
First, two well-known training programs 
for hypokinetic dysarthria in PD are the 
Pitch Limiting Voice Treatment (PLVT)154 
and the Lee Silverman Voice Treatment 
(LSVT).155 Both programs focus on pro-
ducing a loud voice, while the PLVT ad-
ditionally aims at producing a low voice. 
In NMD, a soft voice can be a problem as 
well, however, the PLVT and LSVT are 
both intensive (3–4 times a week, 30 to 60 
minutes, for 4–6 weeks) training programs, 
which are not direct applicable to many 
patients with NMD, especially not when 
respiratory-phonatory impairments are 
present. At some stage, NMD patients can 
be taught to save their energy and produce 
a loud voice when necessary, however, most 
of the time it is too intensive for them to 
persist speaking with a loud voice during 
all conversations.
Second, the intensive therapy program ‘Be 
Clear’ was recently published for patients 
with a non-progressive dysarthria due to 
stroke or traumatic brain injury.173 This 
training program is based on the principles 
of motor learning and is aimed at intensive 
training of (compensatory) speaking tech-
niques (i.e. rate reduction, over-articulation 
and a higher intensity) to improve intelli-
gibility. Because speech therapy in NMD 
should not be aimed at intensive training 
to recover functions, Be Clear is generally 
not suitable for NMD. Still, its individual 
speaking techniques may be applicable. 
As said before, speaking with a higher in-
tensity is most of the time too intensive for 
NMD patients. 
Over-articulation (i.e. speaking with inten-
sified speech movements) is a technique 
that can be used to compensate vocal 
weakness when the articulation is relatively 
preserved. In the case of flaccid articula-
tion, over-articulation may cost too much 
energy. 
Speech rate reduction, however, may be 
easily applicable to NMD. Indeed, studies 
about the value of reducing speech rate 
showed that a wide range of patients might 
benefit.48,174,175 Practically, there are differ-
ent ways to reduce the speaking rate, e.g. 
speaking slower on demand or hand tap-
ping on each word or syllable. 
In NMD, speaking slower on demand is 
probably the most frequently given advise 
by SLTs, however, for many patients this 
technique is not easy to maintain during 
a regular conversation. While other ways 
to reduce the speaking rate may be easier 
to maintain, the fact that they are visible 
(hand tapping) may discourage their use. If 
speech rate reduction has been demonstrat-
ed to have a positive effect on intelligibility, 
the technique should be automated to be 
effective in all communicative situations. 
One way to practice and automate a slower 
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speaking rate is to use the (Dutch) ‘Pros-
odietrainer’ (Figure 8.1).176 An example of 
this approach is given in Box 8.2. 
In severe dysarthria, when patients are 
not able to reach sufficient intelligibility 
with compensatory speaking techniques 
and effective communication becomes a 
problem, AAC strategies should be intro-
duced. Generally, there are not much NMD 
patients who depend on AAC strategies, 
except patients with ALS. AAC includes a 
wide range of strategies, from low-tech ap-
proaches, such as software on a tablet (Fig-
ure 8.2), to high-tech approaches, like an 
eye-tracking system. An SLT should guide 
the clinical decisions and implementation 
regarding AAC to ensure that patients can 
use these strategies in a functional way 
during daily communication. An example 
of the use a voice amplifier (Figure 8.3) is 
given in Box 8.3. 
Principles of motor learning
Optimization and automatization of speak-
ing techniques requires substantial prac-
tice.177 As speech is a complex motor skill, 
principles of motor learning can be applied 
to achieve speaking skills. Motor learning is 
defined as ‘a set of processes associated with 
practice or experience leading to relatively 
permanent changes in the capability for 
movement’.178 Existing therapy programs 
Figure 8.1. The “Prosodietrainer”
Box 8.2. Example of speech rate reduction.
A 39-year-old man with myotonic dystrophy type 1, who lived with his mother, complained about 
frequent unintelligibility, which led to irritations — even between him and his mother. Based on 
a thorough clinical dysarthria assessment, a moderately severe flaccid dysarthria was diagnosed 
with flaccid articulation, hypernasality, and fast speaking rate as key characteristics. Speech rate 
reduction was found to be the most effective compensatory speaking technique, which was con-
firmed by his mother who joined him during his visits at our outpatient clinic. He was motivated 
to improve his intelligibility and, also because computers were his hobby, he started practicing 
with the ‘Prosodietrainer’. Due to some mild cognitive problems, a diary was used to schedule his 
homework. The first month, he visited our outpatient clinic weekly and he practiced every day 
for at least 20 minutes with the ‘Prosodietrainer’. In this stage, the therapy was purely focused 
on learning a slow speaking rate, especially by reading sentences of increasing lengths. The next 
six weeks, he visited our outpatient clinic bi-weekly, while still practicing at home every day for 
at least 20 minutes. This stage of therapy was focused more and more on using the slow speech 
in conversations. It appeared, however, difficult for him to implement this technique in daily life. 
For this reason, a concrete implementation plan (e.g. choose the situations for using the tech-
nique, and how often it should be applied) was made, using his mother as a co-therapist. Yet, 
after four months, the use of slow speech was still not fully automated, perhaps due to the mild 
cognitive dysfunctions. However, he was able to better correct himself and to apply the technique 
more easily, with less misunderstandings and irritations. In addition, he accepted his mother as a 
co-therapist.
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like the PLVT and ‘Be Clear’, but also the 
‘Prosodietrainer’, are based on those princi-
ples. However, when speech therapy is not 
based on a standardized program, the use 
of the principles of motor learning may be 
less explicit or consistent.
Traditionally, speech therapy exercises are 
based on tasks in a blocked schedule (e.g. 
practice the same consonant) based on 
constant practice variability (e.g. practice 
the consonant in the same word position). 
However, there is evidence regarding motor 
speech disorders that variable practice (e.g. 
practice of a consonant in different word 
positions), random practice (e.g. practice 
different consonants in one session), and 
complex targets (difficult sounds and sound 
sequences) can increase the effectiveness of 
motor speech therapy.177 As for feedback, 
traditionally, the focus is on the kinematics 
(‘knowledge of performance feedback’), 
e.g. placement of articulators. There is, 
however, evidence that feedback focused 
on ‘knowledge of result’ (whether the 
sound is correct) produces greater transfer 
of learned skills. Besides, low frequency 
feedback (after a couple of attempts) seems 
to be more effective than high frequency 
feedback, as is feedback provided with a 
delay compared to immediate feedback. 
Finally, there should be an increase in task 
complexity (reading, picture description, 
conversational speech) during the training 
period.177 
An important prerequisite for learning 
speaking techniques, or for motor learning 
Box 8.3. Example of the use of a voice amplifier.
A 39-year-old man suffered from Duchenne muscular dystrophy, used mouthpiece ventilation due 
to a restricted pulmonary function. Therefore, he could not increase the loudness of his voice. He 
loved going to social events and festivals with his friends, but speaking with environmental noise 
was almost impossible. Also during transport in his van — while he was sitting in the back — the 
driver had difficulties to understand him. During a diagnostic therapy session, a voice amplifier 
was shown and tested. After he, his parents, and the speech-language therapist agreed on the 
effectiveness of the voice amplifier, a system was installed on his wheelchair. Everybody was very 
pleased with the final result.
Figure 8.2. AAC software. Figure 8.3. A voice amplifier.
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in general, is that patients have to be moti-
vated and be able to learn. Motivational in-
terviewing techniques can be very valuable 
to formulate learning goals and to elicit 
behavioral change.179
GENERAL DISCUSSIoN PART THREE
Relevance of treatment of dysphagia in 
NMD
In Chapter 2, we demonstrated a high prev-
alence rate of dysphagia in a heterogeneous 
population of NMD patients. Dysphagia 
can have a wide range of consequences. 
First, dysphagia can lead to reduced oral 
intake of food and liquid causing malnutri-
tion and weight loss, which may jeopardize 
physical health. Second, limitations in oral 
intake may directly affect quality of life as 
eating and drinking are important social 
activities.180-182 Third, aspiration of liquid 
or food due to dysphagia combined with a 
reduced ability to cough may cause aspira-
tion pneumonia and even death in the end 
stage of some NMD, for example myotonic 
dystrophy,26,183 inclusion body myositis 
(IBM),65,184 mitochondrial disease,185 and 
Duchenne muscular dystrophy.186 Finally, 
although nowadays rather rare, the most life 
threatening medical emergency is choking, 
i.e. the blockage of air passage into the lungs 
by food.187 All these aspects underscore the 
relevance of dysphagia treatment in NMD, 
and with that the important role of an SLT 
in an interdisciplinary team treating these 
patients.
Treatment options in NMD
Like dysarthria therapy, dysphagia therapy 
in NMD is not focused on intensive mo-
tor training, but rather on education and 
awareness, correction of inadequate com-
pensations, and learning to compensate 
more effectively. Treatment approaches are 
disease-specific, requiring knowledge of 
neurological and other physical aspects of 
the particular disease. In addition, cogni-
tive, behavioral, and emotional character-
istics of the patient have to be taken into 
account.
Education and awareness
In dysphagia therapy, education is aimed at 
explaining the normal swallowing process 
and the influence of a specific disease on 
this process to help the patient and care-
givers to properly understand the problem, 
and to generate awareness of the swallow-
ing function and problems that may occur.
Correction of inadequate compensations
When swallowing is difficult, inadequate 
compensations may become apparent, 
for instance when patients compensate 
pharyngeal transport problems with head 
Box 8.4. Example of a single therapy session in dysphagia therapy.
A 54-year-old woman with facioscapulohumeral muscular dystrophy (FSHD) experienced the ten-
dency of bread getting stuck in her throat. During a single therapy session, it was obvious that her 
body and head position were negatively influenced by weakness of the neck-shoulder region. She 
was educated about the effect of her head and body position on swallowing and these were both 
corrected. Despite the weakness, maintaining the head position was possible for the duration of 
a normal meal. During the session, she experienced that her altered position had a positive effect 
on the pharyngeal transport. After two weeks, a telephone call was made to evaluate the effect of 
the learned adaptation. She was able to maintain a good head position during eating and experi-
enced no complaints anymore. It was agreed upon that she would contact the speech-language 
therapist whenever she would experience any progression of her swallowing complaints. 
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movements like pushing the head forwards 
or by tilting the head backwards (retroflex-
ion of the head). In normal swallowing, it 
has been shown that the head position is an 
important factor and that retroflexion of the 
head may compromise effective swallow-
ing.68-70 In NMD, weak musculature of the 
trunk or neck-shoulder region is frequently 
present, which may lead to an adaptation 
of head and body position. This adaptation 
can have a negative influence on swallow-
ing, in particular, laryngeal elevation. In 
addition, ptosis may be present in NMD, 
which can have a negative effect on head 
position, and thereby on swallowing as well 
(Chapter 4).46 In minimal dysphagia, it is 
possible that a single therapy session of one 
hour, aimed at education, awareness and 
correction of inadequate compensations is 
sufficient, which is illustrated in Box 8.4.
Learning adequate compensations
Dysphagia in NMD is predominantly de-
termined by muscle weakness (Chapter 1), 
causing deterioration of chewing and swal-
lowing: orofacial weakness causes poor 
bolus formation and/or weak mastication, 
and pharyngeal weakness can result in 
pharyngeal residue. In order to reduce 
pharyngeal residue, swallowing techniques 
can be applied that focus on effortful swal-
lowing.73 In an effortful swallow, the pos-
terior tongue base movement is increased 
to facilitate bolus clearance. The patient is 
instructed to swallow hard and squeeze the 
bolus down his throat. In NMD, this tech-
nique can be too intensive, but an effective 
swallow with good attention to the volun-
tary oral phase (bolus control and bolus 
transport) is possible. Other behavior tech-
niques, e.g. consistently swallowing a bolus 
twice (double-swallow) or drinking during 
or after a meal, may reduce pharyngeal res-
idue as well. 
In addition, a few disease-specific remarks 
can be made. First, the Mendelsohn ma-
neuver, which is focused on a voluntary 
prolongation of hyolaryngeal elevation at 
the peak of swallowing, has proven to be 
effective in a population of patients with 
IBM.65 This is a clinically relevant approach, 
as patients maintained their oral intake 
without weight loss during a follow-up 
period of one to five years. Second, not all 
NMD patients tolerate the continuous use 
of swallowing techniques that require high 
levels of muscle strength. For example, my-
asthenia gravis is characterized by excessive 
exercise intolerance and effortful training 
causes fatigue also in mitochondrial myop-
athies.188 In the case of exercise intolerance, 
patients should avoid to continuously use 
maximal muscle strength, but they can still 
be taught to make an effective swallow.189 
If patients are advised to use a specific 
swallowing technique, it is important to 
evaluate if the technique is effective and 
adequately applied in daily life. Adequate 
follow-up is always important to prevent 
non-compliance.190 An example of a short 
rehabilitation process is given in Box 8.5.
When swallowing techniques are not effec-
tive anymore, adjustment of food consis-
tencies becomes necessary in NMD. This 
is particularly relevant when pharyngeal 
residues exist. In fact, food getting stuck in 
the throat is the most frequently mentioned 
complaint by patients with NMD,11,18,191 
whereas most of them do not experience 
problems with fluids. This can be explained 
by the fact that swallowing fluids takes less 
effort than swallowing solid food, as mus-
cle activity required to structurally displace 
the hyoid bone, tongue base and pharynge-
al wall in every swallow depends on bolus 
size and consistency.192 In the case of pha-
ryngeal weakness, the solidity of the food 
is associated with more pharyngeal residue. 
Thus, softening the food is an effective way 
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to reduce pharyngeal residue193 and can 
help to increase the ease of a full oral intake 
without exhaustion.194,195 Besides the effect 
on pharyngeal residue, adjustment of food 
consistencies can also have a positive effect 
in the case of orofacial weakness, because 
soft food is easier to chew.
When swallowing consistently leads to as-
piration or when a full oral intake cannot 
be maintained (e.g. because it is too inten-
sive or it takes too long to eat enough), tube 
feeding is warranted. In particular, PEG 
(i.e. percutaneous endoscopic gastrostomy) 
tube feeding can reduce respiratory infec-
tions and result in weight gain.196,197 Tube 
feeding does not automatically imply that 
oral intake is prohibited. If some consis-
tencies are still safe to swallow, patients can 
maintain such oral intake. This can be very 
important for the quality of life.
fINAL REmARkS
Interdisciplinary treatment
Preferably, dysarthria and dysphagia treat-
ment are part of an interdisciplinary reha-
bilitation approach, since the SLT is rarely 
the only professional involved. The interdis-
ciplinary team will vary dependent on the 
problems of the individual patient. Because 
rehabilitation teams can be very large, we 
will highlight the caregivers that are most 
commonly involved in the rehabilitation of 
patients with NMD. A physician is involved 
for coordination and to medically optimize 
the physical health of the patient, which 
is a prerequisite for speech therapy. For 
example, some diseases, like myasthenia 
gravis and dermatomyositis, may respond 
positively to pharmacological therapy. An-
other medical intervention is dilatation or 
myotomy of the upper esophageal sphinc-
ter (UES) when videofluoroscopy demon-
strates  cricopharyngeal dysfunctioning 
in, for example, patients with OPMD and 
IBM.25,65,198-200 This procedure requires the 
selection of appropriate patients, as not all 
NMD patients will benefit from a myoto-
my, because pharyngeal constriction and 
hyolaryngeal excursion is required to open 
the UES in order to get the food from the 
pharynx into the esophagus. If there is no 
propulsion of the bolus in the pharynge-
al stage, the bolus might get stuck in the 
pharynx, even when the cricopharyngeal 
muscle is surgically ‘opened’. 
Box 8.5. Example of a short rehabilitation process.
A 56-year-old man with auto-immune myositis suffered from recurrent pneumonias. The 
pulmonologist wondered if there was a relationship between his pneumonias and aspiration. 
During the diagnostic process by the speech-language therapist, the patient initially said that he 
had no swallowing problems, but after several swallowing tests he became more aware of the fact 
that he indeed experienced swallowing problems sometimes. He was educated about the effect 
of the myositis on his swallowing and went home with the homework to observe his swallowing 
problems in daily life. One week later, he returned to the outpatient clinic and listed the food that 
was difficult for him and the problems he experienced with solid food due to pharyngeal residue. 
While eating bread, the speech-language therapist found out that an effortful swallow almost 
immediately resulted in a more effective swallow. In the case of pharyngeal residue, drinking 
water was effective to clear the pharynx. Thus, the patient was advised to use these swallowing 
techniques at home. One week later, he returned and had practiced intensively with very good 
experiences, which motivated him to maintain using the techniques. If nevertheless he forgot to 
do so, in the case of food getting stuck in his throat, he was immediately able to correct himself. 
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Working together with a dietician is im-
portant, in particular when food consis-
tencies have to be adjusted. Patients should 
not lose weight and their awareness of 
nutritious food is important. A physical 
therapist can assist in finding an adequate 
posture that can be maintained during 
meals or to optimize physical endurance 
to facilitate training. An occupational ther-
apist can train patients in applying energy 
conservation strategies to alleviate fatigue, 
which can create optimal conditions for 
speech therapy. Besides, an occupational 
therapist can supply adjusted cutlery. If 
necessary, a psychologist is involved in the 
case of acceptance problems.
The influence of external and personal 
characteristics
Until now, we discussed speech and swal-
lowing therapy with the ultimate aim to 
improve the individual level of activity and 
participation.21 Importantly, the influence 
of environmental and personal charac-
teristics on the effect of speech-language 
therapy is indispensable: how large is the 
patient’s need to communicate or eat; is 
he motivated to change his behavior; is he 
physically able to practice; are there cog-
nitive impairments that need to be taken 
into account; is a caregiver available as a 
co-therapist, etc? It is important to realize 
that the level considered to be acceptable 
may differ between patients. This will be 
particularly dependent on personal and 
socio-economical aspects, and requires 
individual evaluation together with the 
patient and his caregivers. For example, a 
salesman will probably suffer more from 
a mild dysarthria than a technician. The 
lack of a strong relationship between the 
observed level of functioning by the SLT 
and patient burden (see Chapter 5) em-
phasizes the value of a personalized reha-
bilitation approach adapted to the patient’s 
needs. Overall, treatment of dysarthria and 
dysphagia in patients with NMD should 
be focused on education and awareness, 
correction of inadequate compensations, 
and learning adequate compensation 
techniques. Interventions should be per-
sonalized, taking multiple (disease-related, 
external and personal) characteristics into 
account.
Future perspectives
In our outpatient clinic, a lot of NMD pa-
tients undergo a single diagnostic session 
of one hour during which assessment and 
education are important goals, which is 
sometimes accompanied by learning ef-
fective compensations. We know from a 
previous study28 and from patient-related 
outcome measures (PROMs) that patients 
highly appreciate these single sessions, but 
we do not know exactly what their effects 
are in individual patients. Which patients 
are able to change their behavior after one 
session and what is an optimal follow-up 
period?
The shortage of studies on interventions 
to alleviate or compensate dysarthria and 
dysphagia in NMD is undoubtedly due to 
the heterogeneity of these disorders, each 
with a low incidence, and due to differenc-
es in therapeutic approaches. Our review 
showed that about half of the patients with 
NMD have problems with speech and 
swallowing, so we presented several treat-
ment options, but mainly based on clinical 
experience. In order to study the value of 
these approaches, there first needs to be a 
certain level of (inter-)national consensus 
among experienced SLTs, which requires 
both qualitative research and longitudinal 
studies. Only when there is general agree-
ment about treatment options and the best 
timing of delivery, clinical trials become an 
obvious next step, using multiple centers 
to be able to include an adequate sample 
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size. However, it should be noted that even 
generally accepted treatment approaches 
in speech and swallow therapy call for per-
sonalized healthcare: interventions have to 
be tailor-made, based on the patient’s pre-
dicted response, and taking into account 
individual characteristics, like cognitive 
and emotional functions. 
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NEDERLANDSE SAmENVATTING 
(SUmmARY IN DUTCH)
Spreken is uniek voor de mens. Ondanks 
de huidige rol van sociale media, blijft de 
dagelijkse communicatie sterk afhankelijk 
van gesproken taal, oftewel spraak. Een 
spraakprobleem kan daarom een enorme 
invloed hebben op het dagelijks leven. 
Gestoorde spraak door een neurologische 
aandoening wordt een dysartrie genoemd. 
Een dysartrie kan veroorzaakt worden door 
(sub-)acute aandoeningen van het centrale 
zenuwstelsel (bijvoorbeeld een hersen-
infarct), chronische neurodegeneratieve 
ziekten van de hersenen (bijvoorbeeld de 
ziekte van Parkinson) of neuromusculaire 
aandoeningen (bijvoorbeeld spierziekten). 
In Deel I van dit proefschrift wordt, naast 
dysartrie, ook aandacht geschonken aan 
dysfagie, dat wil zeggen slikstoornissen, 
omdat deze vaak samen voorkomen. Beide 
aandoeningen worden tenslotte veroor-
zaakt door oraalmotorische problemen 
in overlappende spiergroepen, alhoewel 
de aansturing verschillend is (slikken is 
grotendeels een reflexmatig proces, terwijl 
spraak doelbewust is). 
Zoals in hoofdstuk 1 — de inleiding — is 
weergegeven, zijn voor dit proefschrift drie 
doelstellingen gedefinieerd: 1) het onder-
zoeken van de prevalentie van dysartrie en 
dysfagie in patiënten met neuromusculaire 
aandoeningen (NMA), 2) het zoeken naar 
evidentie voor de behandeling van dysartrie 
en dysfagie in NMA, en 3) het ontwikkelen 
en klinimetrisch evalueren van een gestan-
daardiseerde beoordeling van dysartrie bij 
volwassenen.
Deel I
In Deel I van dit proefschrift worden de 
prevalenties van dysartrie en dysfagie in 
NMA gepresenteerd, evenals de evidentie 
zoals gerapporteerd in de medische litera-
tuur voor de behandeling van dysartrie en 
dysfagie in NMA (doelen 1 en 2).
Hoofdstuk 2 beschrijft het frequent vóór-
komen van dysartrie en dysfagie in een 
grote, heterogene groep (n = 220) patiën-
ten met een NMA. Per patiëntengroep zijn 
gepoolde prevalenties berekend door een 
weegfactor toe te kennen aan de ziekteca-
tegorie (spierziekten, aandoeningen van de 
neuromusculaire overgang, neuropathie-
en en voorhoornaandoeningen) op basis 
van het aantal patiënten in die categorie, 
aangezien de patiëntengroepen niet gelijk 
verdeeld waren. De prevalenties werden 
bepaald in zowel een ongeselecteerd cohort 
van poliklinische patiënten, dat wil zeggen 
een serie opeenvolgende patiënten die een 
poliklinisch logopedisch onderzoek kreeg, 
en een geselecteerd cohort, namelijk pa-
tiënten die specifiek het neuromusculair 
expertise en consultatiecentrum van het 
Radboudumc bezochten. De gepoolde 
prevalentie van dysartrie is 46% in het 
ongeselecteerd cohort en 62% in het gese-
lecteerde cohort, terwijl voor dysfagie de 
getallen 36% en 58% bedragen. Er blijkt een 
matig, maar significant, verband tussen 
de aanwezigheid van een dysartrie en een 
dysfagie (rs = 0,40; p <0,01). Over het al-
gemeen is de ernst van de dysfagie in deze 
populatie licht, de dysartrie varieert meer 
en is matig ernstig tot ernstig in 15% van de 
gevallen. De meest opvallende uitkomst is 
dat dysartrie en dysfagie kunnen voorko-
men in NMA waarbij je deze niet direct 
verwacht, zoals metabole myopathieën en 
de NMA die in de ziektecategorie ‘overige 
myopathieën’ zijn ondergebracht (bijvoor-
beeld nemaline myopathieën). Het feit dat 
dysartrie en dysfagie veel voorkomen in 
patiënten met verschillende typen NMA, 
geeft aan dat het noodzakelijk is dat artsen 
kennis hebben van — en aandacht beste-
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den aan — deze stoornissen, ongeacht het 
type NMA. Ondanks dat logopedie niet bij 
iedere patiënt met een progressieve ziekte 
zal kunnen leiden tot een betere verstaan-
baarheid of slikfunctie, kunnen individueel 
bepaalde functionele compensaties vaak 
toch een positief effect hebben.
In hoofdstuk 3 wordt de prevalentie van 
dysfagie onderzocht in een specifieke 
neurologische aandoening, namelijk in 
myotone dystrofie type 2 (DM2). Dysfagie 
is een bekend kenmerk van myotone dys-
trofie type 1, waarbij het zelfs levensbedrei-
gend kan zijn. Het is echter nog nooit on-
derzocht in welke mate dysfagie voorkomt 
in DM2. DM2 patiënten die geselecteerd 
werden omdat zij slikproblemen hadden 
gerapporteerd op een vragenlijst naar 
gastrointestinale problemen, zijn gevraagd 
te participeren in deze studie (n = 10). 
Deze proefpersonen zijn klinisch onder-
zocht door een logopedist gespecialiseerd 
in NMA. Daarnaast hebben 8 patiënten 
toestemming gegeven voor een flexibele 
endoscopische evaluatie van het slikken 
(FEES). Een dysfagie werd bevestigd in 
alle patiënten (klinisch in 100%, 88% met 
FEES) en blijkt meer uitgesproken aanwe-
zig in oudere DM2 patiënten. De ernst van 
de dysfagie is over het algemeen licht en er 
zijn geen patiënten die een aspiratiepneu-
monie hebben doorgemaakt of waarbij er 
sprake is van ernstig gewichtsverlies.
In hoofdstuk 4 is het wetenschappelijk 
bewijs gezocht voor het effect van logope-
dische interventies in volwassen NMA-pa-
tiënten door middel van een systematische 
review. Hierbij zijn uitsluitend zgn. ‘peer 
reviewed’ artikelen geïncludeerd die ge-
schreven zijn in Engels, Duits, Frans of 
Nederlands. De uitkomstmaten moesten 
betrekking hebben op: 1) informatie en 
advies gericht op voedingsaanpassingen, 
ondersteunde communicatie en educatie 
gericht op de patiënt of zijn naaste, en 2) 
compensatiestrategieën gericht op slikken 
of spraakverstaanbaarheid. Casestudies 
werden geëxcludeerd. De zoekopdracht in 
de literatuur resulteerde in 1772 artikelen, 
maar slechts vier voldeden aan de kwalitei-
ten zoals omschreven in de inclusiecriteria. 
De methodologische kwaliteit van slechts 
één ongecontroleerde pre-post studie bleek 
voldoende. Deze studie onderzocht het 
effect van een ptosis op het slikken in pa-
tiënten met oculofaryngeale spierdystrofie 
(OPMD).46 Deze studie liet zien dat  wan-
neer het hoofd licht voorover gebogen was, 
en dus niet aangepast aan de ptosis, er een 
positief effect werd gevonden op de slikeffi-
ciëntie (niveau III evidentie). De conclusie 
van dit review is dat er slechts zeer beperkte 
gerapporteerde evidentie is voor het effect 
van logopedische interventies in volwassen 
NMA-patiënten.
Deel II
Deel II van dit proefschrift is gericht op de 
ontwikkeling van het Nederlandstalig Dy-
sartrieonderzoek – volwassenen (Radboud 
Dysarthria Assessment [RDA] in het En-
gels), inclusief referentiewaarden voor de 
maximale prestatietaken (doel 3).
Hoofdstuk 5 beschrijft de ontwikkeling en 
validatie van het RDA. In 2007 werd een 
eerste versie van het (ongevalideerde) RDA 
gratis online beschikbaar gesteld, maar 
de behoefte bestond om het onderzoek te 
verbeteren en te valideren. De eerste stap 
was het verkrijgen van nationale consensus 
over de taken en het onderzoeksformulier. 
Als tweede stap werd een vragenlijst over 
de spraak toegevoegd voor de patiënt. In de 
derde stap werden het onderzoeksformu-
lier, de ernstschaal en de vragenlijst klini-
metrisch geëvalueerd. En tot slot werden 
er trainingsvideo’s toegevoegd, waarop alle 
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typen dysartrie in verschillende ernstmaten 
gedemonstreerd werden. Bij de trainingsvi-
deo’s is een ingevuld onderzoeksformulier 
toegevoegd om zelfscholing mogelijk te 
maken. Een exploratieve factoranalyse van 
het onderzoeksformulier identificeerde 
vier factoren (articulatie, resonans, fonatie 
en respiratie/prosodie) die samen een ver-
klaarde variantie van 70,3% hadden. Elke 
individuele factor had een goede interne 
consistentie. De vragenlijst bleek een zeer 
goede interne consistentie te hebben en de 
intra-class correlatiecoëfficiënten van de 
ernstschaal toonden een goede betrouw-
baarheid van de schaal. De ernstscore van 
de dysartrie en de score op de vragenlijst 
correleerden aanzienlijk tot sterk met de 
Spraak Handicap Index (SHI) en aanzien-
lijk met het Nederlandstalig spraakver-
staanbaarheidsonderzoek op zinsniveau 
(NSVO-Z). Gebaseerd op deze resultaten 
kan gesteld worden dat het RDA een valide 
en betrouwbaar onderzoeksinstrument is 
voor het diagnosticeren van de ernst van 
de dysartrie. Nader onderzoek moet aan-
tonen of het gebruik van het RDA ook het 
diagnosticeren van het type dysartrie in de 
dagelijkse praktijk kan vergemakkelijken.
Hoofdstuk 6 beschrijft een studie naar de 
referentiewaarden van verschillende maxi-
male prestatietaken van de spraak. Een gro-
te groep (n = 224) gezonde Nederlandstali-
ge volwassenen tussen 18 en 80 jaar hebben 
de volgende maximale prestatietaken uitge-
voerd: maximale repetitiesnelheid (MRS), 
maximale fonatieduur (MFD), maximaal 
melodisch bereik (MMB) en maximaal dy-
namisch bereik (MDB). In eerste instantie 
is een univariate analyse gebruikt om te 
onderzoeken of er verbanden zijn tussen 
iedere maximale prestatietaak afzonderlijk 
en de persoonsgegevens (leeftijd, geslacht, 
lengte, beroep en rookgedrag). Vervolgens 
is met de data waarbij persoonsgegevens 
een significante invloed hadden op de be-
treffende taak (p < 0,05), een multivariate 
lineaire regressieanalyse uitgevoerd om 
de bijdrage van de individuele invloeden 
te bestuderen. Verschillende statistische 
modellen zijn toegepast op elke individuele 
maximale prestatietaak, en met behulp van 
de Likelihood Ratio is getest welk model 
het best passend model is. MRS, MMB en 
MDB zijn statistisch significant gerelateerd 
aan leeftijd. MFD is gerelateerd aan lengte. 
Kortom, leeftijd is in drie van de vier taken 
de meest bepalende factor, in het bijzon-
der in personen ouder dan 60 jaar. Het is 
onduidelijk welk onderliggend mechanis-
me verantwoordelijk is voor het verval na 
60-jarige leeftijd jaar. Naast zowel neuro-
logische, metabole, hormonale en fysieke 
veranderingen zou ook stijfheid van bind-
weefsel een rol kunnen spelen. Er moet 
worden opgemerkt dat de prestaties binnen 
de gezonde populatie ver uiteenlopen, iets 
wat de interpretatie van de individuele dy-
sartrische spreker moeilijk maakt.
In hoofdstuk 7 is onderzocht of het gebruik 
van de trainingsvideo’s van het RDA het di-
agnosticeren van het type en de ernst van de 
dysartrie kan verbeteren in zowel ervaren 
logopedisten als logopediestudenten. De 
studenten kregen een eendaagse training 
gericht op het diagnosticeren van het type 
en de ernst van de dysartrie, waarbij gebruik 
werd gemaakt van de trainingsvideo’s. Eén 
week voorafgaande aan de training en 10 
dagen na de training werden de studenten 
gevraagd om van dezelfde 10 testvideo’s het 
type en de ernst van de dysartrie te scoren. 
De logopedisten kregen toegang tot 20 on-
line beschikbaar gestelde trainingsvideo’s 
en tot achtergrondinformatie over de ver-
schillende typen dysartrie. De logopedisten 
kregen drie weken tijd om de onlinetrai-
ning te volgen, waarbij het aantal uren wat 
zij eraan besteedden, registreerden. Vlak 
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voor en na de training beoordeelden zij 
eveneens 10 testvideo’s. Alle scores van de 
logopedisten en studenten zijn vergeleken 
met een ‘referentiediagnose’ die gesteld was 
op basis van de consensus van zeven er-
varen experts. Studenten verbeteren door 
de training van 29,2% naar 37,2% overeen-
komst met de consensus over het type dy-
sartrie, terwijl logopedisten van 42,8 naar 
46,9% verbeterden. Met betrekking tot de 
ernst van de dysartrie, verbeteren studen-
ten van 47,9% naar 52,5% en logopedisten 
van 53,2% naar 54,7%. Er is geen significan-
te correlatie tussen het percentage overeen-
stemming met de referentiediagnose en 
het aantal uren zelfstudie in logopedisten, 
evenmin als tussen de overeenstemming en 
het aantal jaren ervaring. Beide trainings-
programma’s leiden niet tot een acceptabel 
niveau van overeenstemming met de re-
ferentiediagnose. Om dit te bereiken, zijn 
wellicht meer intensieve of andere vormen 
van training noodzakelijk.
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APPENDIx 1  LEkENSAmENVATTING
Spraak is onmisbaar in het dagelijks leven, 
of je nu gezellig praat met vrienden, iemand 
telefonisch te woord moet staan of moet on-
derhandelen over de aankoop van een auto. 
Voor mensen met een dysartrie is dit alle-
maal niet zo vanzelfsprekend. Een dysartrie 
is een stoornis van de spraak (dat is iets 
anders dan een taalstoornis) ten gevolge 
van een neurologisch letsel — bijvoorbeeld 
een beroerte, de ziekte van Parkinson of 
een spierziekte. Afhankelijk van de plaats 
van het neurologisch letsel (bijvoorbeeld 
de kleine hersenen of de hersenzenuwen), 
kan een dysartrie op een bepaalde manier 
klinken. Er zijn zeven typen dysartrieën 
te onderscheiden, elk met een specifiek 
hoofdkenmerk: zwakte (slappe dysartrie), 
teveel spierspanning (spastische dysartrie), 
een coördinatiestoornis (atactische dy-
sartrie), te weinig bewegingen (hypokineti-
sche dysartrie), teveel bewegingen (hyper-
kinetische dysartrie), mengbeelden en een 
dysartrie na een beroerte (unilateraal upper 
motor neuron dysartrie). Omdat spraak zo 
belangrijk is in het dagelijks leven, heeft 
een dysartrie een grote invloed op deelna-
me aan de samenleving en de kwaliteit van 
leven. Patiënten maken dit duidelijk, door 
opmerkingen zoals “ik moet vaak herhalen 
wat ik heb gezegd, dat is vervelend”, “ik vind 
het moeilijk om in een groep te praten met 
mensen die ik niet ken” of “mijn dysartrie 
beïnvloedt mijn zelfbeeld negatief.”
De eerste aanzet tot het onderzoek dat 
in dit proefschrift wordt beschreven was 
de gewaarwording dat bij patiënten met 
een spierziekte die het Neuromusculair 
Expertise en Consultatiecentrum van het 
Radboudumc bezochten een dysartrie veel 
vaker voor bleek te komen dan op basis van 
de literatuur verwacht mocht worden
Om dit beter in kaart te brengen, zijn we 
gaan registreren hoe vaak een dysartrie 
voorkwam bij patiënten, bij welk soort 
spierziekte dit dan was en hoe ernstig de 
dysartrie was. Dit wordt beschreven hoofd-
stuk 2 van dit proefschrift. We vonden in 
een groep van 220 patiënten dat er in ruim 
de helft van de gevallen (56%) sprake was 
van een dysartrie. Opvallend was dat een 
dysartrie ook voorkwam bij spierziekten 
waarbij het niet direct verwacht werd of 
waarbij het nog niet eerder was beschreven 
in de literatuur. Er werd ook gekeken naar 
het voorkomen van een slikstoornis (dysfa-
gie). Een dysartrie komt regelmatig samen 
voor met een dysfagie, omdat het dezelfde 
spiergroepen betreft. Een groot verschil is 
echter dat slikken grotendeels reflexmatig 
is, terwijl spraak bewust wordt aange-
stuurd. Bij de 220 patiënten kwam in 47% 
van de gevallen een dysfagie voor. In 38% 
van de patiënten kwamen een dysartrie en 
dysfagie samen voor.
In hoofdstuk 3 hebben we het voorkomen 
van dysfagie in kaart gebracht bij patiënten 
met een specifieke spierziekte, myotone 
dystrofie type 2 (MD2). Een dysfagie is een 
bekend symptoom van myotone dystro-
fie type 1 (MD1), maar het was nog nooit 
onderzocht of het ook voorkwam in MD2. 
Het verschil tussen MD1 en MD2 is dat de 
klachten bij MD2 over het algemeen wat 
milder zijn dan bij MD1 en dat bij MD2 
vooral sprake is van klachten rondom de 
nek, schouders en heupen, in tegenstelling 
tot de onderarmen en onderbenen bij MD1. 
In een groep van 29 MD2-patiënten gaf 41% 
aan moeite te hebben met het doorslikken 
van vaste voeding. Deze patiënten werden 
nader onderzocht door een logopedist 
en een KNO-arts die een FEES (flexibele 
endoscopische evaluatie van het slikken) 
uitvoerde. De slikklachten konden in 100% 
worden bevestigd door de logopedist en in 
88% door de FEES. De slikproblemen wa-
ren relatief licht en kwamen vooral bij de 
oudere patiënten voor. 
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Omdat een dysartrie en dysfagie een grote 
impact op het dagelijks leven kunnen heb-
ben, hebben we in hoofdstuk 4 het weten-
schappelijk bewijs in de medische literatuur 
samengevat hoe je een dysartrie en dysfagie 
logopedisch zou moeten behandelen. Dit 
bewijs blijkt er echter nagenoeg niet te zijn, 
omdat er weinig onderzoek is gedaan of 
onderzoeken van onvoldoende kwaliteit 
zijn. Er was slechts één studie van voldoen-
de kwaliteit, die aantoonde dat mensen met 
oculofaryngeale spierdystrofie (OPMD) 
geleerd moeten worden om te slikken met 
de kin naar de borst, terwijl deze mensen 
juist de neiging hebben om het hoofd naar 
achteren te kantelen om onder hun han-
gende oogleden (een belangrijk symptoom 
van de ziekte) door te kijken.
Om een dysfagie te kunnen vaststellen bij 
een patiënt, zijn naast het luisteren naar de 
klacht (anamnese) en het klinisch logope-
disch onderzoek enkele instrumentele on-
derzoeken mogelijk, bijvoorbeeld een FEES 
of een röntgenslikvideo. Voor het diagnos-
ticeren van een dysartrie zijn er echter voor 
de klinische praktijk geen andere mogelijk-
heden dan gebruikmaken van het mense-
lijk gehoor. De logopedist neem bepaalde 
spraakkenmerken waar, die vervolgens 
geïnterpreteerd moet worden. Omdat er 
in Nederland geen goed gestandaardiseerd 
dysartrieonderzoek beschikbaar was, heb-
ben we er één ontwikkeld: het Nederlands-
talig Dysartrieonderzoek — volwassenen 
(NDO-V), zoals beschreven in hoofdstuk 5 
van dit proefschrift. Een dergelijk dysartrie-
onderzoek is niet alleen belangrijk om te 
kunnen beoordelen van welk type dysartrie 
er sprake is en hoe ernstig deze dysartrie 
is, maar ook als aanknopingspunt voor een 
passende behandeling.
Bij de ontwikkeling van het NDO-V werden 
in meerdere discussieronden de meningen 
gevraagd van een groep logopedisten in 
Nederland en Vlaanderen over de bruik-
baarheid van verschillende spreektaken en 
over de termen die gebruikt worden om af-
wijkende spraakkenmerken te beschrijven. 
Het uiteindelijke instrument bestaat uit een 
handleiding, een beoordelingsformulier, 
een ernstschaal, een korte vragenlijst voor 
de patiënt, een standaard leestekst, 43 vi-
deo’s van patiënten met verschillende typen 
dysartrie en 5 spreektaken die uitgevoerd 
moeten worden (spontaan spreken; hardop 
lezen; zo snel mogelijk lettergrepen herha-
len zoals bijvoorbeeld pa, ta en ka; zo hard 
mogelijk roepen; zo hoog en zo laag moge-
lijk stemgeven en zo lang mogelijk een ‘aa’ 
aanhouden). De verschillende onderdelen 
zijn getoetst en het blijkt dat het NDO-V 
een geschikt onderzoek is, waarvan de ver-
schillende onderdelen meten wat ze horen 
te meten (oftewel valide zijn), de vragenlijst 
en het beoordelingsformulier goed zijn 
samengesteld en er op een betrouwbare 
manier een ernstscore aan de dysartrie kan 
worden gegeven. Het bepalen van het type 
dysartrie blijkt echter niet eenvoudig.
Om de prestatie van patiënten met een 
dysartrie te kunnen vergelijken met gezon-
de personen, zijn de spreektaken ook afge-
nomen bij 224 gezonde personen. Op deze 
manier werden normaalwaarden voor de 
taken bepaald, zoals beschreven in hoofd-
stuk 6. 
Tot slot is gekeken of studenten van de op-
leiding logopedie en ervaren logopedisten 
het type dysartrie beter kunnen beoordelen 
wanneer zij geschoold zijn met de video’s 
die horen bij het NDO-V, zoals beschreven 
in hoofdstuk 7. Bij de studenten die een dag 
lang werden geschoold met de video’s was 
het leereffect groter dan bij logopedisten 
die aan zelfscholing deden met behulp van 
dezelfde video’s. Omdat uiteindelijk de log-
opedisten maar in 50% van de gevallen tot 
het juiste type dysartrie kwamen, zal ver-
volgonderzoek zich (ook) moeten richten 
op alternatieve manieren van scholing.
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APPENDIx 2  DANkwooRD
Persoonlijk sla ik een proefschrift altijd 
open bij het dankwoord, omdat je in het 
dankwoord de persoonlijkheid van de 
auteur iets beter leert kennen. De meeste 
mensen weten van mij dat ik op schrift al-
tijd kort en krachtig ben. Dat is dan ook de 
stijl van dit dankwoord. 
Alle patiënten die aan de totstandkoming 
van de afzonderlijke artikelen hebben bij-
gedragen, verdienen het als eerste enorm 
bedankt te worden. Bij deze! 
Vervolgens komt veel dank toe aan de per-
sonen zonder wie ik dit proefschrift niet tot 
een goed einde had kunnen brengen. 
Prof. Geurts, beste Sander, de gesprekken 
met jou waren altijd erg inspirerend, waar-
door ik na elk gesprek weer zin had om met 
de nieuwe ideeën of inzichten aan de slag 
te gaan. Ik vond het erg waardevol dat we 
spraakmotoriek konden bediscussiëren in 
het kader van de algehele motoriek. Maar 
het meest heb ik geleerd van jouw schrijf-
stijl: daar waar ik vastliep in lastige zinnen, 
wist jij altijd met een jaloersmakende een-
voud de boodschap weer te geven.
Prof. van Engelen, beste Baziel, jij was voor-
al betrokken bij Deel I van dit proefschrift. 
Jij kunt als de beste associëren en filosofe-
ren, waardoor er tijdens de overlegmomen-
ten vaak nieuwe kanten belicht werden. 
Het mooie aan jou is dat je je altijd afvraagt 
‘wat levert het de patiënt of de zorgverlener 
op’, waardoor we altijd dichtbij de klinische 
praktijk bleven.
Dr. de Swart, beste Bert, wij kennen elkaar 
al erg lang. Bij jou is (bijna) alles mogelijk 
en dat bleek ook tijdens dit proces. Ik waar-
deer het enorm dat jij destijds hebt geaccep-
teerd dat ik wachtte op een promotietraject 
waar mijn hart lag. Waarschijnlijk is juist 
hierdoor het proces zonder ernstige diep-
tepunten verlopen. (Of ben ik echt gewoon 
zo’n nuchtere Zeeuw?) Ik heb heel veel van 
je geleerd en hoop de komende jaren ook 
nog veel van je te leren.
Dr. Kalf, beste Hanneke, jij bent onmis-
baar geweest bij de totstandkoming van 
dit boekje. Jij bent enorm gedreven, maar 
hebt het ook geaccepteerd dat ik dit binnen 
de mogelijkheden van het runnen van een 
jong gezin deed. Daarnaast ben je uiterma-
te correct in schrijven, waarvan ik heel veel 
heb geleerd. Onder het mom ‘het wordt er 
alleen maar beter van’ zijn er heel wat ver-
sies heen en weer gemaild, maar nu zet ik er 
toch echt een punt achter!
Ik dank de manuscriptcommissie voor het 
kritisch doorlezen van het manuscript en 
goedkeuren ervan.
Alle medeauteurs van de afzonderlijke 
artikelen dank ik hartelijk, met in het bij-
zonder dr. Jan Hendriks voor de statistische 
ondersteuning. 
Een goede werksfeer verhoogt het werk-
plezier! Al mijn geweldige collega’s (naast 
Bert en Hanneke) hebben het proces van 
heel dichtbij kunnen aanschouwen (alfa-
betisch): Irma, Frieda, Anne, Puck, Em-
melien, Rosemarie, Renée, Jacintha, Judith, 
Kim, Pauline en Janneke. Een hele hoop 
persoonlijkheden bij elkaar, maar wat kun-
nen we goed samenwerken! We slagen er al 
jaren in om de patiëntenzorg op een zeer 
hoog niveau te houden. Naast hard werken 
kunnen we gelukkig ook heel hard lachen 
samen. Jullie hebben mij zoveel mogelijk 
uit de wind gehouden wanneer dat nodig 
was. Ik kan me geen betere collega’s voor-
stellen!
Alle collega’s van ‘de kinderkant’: Marjo, 
Lenie, Leenke, Karen, Sandra, Marloes en 
Sanne: we hebben elkaar de laatste jaren 
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(tot mijn grote vreugde) steeds meer weten 
te vinden, omdat kleine kinderen nou een-
maal groot worden. De discussies over ver-
schillen tussen kinderen en volwassenen 
waren zeer waardevol en ik weet dan ook 
zeker dat het NDO-K een prachtig product 
gaat worden. 
Ook dank ik mijn lieve paranimfen Heidi 
en Janneke (sorry Allan en Edith ;-)). 
Heidi, wij leerden elkaar kennen op winter-
sport toen we allebei nog (heel) jong waren. 
Wat je op vakantie oppikt aan vrienden of 
liefdes is niet altijd een lang leven bescho-
ren, maar dat is bij ons gelukkig anders. Ik 
ben jaren geleden jouw getuige geweest, jij 
nu de mijne! 
Janneke, jij was aanvankelijk mijn partner 
in crime, maar bent een iets andere weg in-
geslagen. Je bent in staat je hart te volgen en 
dat bewonder ik enorm aan je. Je bent een 
heel fijn mens en ik vind het geweldig dat jij 
vandaag naast mij staat! 
Ook een heel speciaal woord van dank voor 
de projectgroep van het NDO-V: Harry 
Goos, Lotte Kromhout, Judith Kocken, 
Marjo van Gerven, Hanneke Kalf en Bert de 
Swart. We hebben heel wat uren vergaderd 
met cake, koek, chips en chocola. De eer-
lijkheid en openheid die jullie altijd hebben 
gehad, heb ik uitermate gewaardeerd. Ook 
in dit rijtje dank ik Puck Goossens die wat 
later in het proces aansloot toen de koppel-
structuur met de HAN ontstond, evenals 
alle studenten die door PO-opdrachten bij 
verschillende projecten betrokken waren. 
Er zijn veel logopedisten in Nederland en 
Vlaanderen die de moeite hebben genomen 
om mee te denken bij de ontwikkeling van 
het NDO-V. Allen hartelijk bedankt.
Alle leden van het OZO die de afgelopen 
jaren zijn gepasseerd: ik ga jullie niet alle-
maal persoonlijk noemen, omdat ik bang 
ben dat ik iemand vergeet. Ik leek mis-
schien de eeuwige promovendus tussen alle 
fulltime onderzoekers, maar hierbij heb 
ik het tegendeel bewezen! Dank dat jullie 
altijd bereid waren om mee te denken over 
logopedische dilemma’s.
Lieve vrienden en vriendinnen, ik gooi 
jullie bij deze (bijna) allemaal op één hoop. 
Tijdens dit proces is er heel wat gegeten, ge-
borreld, gelachen, gehuild, geshopt, gefeest, 
gereisd enz. enz. Ik ben blij met jullie alle-
maal! De enige vriendin die ik in het bij-
zonder wil noemen is Marieke Vloet. Jij liet 
je door het onderwerp inspireren om het 
beeld te maken voor op de omslag van dit 
proefschrift. Het is prachtig geworden en 
heeft het boekje extra bijzonder gemaakt! 
Ik dank de Beachbabes en mijn tennis-
maatjes dat ik dit proces in een goede con-
ditie heb kunnen voltooien. 
Lieve familie en schoonfamilie, dank dat 
jullie altijd interesse hebben getoond en er 
altijd voor ons zijn geweest. Jullie wonen 
helaas allemaal niet zo dichtbij, maar dat 
maakt wel dat we er bij elk bezoek ‘lekker 
tussenuit’ waren – iets wat in een promotie-
traject onmisbaar is.
Lieve Luuk en Saar, jullie zijn mijn grootste 
schatten, bij wie ik (bijna) alle beslomme-
ringen van het werk vergeet. Ik had natuur-
lijk heel wat uren zwembad, voetbalveld en 
dansschool anders kunnen benutten, maar 
ik heb geen moment spijt van het feit dat ik 
er (voor mijn gevoel) altijd voor jullie ben 
geweest. 
Lieve Jasper, je hebt het als basaal onder-
zoeker goed uitgehouden met een klinisch 
onderzoeker in spe. Dat onderwijzersbloed 
in jou kon ik bij tijd en wijle wel drinken, 
maar ik moet toegeven dat het mij tegelij-
kertijd ook vaak heeft geholpen. En zonder 
jou was de lay-out van dit boekje een stuk 
minder fraai geworden. Dank voor alles!
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APPENDIx 3  CURRICULUm VITAE
Simone Knuijt werd geboren in Middelburg op 17 maart 1973. Na het behalen van haar 
HAVO-diploma in 1990 (Christelijke Scholengemeenschap Walcheren, Middelburg) startte 
zij met de studie logopedie aan de Hogeschool van Arnhem en Nijmegen (HAN). Haar 
vierdejaars-stage liep Simone op de afdeling Logopedie van het Radboudumc (destijds 
Academisch Ziekenhuis Nijmegen). Hier werd haar enthousiasme gewekt voor neurologi-
sche spraak-, taal- en slikstoornissen. 
Na haar afstuderen in 1994 kon ze parttime blijven werken in het Radboudumc, naast haar 
studie Spraak-taalpathologie aan de Radboud Universiteit Nijmegen. Deze studie rondde 
zij in 1997 af, waarna zij fulltime aan de slag ging als logopedist in het Radboudumc. De 
eerste kennismaking van Simone met wetenschappelijk onderzoek was het onderzoek naar 
de spraak-taalontwikkeling van ex-premature kinderen. Haar hart bleek echter te liggen bij 
volwassen patiënten met neuromusculaire aandoeningen. 
Simone raakte betrokken bij onderzoek naar de indicatiestelling voor paramedische zorg 
bij neuromusculaire patiënten. Uit dit onderzoek kwamen de eerste artikelen van dit proef-
schrift tot stand. In 2011 werd, in samenwerking met het Lectoraat Neurorevalidatie van 
de HAN, een RAAK-subsidie verworven voor de ontwikkeling van het Nederlandstalig 
Dysartrieonderzoek – volwassenen (NDO-V), zoals beschreven in het tweede deel 
van dit proefschrift. Dit NDO-V wordt sinds 2014 uitgegeven door Bohn Stafleu van 
Loghum en werd in 2015 genomineerd voor zowel een RAAK-award als de Branco van 
Dantzigprijs. Simone werkt nog altijd met veel plezier als logopedist en onderzoeker in het 
Radboudumc.
Simone woont samen met Jasper Visser. Samen hebben zij twee kinderen, Luuk en Saar.
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DoNDERS GRADUATE SCHooL foR CoGNITIVE NEURoSCIENCE
For a successful research Institute, it is vital to train the next generation of young scientists. 
To achieve this goal, the Donders Institute for Brain, Cognition and Behaviour established 
the Donders Graduate School for Cognitive Neuroscience (DGCN), which was officially 
recognised as a national graduate school in 2009. The Graduate School covers training at 
both Master’s and PhD level and provides an excellent educational context fully aligned 
with the research programme of the Donders Institute. 
The school successfully attracts highly talented national and international students in 
biology, physics, psycholinguistics, psychology, behavioral science, medicine and related 
disciplines. Selective admission and assessment centers guarantee the enrolment of the best 
and most motivated students.
The DGCN tracks the career of PhD graduates carefully. More than 50% of PhD alumni 
show a continuation in academia with postdoc positions at top institutes worldwide, e.g. 
Stanford University, University of Oxford, University of Cambridge, UCL London, MPI 
Leipzig, Hanyang University in South Korea, NTNU Norway, University of Illinois, North 
Western University, Northeastern University in Boston, ETH Zürich, University of Vienna 
etc. Positions outside academia spread among the following sectors: specialists in a medical 
environment, mainly in genetics, geriatrics, psychiatry and neurology. Specialists in a psy-
chological environment, e.g. as specialist in neuropsychology, psychological diagnostics or 
therapy. Positions in higher education as coordinators or lecturers. A smaller percentage 
enters business as research consultants, analysts or head of research and development. 
Fewer graduates  stay in a research environment as lab coordinators, technical support 
or policy advisors. Upcoming possibilities are positions in the IT sector and management 
position in pharmaceutical industry. In general, the PhDs graduates almost invariably con-
tinue with high-quality positions that play an important role in our knowledge economy.
For more information on the DGCN as well as past and upcoming defenses please visit:
http://www.ru.nl/donders/graduate-school/phd/.
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